
<html lang="en"     class="pb-page"  data-request-id="67c3112a-3af6-433f-a701-2ffd416d4e35"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm800790t;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2009.52.issue-2;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Structure−Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors" /></meta><meta name="dc.Creator" content="Paul A.  Renhowe" /></meta><meta name="dc.Creator" content="Sabina  Pecchi" /></meta><meta name="dc.Creator" content="Cynthia M.  Shafer" /></meta><meta name="dc.Creator" content="Timothy D.  Machajewski" /></meta><meta name="dc.Creator" content="Elisa M.  Jazan" /></meta><meta name="dc.Creator" content="Clarke  Taylor" /></meta><meta name="dc.Creator" content="William  Antonios-McCrea" /></meta><meta name="dc.Creator" content="Christopher M.  McBride" /></meta><meta name="dc.Creator" content="Kelly  Frazier" /></meta><meta name="dc.Creator" content="Marion  Wiesmann" /></meta><meta name="dc.Creator" content="Gena R.  Lapointe" /></meta><meta name="dc.Creator" content="Paul H.  Feucht" /></meta><meta name="dc.Creator" content="Robert L.  Warne" /></meta><meta name="dc.Creator" content="Carla C.  Heise" /></meta><meta name="dc.Creator" content="Daniel  Menezes" /></meta><meta name="dc.Creator" content="Kimberly  Aardalen" /></meta><meta name="dc.Creator" content="Helen  Ye" /></meta><meta name="dc.Creator" content="Molly  He" /></meta><meta name="dc.Creator" content="Vincent  Le" /></meta><meta name="dc.Creator" content="Jayesh  Vora" /></meta><meta name="dc.Creator" content="Johanna M.  Jansen" /></meta><meta name="dc.Creator" content="Mary Ellen  Wernette-Hammond" /></meta><meta name="dc.Creator" content="Alex L.  Harris" /></meta><meta name="dc.Description" content="The inhibition of key receptor tyrosine kinases (RTKs) that are implicated in tumor vasculature formation and maintenance, as well as tumor progression and metastasis, has been a major focus in onc..." /></meta><meta name="Description" content="The inhibition of key receptor tyrosine kinases (RTKs) that are implicated in tumor vasculature formation and maintenance, as well as tumor progression and metastasis, has been a major focus in onc..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 29, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm800790t" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm800790t" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm800790t" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm800790t" /></link>
        
    
    

<title>Design, Structure−Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm800790t" /></meta><meta property="og:title" content="Design, Structure−Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0001.jpeg" /></meta><meta property="og:description" content=" The inhibition of key receptor tyrosine kinases (RTKs) that are implicated in tumor vasculature formation and maintenance, as well as tumor progression and metastasis, has been a major focus in oncology research over the last several years. Many potent small molecule inhibitors of vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) kinases have been evaluated. More recently, compounds that act through the complex inhibition of multiple kinase targets have been reported and may exhibit improved clinical efficacy. We report herein a series of potent, orally efficacious 4-amino-3-benzimidazol-2-ylhydroquinolin-2-one analogues as inhibitors of VEGF, PDGF, and fibroblast growth factor (FGF) receptor tyrosine kinases. Compounds in this class, such as 5 (TKI258), are reversible ATP-competitive inhibitors of VEGFR-2, FGFR-1, and PDGFRβ with IC50 values &lt;0.1 μM. On the basis of its favorable in vitro and in vivo properties, compound 5 was selected for clinical evaluation and is currently in phase I clinical trials." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm800790t"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm800790t">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm800790t&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm800790t&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm800790t&amp;href=/doi/10.1021/jm800790t" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 278-292</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm800657z" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm800977q" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Structure−Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+A.++Renhowe">Paul A. Renhowe</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sabina++Pecchi">Sabina Pecchi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cynthia+M.++Shafer">Cynthia M. Shafer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+D.++Machajewski">Timothy D. Machajewski</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elisa+M.++Jazan">Elisa M. Jazan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Clarke++Taylor">Clarke Taylor</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William++Antonios-McCrea">William Antonios-McCrea</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+M.++McBride">Christopher M. McBride</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kelly++Frazier">Kelly Frazier</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marion++Wiesmann">Marion Wiesmann</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gena+R.++Lapointe">Gena R. Lapointe</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+H.++Feucht">Paul H. Feucht</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+L.++Warne">Robert L. Warne</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carla+C.++Heise">Carla C. Heise</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Menezes">Daniel Menezes</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly++Aardalen">Kimberly Aardalen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Helen++Ye">Helen Ye</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Molly++He">Molly He</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincent++Le">Vincent Le</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jayesh++Vora">Jayesh Vora</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Johanna+M.++Jansen">Johanna M. Jansen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+Ellen++Wernette-Hammond">Mary Ellen Wernette-Hammond</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alex+L.++Harris">Alex L. Harris</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: +1-510-923-4055. Fax: +1-510-923-3360. E-mail: <a href="/cdn-cgi/l/email-protection#225243574e0c50474c4a4d5547624c4d544350564b510c414d4f"><span class="__cf_email__" data-cfemail="f68697839ad88493989e998193b69899809784829f85d895999b">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm800790t&amp;href=/doi/10.1021%2Fjm800790t" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 278–292</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 29, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 June 2008</li><li><span class="item_label"><b>Published</b> online</span>29 December 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 January 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm800790t" title="DOI URL">https://doi.org/10.1021/jm800790t</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D278%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPaul%2BA.%2BRenhowe%252C%2BSabina%2BPecchi%252C%2BCynthia%2BM.%2BShafer%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D2%26contentID%3Djm800790t%26title%3DDesign%252C%2BStructure%25E2%2588%2592Activity%2BRelationships%2Band%2Bin%2BVivo%2BCharacterization%2Bof%2B4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones%253A%2BA%2BNovel%2BClass%2Bof%2BReceptor%2BTyrosine%2BKinase%2BInhibitors%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D292%26publicationDate%3DJanuary%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm800790t"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6133</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">101</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm800790t" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Structure−Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;A. Renhowe&quot;},{&quot;first_name&quot;:&quot;Sabina&quot;,&quot;last_name&quot;:&quot;Pecchi&quot;},{&quot;first_name&quot;:&quot;Cynthia&quot;,&quot;last_name&quot;:&quot;M. Shafer&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;D. Machajewski&quot;},{&quot;first_name&quot;:&quot;Elisa&quot;,&quot;last_name&quot;:&quot;M. Jazan&quot;},{&quot;first_name&quot;:&quot;Clarke&quot;,&quot;last_name&quot;:&quot;Taylor&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;Antonios-McCrea&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;M. McBride&quot;},{&quot;first_name&quot;:&quot;Kelly&quot;,&quot;last_name&quot;:&quot;Frazier&quot;},{&quot;first_name&quot;:&quot;Marion&quot;,&quot;last_name&quot;:&quot;Wiesmann&quot;},{&quot;first_name&quot;:&quot;Gena&quot;,&quot;last_name&quot;:&quot;R. Lapointe&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;H. Feucht&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;L. Warne&quot;},{&quot;first_name&quot;:&quot;Carla&quot;,&quot;last_name&quot;:&quot;C. Heise&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Menezes&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;Aardalen&quot;},{&quot;first_name&quot;:&quot;Helen&quot;,&quot;last_name&quot;:&quot;Ye&quot;},{&quot;first_name&quot;:&quot;Molly&quot;,&quot;last_name&quot;:&quot;He&quot;},{&quot;first_name&quot;:&quot;Vincent&quot;,&quot;last_name&quot;:&quot;Le&quot;},{&quot;first_name&quot;:&quot;Jayesh&quot;,&quot;last_name&quot;:&quot;Vora&quot;},{&quot;first_name&quot;:&quot;Johanna&quot;,&quot;last_name&quot;:&quot;M. Jansen&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Ellen Wernette-Hammond&quot;},{&quot;first_name&quot;:&quot;Alex&quot;,&quot;last_name&quot;:&quot;L. Harris&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;278-292&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm800790t&quot;},&quot;abstract&quot;:&quot;The inhibition of key receptor tyrosine kinases (RTKs) that are implicated in tumor vasculature formation and maintenance, as well as tumor progression and metastasis, has been a major focus in oncology research over the last several years. Many potent small molecule inhibitors of vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) kinases have been evaluated. More recently, compounds that act through the complex inhibition of multiple kinase targets have been reported and may exhibit improved clinical efficacy. We report herein a series of potent, orally efficacious 4-amino-3-benzimidazol-2-ylhydroquinolin-2-one analogues as inhibitors of VEGF, PDGF, and fibroblast growth factor (FGF) receptor tyrosine kinases. Compounds in this class, such as 5 (TKI258), are reversible ATP-competitive inhibitors of VEGFR-2, FGFR-1, and PDGFRβ with IC50 values &lt;0.1 μM. On the basis of its favorable in vitro and in vivo properties, compound 5 was selected for clinical evalua&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800790t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800790t" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800790t&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800790t" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800790t&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800790t" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm800790t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800790t&amp;href=/doi/10.1021/jm800790t" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm800790t" /></input><a href="/doi/pdf/10.1021/jm800790t" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (506 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm800790t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm800790t%26sid%3Dliteratum%253Aachs%26pmid%3D19113866%26genre%3Darticle%26aulast%3DRenhowe%26date%3D2009%26atitle%3DDesign%252C%2BStructure%25E2%2588%2592Activity%2BRelationships%2Band%2Bin%2BVivo%2BCharacterization%2Bof%2B4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones%253A%2BA%2BNovel%2BClass%2Bof%2BReceptor%2BTyrosine%2BKinase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D2%26spage%3D278%26epage%3D292%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The inhibition of key receptor tyrosine kinases (RTKs) that are implicated in tumor vasculature formation and maintenance, as well as tumor progression and metastasis, has been a major focus in oncology research over the last several years. Many potent small molecule inhibitors of vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) kinases have been evaluated. More recently, compounds that act through the complex inhibition of multiple kinase targets have been reported and may exhibit improved clinical efficacy. We report herein a series of potent, orally efficacious 4-amino-3-benzimidazol-2-ylhydroquinolin-2-one analogues as inhibitors of VEGF, PDGF, and fibroblast growth factor (FGF) receptor tyrosine kinases. Compounds in this class, such as <b>5</b> (TKI258), are reversible ATP-competitive inhibitors of VEGFR-2, FGFR-1, and PDGFRβ with IC<sub>50</sub> values <0.1 μM. On the basis of its favorable in vitro and in vivo properties, compound <b>5</b> was selected for clinical evaluation and is currently in phase I clinical trials.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46411" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46411" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Angiogenesis and maintenance of newly formed blood vessels are important normal physiological processes that are also utilized by tumors to promote their survival, growth, and metastasis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> A subset of growth factors (VEGF<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: RTKs, receptor tyrosine kinases; VEGFR, vascular endothelial growth factor receptor; PDGFR, platelet-derived growth factor receptor; FGFR, fibroblast growth factor receptor; CSF-1R, colony stimulating factor-1 receptor; AML, acute myelogenous leukemia; MDS, myelodysplastic syndrome; RCC, renal cell carcinoma; HTS, high throughput screening; HMVEC, human vascular endothelial cells; VDW, Van Der Waals; CL, plasma clearance; <i>V</i><sub>ss</sub>, volume of distribution; MED, minimum effective dose; CR, complete response; PR, partial response; ITD, internal tandem duplication.</p></div> , FGF, and PDGF) and their receptor tyrosine kinases are key signaling molecules during angiogenesis and vascular maintenance. Not surprisingly, many cancer types secrete these growth factors, which can, in turn, stimulate the surrounding tissues and encourage new blood vessel formation. Among the three growth factors, VEGF is considered most important for both normal and pathological angiogenesis.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In addition, some tumors have been found to overexpress the receptors to VEGF, PDGF, and FGF, which allows them to attain additional growth advantages and promote tumor survival.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> Therefore, direct antitumor effects may be achievable in these tumors if signaling through the receptors is blocked by ATP competitive small molecules that inhibit tyrosine kinase activity. Recent approvals of VEGFR-2 and PDGFRβ inhibiting agents, such as small molecules Sunitinib (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, <b>1</b>, SU11248) and Sorafenib (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, <b>2</b>, BAY43-9006), confirm the attractiveness of targeting these receptors for cancer therapy.<a onclick="showRef(event, 'ref1 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref6">(1, 6)</a> In addition, several multitargeted small molecule kinase inhibitors have been developed and are being evaluated in clinical trials.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> For example, <b>3</b> (ABT-869) is an inhibitor of CSF-1R (colony stimulating factor-1 receptor), PDGFRβ, VEGFR-1, VEGFR-2, and FLT-3 and is in phase I clinical trials for acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In addition, Axitinib (AG-013736, <b>4</b>) is an inhibitor of CSF-1R, VEGFR, and PDGFR and is in phase II clinical studies for solid tumors, including metastatic renal cell carcinoma (RCC).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Multikinase Inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While embarking on an effort to develop RTK inhibitors, we discovered a class of molecules based on a 3-benzimidazol-2-ylhydroquinolin-2-one scaffold (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) that potently inhibit VEGF, FGF, and PDGF receptor kinases with IC<sub>50</sub> values <0.1 μM. These compounds were also found to possess attractive pharmacokinetic characteristics and efficacy in several human tumor xenograft models. Herein, we describe our progress from lead discovery and optimization of this new class of compounds through the selection of a molecule, <b>5</b> (TKI258, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), for clinical development.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. 3-Benzimidazol-2-ylhydroquinolin-2-one Scaffold and <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10882" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10882" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Multiple synthetic routes for the synthesis of the 3-benzimidazol-2-ylhydroquinolin-2-one scaffold were explored before optimal conditions were developed. The initial method involved the reaction of anthranilic acid esters (<b>6a</b> and <b>6b</b>) with methyl malonyl chloride. The products (<b>7a</b> and <b>7b</b>) were then condensed with phenylenediamine at elevated temperatures in the absence of solvent<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> to yield the 4-hydroxy-3-benzimidazol-2-ylhydroquinolin-2-ones (<b>8a</b> and <b>8b</b>)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> in low to moderate yields (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, a). The synthesis of <b>8c</b> started from anthranilonitrile and used the same conditions as for the preparation of <b>8a</b> and <b>8b</b> to yield the 4-<i>amino</i>-3-benzimidazol-2-ylhydroquinolin-2-one <b>8c</b> in poor yield (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, a). The formation of the <i>N</i><sup>1</sup>,<i>N</i><sup>1′</sup>-dimethylated analogue <b>10</b> was achieved by the reaction of <i>N</i>-methylisatoic anhydride <b>9</b> and ethyl 2-(1-methyl)benzimidazol-2-ylacetate in the presence of LHMDS in THF (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, b), while the 4-unsubstituted analogue (<b>12</b>) could be obtained by condensation of 2-aminobenzaldehyde <b>11</b> and ethyl 2-benzimidazol-2-ylacetate under Knoevenagel conditions (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, c).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0004.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of 3-Benzimidazol-2-ylhydroquinolin-2-one Scaffold</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Examples introducing basic amines at C4 were synthesized as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and previously described.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The length of this route and the harsh conditions employed for the removal of the protecting group in the last step made it impractical for compounds bearing a simple NH<sub>2</sub> at C4, in particular when the introduction of substituents on either the A ring or the D ring was required.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0005.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-one Scaffold via the Isatoic Anhydride Route<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LHMDS, THF (b) Tf<sub>2</sub>O, Pyr (c) R′R′′NH<sub>2</sub>, DIEA; (d) triflic acid, HCl, 80 °C.</p></p></figure><div class="NLM_p">A new synthetic route was thus required that was short, amenable to scale up, and tolerant of a variety of functional groups. To this end, the condensation of benzimidazole acetates with anthranilonitriles in the presence of LHMDS in THF was discovered. This reaction resulted in the formation of the desired 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones in good yields (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> was amenable to multigram scale, and was able to accommodate the presence of many diverse functional groups such as free amines, nitriles, and esters on either the benzimidazole acetate or anthranilonitrile. Worth noting is that the position and nature of R<sub>1</sub> affect the yield of the condensation reaction. When R<sub>1</sub> is ortho to the nitrile and is bulkier than H or F, the formation of the quinolinone ring is much less efficient. For example, the yields of compounds <b>5</b> and <b>19a</b>, which are substituted at C5, respectively, with a fluorine and hydrogen were 60 and 50%. Compounds <b>19k</b> and <b>19l</b>, however, which are substituted with a chlorine and methyl at C5, both had significantly lower isolated yields (8%).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0006.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-one Scaffold via the LHMDS Route</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For novel benzimidazoles, the required phenylenediamine could be prepared from commercially available starting materials. For instance, introduction of amino-linked substituents at the 5′ site on the benzimidazole ring was achieved by reaction of 2-nitro-5-fluoroaniline with amines at elevated temperatures to yield the 5-amino-2-nitroanilines <b>21</b> in high yield and purity (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Ether linked moieties were accessed by reaction of 3-amino-4-nitrophenol with alcohols under Mitsunobu conditions (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, b) to give <b>24</b>. Reduction of <b>21</b> or <b>24</b> in the presence of Pd/C and H<sub>2</sub> in EtOH provided the phenylenediamines <b>22</b> and <b>25</b>, which were used immediately to avoid oxidative decomposition (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). The condensation of phenylenediamines with ethyl 3-ethoxy-3-iminopropanoate hydrochloride <b>20</b> in EtOH then provided the requisite benzimidazole acetates in good yield (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, <b>23a</b>−<b>d</b> and <b>26</b>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0007.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Novel Benzimidazole Acetates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>2</sub>NH, Et<sub>3</sub>N, NMP, 90 °C; (b)H<sub>2</sub>, Pd/c, EtOH; (c)EtOH, 80 °C, (d) ROH, PPh<sub>3</sub>, DIAD, THF.</p></p></figure><div class="NLM_p">The benzimidazole acetates were then reacted with anthranilonitriles in the presence of LHMDS to provide the desired 4-amino-3-benzimidazol-2-ylhydroquinoloin-2-ones (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Further modifications could then be carried out as outlined in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. For instance, methyl 2-(4-amino-2-<i>oxo</i>-1,2-dihydroquinolin-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole-5-carboxylate <b>19ad</b> could be converted to the piperazinyl amide <b>19h</b> or the piperazinylmethyl analogue <b>19i</b> under standard conditions (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>, a). Furthermore, acylation of the secondary amine <b>19ah</b> with bromoacetyl chloride, followed by displacement of the bromine with dimethylamine, gave amide <b>19j</b>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0008.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Late Stage Modifications to the 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-one Core<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EtOH, KOH; (b) <i>N</i>-methylpiperazine, EDCI, HOAT, Et<sub>3</sub>N, DMF; (c) DIBAL-H, PhMe; (d) MnO<sub>2</sub>, DMA; (e) <i>N</i>-methylpiperazine, Na(OAc)<sub>3</sub>BH, DMA; (f) bromoacetyl chloride, DMA, Et<sub>3</sub>N; (g) dimethylamine, EtOH.</p></p></figure><div class="NLM_p">A variety of moieties could also be incorporated into the A-ring of the hydroquinolin-2-one either on the anthranilonitrile starting material or on an advanced 4-amino-3-benzimidazol-2-ylhydroquinoloin-2-one intermediate. For instance, amines such as <i>N</i>-methylpiperazine could be introduced into the 5- and 6-positions of the hydroquinolin-2-one by synthesizing the appropriate piperazinyl anthranilonitriles <b>27a</b> and <b>27c</b> according to reported methods (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>, a and c).<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> The introduction of an ether such as <i>N</i>-methylpiperidin-3-yloxy at the 5-position of ring A was achieved by reaction of 3-hydroxy-<i>N</i>-methylpiperidine with 2-amino-6-fluorobenzonitrile in the presence of NaH in NMP at 100 °C (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>, b, <b>27b</b>). These modified anthranilonitriles could be carried forward as described in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Other compounds could be synthesized by a late-stage modification, as in the formation of the amide (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>, reaction d, <b>19t</b>). In this case, 4-aminoisophthalonitrile reacted with ethyl 2-[5-(4-methylpiperazinyl)benzimidazol-2-yl]acetate <b>23b</b> under the standard LHMDS reaction conditions to give the advanced intermediate <b>19ai</b>. The nitrile on the A ring was then hydrolyzed to the carboxylic acid and coupled to benzylamine to give <b>19t</b>.</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0009.jpeg" id="gs6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Ring A Substituted 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-methylpiperazine, DMF, 90°C; (b) H<sub>2</sub>, Pd/C, EtOH; (c) ethyl 2-benzimidazol-2-ylacetate, LHMDS, THF; (d) NaH, NMP, 100°C; (e) <i>N</i>-methylpiperazine, Et<sub>3</sub>N, NMP, 50°C; (f) 23b, LHMDS, THF; (g) NaOH, EtOH, 100°C; (h) benzylamine, EDCI, HOAT, Et<sub>3</sub>N, DMF.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Identification of Lead Scaffold and Structure−Activity Relationships</h3><div class="NLM_p">Compound <b>8a</b>, a commercially available compound, was identified through high throughput screening (HTS) as an inhibitor of VEGFR-2, FGFR-1, and PDGFRβ. While the submicromolar activity and low molecular weight of the molecule led us to consider this a good initial hit, it had undesirable physicochemical properties (e.g., solubility) that required further optimization to yield a drug-like compound. Initially, the key structural features required for potent kinase inhibition needed to be determined. Molecular modeling suggested that the NH in position 1 of the hydroquinolin-2-one, the quinolinone carbonyl and the benzimidazole NH formed a donor−acceptor−donor motif that would bind to the hinge region of the RTKs. To test this hypothesis, we systematically masked the hydrogen bond donors by methylation as in <b>8b</b>, <b>8d</b>, and <b>10</b>. These changes led to significant potency loss against all three RTKs, with the dimethylated analogue <b>10</b> showing no kinase activity up to 25 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Interestingly, monomethylation seemed to affect the kinase selectivity profile as well. Introduction of a methyl on the benzimidazole NH (<b>8d</b>) had a more dramatic effect on VEGFR-2 affinity than removal of the contact from the NH in position 1 of the hydroquinoloin-2-one (<b>8b</b>). The effect is opposite for FGFR-1, which indicates that despite the high homology of the two ATP binding sites, selectivity opportunities still exist that are likely due to small changes in the binding site shape, influencing the accessibility of alternate binding poses of the methylated ligands.</div><div class="NLM_p">Having established the necessity of the donor−acceptor−donor binding motif, the contribution of the C4 hydroxy to the RTK affinity was explored. Removal of the hydroxyl group (<b>12</b>) led to significant loss in biochemical potency against VEGFR-2 and FGFR-1; however, cell-based activity in VEGF-driven proliferation of human vascular endothelial cells (HMVEC) was maintained. Replacing the hydroxyl with an unsubstituted amino group (<b>8c</b>) significantly improved RTK affinity and also led to improved cell potency with an EC<sub>50</sub> of 0.078 μM. The potency decrease observed (NH<sub>2</sub> > OH > H) suggests an important role for a hydrogen bond donating group in the C4 position (<b>8c</b>, <b>8a</b>, and <b>12</b>). This observation is further supported by a 4-fold decrease in potency when a methylamino group (<b>16a</b>) is replaced with a dimethylamino group (<b>16b</b>). However, this loss in RTK affinity is not as dramatic as the loss caused by masking one of the hydrogen bonds in the donor−acceptor−donor motif, which interacts with the hinge region. One hypothesis to explain this more subtle effect is that the hydrogen on the C4 substituent is needed to stabilize the benzimidazole tautomer such that the hydrogen bond donating moiety points toward the hinge and presents the full donor−acceptor−donor motif.</div><div class="NLM_p">Once the basic structural components needed for affinity to our targets of interest were understood, a study of the structure−activity relationship around the periphery of the scaffold was undertaken together with the incorporation of moieties that might impart favorable physicochemical properties. Thus, incorporation of larger substituents on the C4 NH of the hydroquinolin-2-one was explored and found to be tolerated (<b>16a</b>−<b>d</b>). When the substituent carried an additional basic nitrogen, solubility was improved.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> More importantly, it was discovered that this position was useful in modulating the selectivity profile of this class of compounds among the RTKs. For instance, both <b>16c</b> and <b>16d</b> are more potent against PDGFR than VEGFR-1 (3000-fold) and FGFR (>1500-fold), with similar trends seen against other kinases as well. In particular, incorporation of a large basic amine such as an aminoquinuclidine as in <b>16c</b> led to very potent CHK-1 and GSK-3 inhibitors.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> For our RTK inhibitor program, however, the NH<sub>2</sub> group was the optimal substituent at C4 as it avoided inhibition of these additional serine threonine kinases, which could complicate the pharmacological application of these agents. The NH<sub>2</sub> substitution at C4 was thus maintained, and subsequent efforts focused on modifying the A and D rings to attain additional enzymatic affinity and to improve physicochemical properties.</div><div class="NLM_p">Initially, small groups such as methyl were appended to the D ring and were generally tolerated (<b>19a</b>−<b>19b</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The major goal for this series was to improve solubility. In fact, the poor physicochemical properties of the early compounds prevented us from obtaining a meaningful pharmacokinetic profile as a suitable formulation for in vivo dosing could not be found. To this end, a number of solubilizing groups was explored (<b>19c</b>−<b>19j</b>). It was found that C5′ tolerated a variety of substituents including amines (<b>19c</b>−<b>19f</b>), ethers (<b>19g</b>), amides (<b>19h</b> and <b>19j</b>), and methylene extended amines (<b>19i</b>) without significant variations in in vitro potency. Carboxylic acid, ester, and nitrile C5′ substitutions were also tolerated.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Varying the substituent in this position did not affect the selectivity profile, suggesting that this substituent is most likely solvent exposed. A basic amine with a p<i>K</i><sub>a</sub> in the range of 7−9 on the C5′ substituent (as in <b>19d</b>−<b>19j</b>) improved the cellular potency 2-fold.</div><div class="NLM_p">As the C5′ 1-methylpiperazine moiety afforded a potent compound (<b>19d</b>) with adequate solubility and in vivo properties, 1-methylpiperazine was selected as the default D ring substituent for A ring SAR (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Small, electronegative substituents such as fluorine are tolerated at C5 (<b>5</b>), C6 (<b>19n</b>), and C7 (<b>19u</b>) of ring A. However, a fluorine substituent at C8 (<b>19w</b>) as well as difluoro substitution (<b>19x</b> and <b>19y</b>) resulted in a degradation of affinity. Introducing a chlorine (<b>19k</b>) or methyl (<b>19l</b>) at C5 slightly improves affinity, whereas C5-methylamino (<b>19m</b>) retains affinity compared to <b>19d</b>. Incorporation of substituents at C6 such as chlorine (<b>19o</b>) and a primary amine (<b>19p</b>) preserves activity, however, a dimethylamino group at this position (<b>19q</b>) shows a slight drop in affinity with a complete loss of cell-based potency. At C6, some aromatic substituents caused no change in affinity (<b>19s</b> and <b>19t</b>) while others did (<b>19r</b>) depending on the length and flexibility of the linker to the scaffold. In spite of the fact that the biochemical potency for compounds <b>19s</b> and <b>19t</b> is similar to the unsubstituted example (<b>19d</b>), the cell potency loss is significant. This may be a function of a difference in cell permeability and access to the relevant subcellular compartments; however, no data were collected to determine the above parameters.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> At C7, any substituent larger than a fluorine led to significant decrease in potency against all targets (<b>19v</b> and <b>19z</b>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure−Activity Relationships at C4</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0010.gif" alt="" id="gr10" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left" valign="top"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0011.gif" alt="" id="gr11" /></img></td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structure−Activity Relationships Around Ring D</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0012.gif" alt="" id="gr12" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left" valign="top"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0013.gif" alt="" id="gr13" /></img></td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structure−Activity Relationships around Ring A</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0014.gif" alt="" id="gr14" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">R<sup>5</sup></th><th align="center" valign="middle">R<sup>6</sup></th><th align="center" valign="middle">R<sup>7</sup></th><th align="center" valign="middle">R<sup>8</sup></th><th align="center" valign="middle" char=".">VEGFR-2 IC<sub>50</sub> (μM)</th><th align="center" valign="middle" char=".">FGFR-1 IC<sub>50</sub> (μM)</th><th align="center" valign="middle" char=".">PDGFRβ IC<sub>50</sub> (μM)</th><th align="center" valign="middle" char=".">HMVEC EC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>19d</b></td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.042</td><td align="char" valign="top" char=".">0.009</td><td align="char" valign="top" char=".">0.002</td><td align="char" valign="top" char=".">0.019</td></tr><tr valign="top"><td align="left" valign="top"><b>5</b></td><td align="left" valign="top">F</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.065</td><td align="char" valign="top" char=".">0.011</td><td align="char" valign="top" char=".">0.005</td><td align="char" valign="top" char=".">0.013</td></tr><tr valign="top"><td align="left" valign="top"><b>19k</b></td><td align="left" valign="top">Cl</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.014</td><td align="char" valign="top" char=".">0.002</td><td align="char" valign="top" char=".">0.0003</td><td align="char" valign="top" char=".">0.012</td></tr><tr valign="top"><td align="left" valign="top"><b>19l</b></td><td align="left" valign="top">Me</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.012</td><td align="char" valign="top" char=".">0.003</td><td align="char" valign="top" char=".">0.0007</td><td align="char" valign="top" char=".">0.005</td></tr><tr valign="top"><td align="left" valign="top"><b>19m</b></td><td align="left" valign="top">MeNH</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.053</td><td align="char" valign="top" char=".">0.015</td><td align="char" valign="top" char=".">0.002</td><td align="char" valign="top" char=".">0.017</td></tr><tr valign="top"><td align="left" valign="top"><b>19n</b></td><td align="left" valign="top">H</td><td align="left" valign="top">F</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.078</td><td align="char" valign="top" char=".">0.040</td><td align="char" valign="top" char=".">0.001</td><td align="char" valign="top" char=".">0.010</td></tr><tr valign="top"><td align="left" valign="top"><b>19o</b></td><td align="left" valign="top">H</td><td align="left" valign="top">Cl</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.043</td><td align="char" valign="top" char=".">0.024</td><td align="char" valign="top" char=".">0.008</td><td align="char" valign="top" char=".">0.039</td></tr><tr valign="top"><td align="left" valign="top"><b>19p</b></td><td align="left" valign="top">H</td><td align="left" valign="top">NH<sub>2</sub></td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.019</td><td align="char" valign="top" char=".">0.007</td><td align="char" valign="top" char=".">0.007</td><td align="char" valign="top" char=".">0.017</td></tr><tr valign="top"><td align="left" valign="top"><b>19q</b></td><td align="left" valign="top">H</td><td align="left" valign="top">Me<sub>2</sub>N</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.16</td><td align="char" valign="top" char=".">0.083</td><td align="char" valign="top" char=".">0.007</td><td align="char" valign="top" char=".">2</td></tr><tr valign="top"><td align="left" valign="top"><b>19r</b></td><td align="left" valign="top">H</td><td align="left" valign="top">PhC(O)NH</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.98</td><td align="char" valign="top" char=".">0.90</td><td align="char" valign="top" char=".">0.039</td><td align="char" valign="top" char=".">-</td></tr><tr valign="top"><td align="left" valign="top"><b>19s</b></td><td align="left" valign="top">H</td><td align="left" valign="top">BnNH</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.021</td><td align="char" valign="top" char=".">0.008</td><td align="char" valign="top" char=".">0.0006</td><td align="char" valign="top" char=".">1.1</td></tr><tr valign="top"><td align="left" valign="top"><b>19t</b></td><td align="left" valign="top">H</td><td align="left" valign="top">BnNHC(O)</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.050</td><td align="char" valign="top" char=".">0.010</td><td align="char" valign="top" char=".">0.0001</td><td align="char" valign="top" char=".">0.12</td></tr><tr valign="top"><td align="left" valign="top"><b>19u</b></td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">F</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.014</td><td align="char" valign="top" char=".">0.003</td><td align="char" valign="top" char=".">0.0004</td><td align="char" valign="top" char=".">0.034</td></tr><tr valign="top"><td align="left" valign="top"><b>19v</b></td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">MeNH</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">1.0</td><td align="char" valign="top" char=".">0.37</td><td align="char" valign="top" char=".">0.009</td><td align="char" valign="top" char=".">0.27</td></tr><tr valign="top"><td align="left" valign="top"><b>19w</b></td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">F</td><td align="char" valign="top" char=".">0.56</td><td align="char" valign="top" char=".">0.19</td><td align="char" valign="top" char=".">0.014</td><td align="char" valign="top" char=".">0.42</td></tr><tr valign="top"><td align="left" valign="top"><b>19x</b></td><td align="left" valign="top">H</td><td align="left" valign="top">F</td><td align="left" valign="top">F</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.19</td><td align="char" valign="top" char=".">0.11</td><td align="char" valign="top" char=".">0.003</td><td align="char" valign="top" char=".">0.48</td></tr><tr valign="top"><td align="left" valign="top"><b>19y</b></td><td align="left" valign="top">F</td><td align="left" valign="top">H</td><td align="left" valign="top">F</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.13</td><td align="char" valign="top" char=".">0.030</td><td align="char" valign="top" char=".">0.005</td><td align="char" valign="top" char=".">0.080</td></tr><tr valign="top"><td align="left" valign="top"><b>19z</b></td><td align="left" valign="top">H</td><td align="left" valign="top">F</td><td align="left" valign="top">Me<sub>2</sub>N</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">5.3</td><td align="char" valign="top" char=".">1.8</td><td align="char" valign="top" char=".">0.030</td><td align="char" valign="top" char=".">3.3</td></tr></tbody></table></div></div><div class="NLM_p">To finish exploring the SAR of the A ring, a number of solubilizing groups at the C5 and C6 positions were incorporated (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). At C5, groups such as piperazine (<b>19aa</b>) and 1-methylpiperidin-3-ol (<b>19ab</b>) yielded highly potent analogues. The cellular potency for <b>19aa</b> decreased, but for <b>19ab</b>, the cellular potency was retained. Finally, adding a piperazine at C6 (<b>19ac</b>) led to significant loss of affinity for VEGFR-2 and FGFR-1.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Incorporation of Solubilizing Groups on Ring A</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0016.gif" alt="" id="gr15" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left" valign="top"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0015.gif" alt="" id="gr16" /></img></td></tr></tbody></table></div></div><div class="NLM_p">Many of the compounds highlighted in this paper show greater in vitro potency against PDGFRβ than VEGFR-2 or FGFR-1. However, for <b>5</b>, biochemical inhibition of VEGFR-2, FGFR-1, and PDGFRβ translated into comparable EC<sub>50</sub>s for inhibition of VEGFR-2 and PDGFRβ phosphorylation (0.046 and 0.051 μM) and 3-fold less potent inhibition of FGFR-1 phosphorylation in cells (0.166 μM).<a onclick="showRef(event, 'ref10 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref12">(10, 12)</a></div><div class="NLM_p last">The culmination of the medicinal chemistry effort led to the selection of compound <b>5</b> as a candidate for further development. Compound <b>5</b> has high potency not only against VEGFR-2, FGFR-1, and PDGFRβ but also against VEGFR-1/3, FGFR-3, c-Kit, CSF-1R, and FLT-3 enzymes (IC<sub>50</sub> values between 3 and 27 nM), which translates to inhibition of VEGF-, FGF-, SCF-, CSF-, and PDGF-mediated cell proliferation and induction of apoptosis in specific cancer cell lines.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> The antiproliferative effect of <b>5</b> corresponded with reduction of VEGF-mediated KDR/VEGFR-2 and ERK phosphorylation in endothelial cells.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In summary, <b>5</b> inhibits multiple growth factor receptor tyrosine kinases that are important for tumor angiogenesis and tumor growth.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Molecular Modeling</h3><div class="NLM_p">VEGFR-2 binding site models for the 4-amino-3-benzimidazol-2-ylhydroquinolin-2-one based inhibitors described herein were developed using a homology model based on the FGFR-1 crystal structure (PDB access code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FGI">2FGI</a>)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and optimized using the observed SAR as well as crystal structure data for a compound with the same core in CHK-1.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The conformation of the activation loop in the FGFR-1 template has the highly conserved Asp-Phe-Gly (or DFG) motif in the active and so-called “in” conformation in which the phenylalanine packs under helix C and fits in an internal hydrophobic pocket. Inactive kinase structures have been crystallized where the DFG motif adopts a radically different conformation, which perturbs the catalytically active orientation of the activation loop and helix C and moves the phenylalanine of the DFG-motif “out” of its pocket, leaving it available for occupancy by inhibitors.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">The choice for the DFG-in conformation as a template was based on the fact that the current series of inhibitors does not seem to extend far enough into the phosphate binding region to induce the DFG-out conformational shift. It is quite possible that the protein exhibits a conformational equilibrium between DFG-in and DFG-out conformations while bound to these inhibitors,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> but for the purposes of understanding SAR from a structural perspective, the DFG-in conformation seems most appropriate.</div><div class="NLM_p">The model derived for <b>5</b> is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. The interactions with the modeled active site include an optimal set of three hydrogen bonds to the hinge domain (Glu917 and Cys919). The A-ring makes good Van Der Waals (VDW) contacts to the gatekeeper residue, Val916, and is in addition well-positioned to engage in an S−H/π interaction with Cys1045. This is a similar interaction as described for a newly designed FLT-3 kinase inhibitor<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and involves the residue preceding the DFG-motif. Residues engaged in favorable VDW contacts with the ligand are Leu840, Val848 (both in the P-loop and ceiling of the purine pocket), Ala866 (ceiling of the purine pocket), Val 899 (floor of the purine pocket), Phe918 (part of the hinge), Lys920, Gly922 (both in the lower hinge region), and Leu1035 (floor of the purine pocket).</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding site model for compound <b>5</b> in the VEGFR-2 homology model. (a) Cartoon representation of the kinase with residues interacting with the ligand in stick model. (b) Surface representation, with the surface colored by atom type (red = oxygen, blue = nitrogen, yellow = sulfur, gray = carbon/hydrogen). The donor−acceptor−donor motif is shown to interact with the hinge region while the 1-methylpiperazine substituent on C5′ points into solution.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To validate this binding mode model, the SAR described above is evaluated in context of the model. The 7- and 8-positions of the core are in close contact with the gatekeeper residue (Val916), while the 8-position is also in VDW contact with the hinge (Glu917). This snug fit explains why not even F-substitution is allowed at the 8-position, and at the 7-position, nothing bigger than F seems to be tolerated without effecting affinity. The 6-position has a vector pointing into available space, supported by the observation of various high affinity 6-substituted analogues like <b>19t</b>. The C6-vector does point toward the catalytic Lys868, which may be why the rigid C6-piperazine analogue (<b>19ac</b>) has highly reduced affinity. The reduced affinity for the C6-dimethyl-amino compound (<b>19q</b>) is hypothesized to be due to a clash of one of the methyl groups with the Lys868/ Glu885 salt-bridge. The benzyl-amide analogue <b>19t</b> would experience a similar steric clash, but the C═O functionality in the ligand might induce a conformational change in the protein to allow a hydrogen bond between the C═O and the side chain of Lys868. The vector available for substitution on C5 is pointing into the biggest area of available space, which is supported by the good affinity for all 5-substituted analogues. Finally, substituting the C5′ position has little effect on potency or selectivity, which is in agreement with this model where substituents on that position are solvent-exposed and the kinases in our panel are expected to have comparable solvent access from the ATP binding site.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Pharmacokinetic Profile</h3><div class="NLM_p">Once solubility was improved, the attractive pharmacokinetic properties of the scaffold were apparent. The single dose pharmacokinetics of <b>5</b> were studied in mice and rats, and the summary of PK parameters is presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In both species, oral bioavailability was high (>70%). After intravenous injection, <b>5</b> exhibited moderate to high plasma clearance (CL) relative to liver plasma flow, a large volume of distribution (<i>V</i><sub>ss</sub>) and was eliminated with a terminal half-life (<i>t</i><sub>1/2</sub>) of approximately 3 h.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Summary of Plasma Pharmacokinetic Parameters of <b>5</b><a class="ref internalNav" href="#tbl5-fn3" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">species</th><th align="center" valign="middle">dose (mg/kg)</th><th align="center" valign="middle" char=".">%<i>F</i><a class="ref internalNav" href="#tbl5-fn1" aria-label="b">b</a></th><th align="center" valign="middle" char="."><i>C</i><sub>max</sub> (ng/mL)<a class="ref internalNav" href="#tbl5-fn1" aria-label="b">b</a></th><th align="center" valign="middle" char=".">AUC (ng·min/mL)<a class="ref internalNav" href="#tbl5-fn1" aria-label="b">b</a></th><th align="center" valign="middle" char=".">CL (mL/min/kg)<a class="ref internalNav" href="#tbl5-fn2" aria-label="c">c</a></th><th align="center" valign="middle" char="."><i>V</i><sub>ss</sub> (mL/kg)<a class="ref internalNav" href="#tbl5-fn2" aria-label="c">c</a></th><th align="center" valign="middle" char="."><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#tbl5-fn2" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">mouse</td><td align="left" valign="top">5 (IV)/20 (PO)</td><td align="char" valign="top" char=".">77</td><td align="char" valign="top" char=".">670</td><td align="char" valign="top" char=".">360000</td><td align="char" valign="top" char=".">42</td><td align="char" valign="top" char=".">12000</td><td align="char" valign="top" char=".">2.7</td></tr><tr valign="top"><td align="left" valign="top">rat</td><td align="left" valign="top">5 (IV)/20 (PO)</td><td align="char" valign="top" char=".">73</td><td align="char" valign="top" char=".">480</td><td align="char" valign="top" char=".">340000</td><td align="char" valign="top" char=".">43</td><td align="char" valign="top" char=".">13000</td><td align="char" valign="top" char=".">3.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn3"><div class="footnote" id="tbl5-fn3"><sup>a</sup><p class="last">CL, clearance; <i>F</i>, oral bioavailability; <i>t</i><sub>1/2</sub>, half-life; <i>V</i><sub>ss</sub>, volume of distribution.</p></div><div class="footnote" id="tbl5-fn1"><sup>b</sup><p class="last">Determined from the oral data.</p></div><div class="footnote" id="tbl5-fn2"><sup>c</sup><p class="last">Determined from the intravenous data.</p></div></div></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> In Vivo Pharmacology of <b>5</b> in Preclinical Models</h3><div class="NLM_p">Dose−response effects of <b>5</b> were examined for potency in preclinical models of angiogenesis and specific target-driven cancers. The murine Matrigel model of bFGF-induced neovascularization was used to evaluate the effects of <b>5</b> on in vivo angiogenesis. Supplementation with bFGF induces blood vessel formation in Matrigel implants that was quantified by measuring the amount of hemoglobin in Matrigel plugs following removal from animals (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Compound <b>5</b> administered orally at doses from 3 to 300 mg/kg for 8 days demonstrated a dose-dependent inhibition of angiogenesis with a calculated ED<sub>50</sub> of 3 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Substantial antiangiogenic activity with <b>5</b> was observed at 3 mg/kg/d (54%, <i>p</i> = 0.01), indicating potent inhibition of bFGF-driven angiogenesis in vivo.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Treatment with <b>5</b> inhibits angiogenesis in a bFGF-induced Matrigel model in vivo. Matrigel containing bFGF was injected subcutaneously into mice, and <b>5</b> was administrated orally for 8 days (0−200 mg/kg/d). The Matrigel plugs were removed, and hemoglobin concentration was measured (<i>n</i> = 8 mice/group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The efficacy of <b>5</b> was examined in three subcutaneous human xenograft tumor models, KM12L4A (colon), DU145 (prostate), and MV4;11 (AML) (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). In efficacy studies, mice with subcutaneous tumors were randomized at a mean size of 200−500 mm<sup>3</sup>, and treatments of vehicle or <b>5</b> were administered daily by oral gavage. Dose response effects and statistically significant tumor growth inhibition were observed in all three models tested, with disease stabilization and some tumor regressions occurring at 100 mg/kg/d dose level (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). The minimum effective dose (MED) for KM12L4A (expressing VEGFR and PDGFRβ) and DU145 (expressing VEGFR, FGFR, and PDGFRβ) were 10 mg/kg/d and 30 md/kg/d, respectively, and the corresponding calculated ED<sub>50</sub>ʼs were 17 and 23 mg/kg/d, respectively. In comparison, in the MV4;11 xenograft tumor model, driven by FLT-3 ITD mutations, potent tumor growth inhibition was observed at doses of ≥1 mg/kg/d with a MED of 1 mg/kg/d. Pertinently, in this target-driven FLT-3 ITD MV4;11 model, significantly lower ED50s (3 mg/kg/d vs 17−23 mg/kg/d in KM12L4A or DU145) and significantly higher numbers of responses (both CR and PR) were observed at doses ≥10 mg/kg/d.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Efficacy of 5 in Tumor Xenograft Models in Vivo<a class="ref internalNav" href="#tbl6-fn5" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">tumor model (cancer type)</th><th align="center" valign="middle">target RTKs expressed</th><th align="center" valign="middle">TGI<a class="ref internalNav" href="#tbl6-fn1" aria-label="b">b</a> (dose, mg/kg/d; tumor responses<a class="ref internalNav" href="#tbl6-fn2" aria-label="c">c</a>)</th><th align="center" valign="middle" char=".">MED (mg/kg/d)<a class="ref internalNav" href="#tbl6-fn4" aria-label="e">e</a></th><th align="center" valign="middle" char=".">ED<sub>50</sub> (mg/kg/d)<a class="ref internalNav" href="#tbl6-fn3" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">KM12L4A (colon)</td><td align="left" valign="top">VEGFR</td><td align="left" valign="top">44% (10; 0 CR/PR)</td><td align="char" valign="top" char=".">10</td><td align="char" valign="top" char=".">17</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">PDGFRβ</td><td align="left" valign="top">55% (30; 0 CR/PR)</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top">95% (100; 1CR, 3PR)</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top">DU145 (prostate)</td><td align="left" valign="top">VEGFR</td><td align="left" valign="top">39% (10; 0 CR/PR)</td><td align="char" valign="top" char=".">30</td><td align="char" valign="top" char=".">23</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">PDGFRβ</td><td align="left" valign="top">70% (30; 0 CR/PR)</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">FGFR</td><td align="left" valign="top">86% (100; 1PR)</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top">MV4;11 (AML)</td><td align="left" valign="top">FLT-3 ITD</td><td align="left" valign="top">23% (1; 0 CR/PR)</td><td align="char" valign="top" char=".">1</td><td align="char" valign="top" char=".">3</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">VEGFR</td><td align="left" valign="top">65% (5; 0 CR/PR)</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">cKIT</td><td align="left" valign="top">92% (10; 1CR, 5PR)</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">PDGFRβ</td><td align="left" valign="top">96% (30; 1CR; 8PR)</td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char="."> </td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">FGFR</td><td align="left" valign="top"> </td><td align="char" valign="top" char="."> </td><td align="char" valign="top" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn5"><div class="footnote" id="tbl6-fn5"><sup>a</sup><p class="last">Subcutaneous KM12L4A, HCT-116, DU145, or MV4;11 tumors in nude or SCID-NOD mice (size of 200−500 mm<sup>3</sup>, 10/group) were treated with daily oral administration of either vehicle or <b>5</b>. RTK, receptor tyrosine kinase; ITD, internal tandem duplication.</p></div><div class="footnote" id="tbl6-fn1"><sup>b</sup><p class="last">Tumor growth inhibition (TGI) was calculated as [1 − (mean tumor volume of treated group/mean tumor volume of control group) × 100], when mean of vehicle tumors were ∼1000−2000 mm<sup>3</sup>, KM12L4A (day 9); DU145 (day 22); MV4;11 (day 15).</p></div><div class="footnote" id="tbl6-fn2"><sup>c</sup><p class="last">Tumor responses were defined as either complete (no measurable tumor; CR), or partial (50−99% tumor volume reduction; PR) compared to tumor volume for each animal at treatment initiation.</p></div><div class="footnote" id="tbl6-fn3"><sup>d</sup><p class="last">MED = minimum effective dose; lowest dose that is statistically different vs vehicle treatment.</p></div><div class="footnote" id="tbl6-fn4"><sup>e</sup><p class="last">ED<sub>50</sub> = dose of test agent producing 50% TGI.</p></div></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, the 4-amino-3-benzimidazol-2-ylhydroquinolin-2-one series represents a novel scaffold with multikinase affinity. These compounds inhibit RTKs such as VEGFR-2, FGFR-1, PDGFRβ, and FLT-3, possess good pharmacokinetic and pharmacological characteristics, and are well tolerated. They may find application in the treatment of solid and hematological malignancies, acting not only as antiangiogenic agents but also affecting tumors in which the above pathways are deregulated and contribute to tumorigenesis. Among all compounds surveyed, <b>5</b> was selected to advance to development, based on its favorable in vitro potency, drug-like properties, and attractive pharmacological and toxicological profiles. Compound <b>5</b> is currently in phase I clinical trials.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56037" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56037" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Chemistry</h3><div class="NLM_p"><sup>1</sup>H and <sup>13</sup>C NMR spectra of all compounds were recorded at 300 and 75 MHz, respectively. <sup>1</sup>H shifts are referenced to the residual protonated solvent signal (δ 2.50 for DMSO-<i>d</i><sub>6</sub>), and <sup>13</sup>C shifts are referenced to the deuterated solvent signal (δ 39.5 for DMSO-<i>d</i><sub>6</sub>). <sup>13</sup>C multiplicities were deduced from DEPT or APT experiments. Mass spectrometric analysis was performed on one of two LCMS instruments: a Waters system (Alliance HT HPLC and a Micromass ZQ mass spectrometer; column: Eclipse XDB-C18, 2.1 mm × 50 mm; solvent system: 5−95% acetonitrile in water with 0.1% TFA; flow rate: 0.8 mL/min; molecular weight range: 150−850; cone voltage: 20 V; column temperature 40 °C) or a Hewlett-Packard system (Series 1100 HPLC; column: Eclipse XDB-C18, 2.1 mm × 50 mm; solvent system: 5−95% acetonitrile in water with 0.1% TFA; flow rate: 0.8 mL/min; molecular weight range: 150−850; cone voltage: 50 V; column temperature 30 °C). All masses were reported as those of the protonated parent ions.</div><div class="NLM_p">The following compounds were commercially available: 2-aminobenzonitrile (Aldrich), 2-amino-5-chlorobenzonitrile (Aldrich), 2-amino-5-fluorobenzonitrile (Aldrich), 2-amino-6-chlorobenzonitrile (Alfa Aesar), 2,5-diaminobenzonitrile (Apin), 2-amino-6-methylbenzonitrile (Fluka), <b>8a</b> and <b>8b</b> (Aurora Screening Library). The synthesis of 2-amino-5-(dimethylamino)benzonitrile,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> 2-amino-4-fluorobenzonitrile,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> have previously been described. <sup>1</sup>H and <sup>13</sup>C NMR spectra of the 4-amino-3-benzymidazol-2-yl hydroquinolinones were recorded on the hydrochloride salts, except for <b>12</b>, which was recorded as the free base and <b>5</b>, which was recorded as the sulfate salt. Elemental analyses were performed on free base.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 4-Hydroxy-1-methyl-3-(1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)quinolin-2(1<i>H</i>)-one (<b>10</b>)</h4><div class="NLM_p last">To a solution of ethyl 2-(1-methyl)-benzimidazol-2-ylacetate (122 mg, 0.56 mmol, 1.0 equiv) in a mixture of anhydrous THF at −78 °C under an atmosphere of nitrogen was added LHMDS (1 M in THF, 0.85 mL, 1.5 equiv). After 1 h, a solution of 1-methylbenzo[<i>d</i>]1,3-oxazaperhydroine-2,4-dione 9 (100 mg, 0.56 mmol, 1.0 equiv) in anhydrous THF was added dropwise, and the resulting mixture was allowed to warm to room temperature and stirred overnight. The reaction was then quenched with NH<sub>4</sub>Cl (aq, sat.), and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4×). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo, and the resulting crude material was purified by column chromatography on silica gel to afford 10 (30 mg, 20% yield) as an off-white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 8.16 (1 H, dd, <i>J</i> = 7.8, 1.5 Hz), 7.96 (1 H, m), 7.81 (1 H, m), 7.73 (1 H, m), 7.57 (3H, m), 7.30 (1 H, dd, <i>J</i> = 8.1, 7.2 Hz), 3.85 (3 H, s), 3.60 (3 H, s). LCMS (<i>m</i>/<i>z</i>) 306 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.95 min.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 3-Benzimidazol-2-ylhydroquinolin-2-one (<b>12</b>)</h4><div class="NLM_p last">2-Aminobenzaldehyde <b>11</b> (180 mg, 1.47 mmol, 1.0 equiv) and ethyl 2-benzimidazol-2-ylacetate (300 mg, 1.47 mmol, 1.0 equiv) were dissolved in EtOH (6 mL). Piperidine (0.150 mL, 129 mg, 1.47 mmol, 1.0 equiv) was added, and the solution was heated at 70 °C overnight. A precipitate formed, which was filtered. The solid was washed with EtOH and dried to obtain <b>12</b> (300 mg, 78% yield) as bright-yellow needles. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 12.65 (1 H, s, NH), 12.47 (1 H, s, NH), 9.11 (1 H, s), 7.95 (1 H, d, <i>J</i> = 7.8 Hz), 7.70 (2 H, bs), 7.61 (1 H, dd, <i>J</i> = 8.1, 7.2 Hz), 7.44 (1 H, d, <i>J</i> = 8.1 Hz), 7.27 (1 H, dd, <i>J</i> = 7.8, 7.2 Hz), 7.20 (2 H, m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 160.8, 147.7, 142.8, 138.1, 138.7, 134.4, 131.6, 129.0, 122.6, 122.1 (2 Cs), 120.0, 119.1, 118.3, 115.2, 112.8. LCMS (<i>m</i>/<i>z</i>) 262.2 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.88 min. HRMS found <i>m</i>/<i>z</i> 262.0974; C<sub>16</sub>H<sub>12</sub>N<sub>3</sub>O requires 262.0981. Anal. calcd for C<sub>16</sub> H<sub>11</sub>N<sub>3</sub>O: C 73.55 H 4.24, N 16.08; found: C 70.79, H 3.95, N 15.28.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 4-amino-3-(1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)quinolin-2(1<i>H</i>)-one (<b>8c</b>)</h4><div class="NLM_p last">To 2-aminobenzenecarbonitrile <b>6c</b> (0.1 g, 0.85 mmol, 1.0 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added sequentially Et<sub>3</sub>N (0.36 mL, 2.55 mmol, 3.0 equiv) and methyl malonylchloride (0.11 mL, 1.02 mmol, 1.2 equiv). The reaction was stirred at room temperature for 30 min, upon which starting materials had been consumed as monitored by LCMS. The reaction was quenched with NaHCO<sub>3</sub> (aq., satd.) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3x). The combined organics were dried (MgSO<sub>4</sub>), filtered, and concentrated to a yellow oil (106 mg), which was purified by silica gel chromatography to provide <b>7c</b> as a white solid (77 mg, 0.35 mmol, 41% yield). Compound <b>7c</b> was then combined with phenylenediamine (0.038 g, 0.35 mmol) in a vial. The two solids were ground together with a glass rod, and the vial was capped and heated in an oil bath with stirring at 150 °C for 4 h. The reaction was then cooled to room temperature, and DMF was added. The reaction was subjected to sonication, and the resulting white solid was collected and dried to provide <b>8c</b> (8.8 mg, 9% yield).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Method for LHMDS Cyclization (Method A)</h4><div class="NLM_p last">LHMDS (1.65 mL, 1 M in THF, 1.65 mmol, 5.0 equiv) was added dropwise to a solution of ethyl 2-(1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)acetate (67.6 mg, 0.33 mmol, 1.0 equiv), 2-aminobenzenecarbonitrile <b>6c</b> (60 mg, 0.5 mmol, 1.5 equiv), and anhydrous THF (15 mL). The resulting solution was stirred at room temperature for 5 h and then quenched with NH<sub>4</sub>Cl (aq, sat.). The mixture was diluted with H<sub>2</sub>O and extracted with EtOAc (3×). The combined organic layers were washed once with water, dried with MgSO<sub>4</sub>, and concentrated to approximately 10 mL. A yellow solid precipitated, which was collected via filtration and dried under reduced pressure to provide <b>8c</b> (28 mg). Additional material (16 mg) was obtained by concentrating the filtrate and purifying the resulting solid by silica gel chromatography (5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>). Overall 44 mg (48% yield) of <b>8c</b> was obtained. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.38 (1 H, s), 8.19 (1 H, d, <i>J</i> = 8.3 Hz), 7.65 (2 H, bs), 7.56 (1 H, dd, <i>J</i> = 8.3, 1.0 Hz), 7.33 (1 H, d, <i>J</i> = 8.3 Hz), 7.23 (1 H, dd, <i>J</i> = 8.3, 1.0 Hz), 7.15 (2 H, m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 161.6, 155.2, 139.6, 133.4, 128.7, 126.7, 126.2, 125.0, 124.4, 122.5, 116.8, 114.5, 113.3, 89.1. LCMS (<i>m</i>/<i>z</i>) 276.8 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.68 min. HRMS found <i>m</i>/<i>z</i> 277.1087; C<sub>16</sub>H<sub>13</sub>N<sub>4</sub>O requires 277.1083.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Ethyl 2-(6-Methylbenzimidazol-2-yl)acetate (<b>18a</b>)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></h4><div class="NLM_p last">Synthesized as in example <b>18c</b>. (80% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 7.37 (1 H, d, <i>J</i> = 8.1 Hz), 7.27 (1 H, bs), 6.95 (1 H, dd, <i>J</i> = 8.1, 1.5 Hz), 4.11 (2 H, q, <i>J</i> = 7.2 Hz), 3.91 (2 H s), 3.37 (3 H, s), 1.18 (3 H, t, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 168.8, 147.3, 138.0, 136.6, 130.6, 122.9, 114.7, 114.0, 60.7, 35.1, 21.2, 14.0. LCMS (<i>m</i>/<i>z</i>) 219.1 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.42 min. HPLC <i>R</i><sub>t</sub> 14.90 min. Anal. calcd for C<sub>12</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>: C 66.04, H 6.47, N 12.48; found C 66.18, H 6.34, N 12.55.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-Amino-3-(6-methylbenzimidazol-2-yl)hydroquinolin-2-one (<b>19a</b>)</h4><div class="NLM_p last">Method A (50% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.53 (1 H, s, NH), 8.36 (1 H, d, <i>J</i> = 8.1 Hz), 7.68 (1 H, d, <i>J</i> = 8.7 Hz), 7.62 (1 H, d, <i>J</i> = 8.1 Hz), 7.59 (1 H, bs), 7.41 (1 H, d, <i>J</i> = 7.5 Hz), 7.27 (2 H, m), 2.50 (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 160.9, 154.4, 146.3, 139.0, 134.0, 132.5, 131.0, 125.7, 124.1, 121.6, 116.1, 113.5, 113.3, 112.7, 88.4, 21.2. LCMS (<i>m</i>/<i>z</i>): 291.1 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.89 min. HPLC <i>R</i><sub>t</sub> 19.66 min. HRMS found <i>m</i>/<i>z</i> 291.1255; C<sub>17</sub>H<sub>15</sub>N<sub>4</sub>O requires 291.1240.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Ethyl 2-(5,6-Dimethylbenzimidazol-2-yl)acetate (<b>18b</b>)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></h4><div class="NLM_p last">Synthesized as in example <b>18c</b> (86% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 12.0 (1 H, bs, NH), 7.24 (2 H, s), 4.10 (2 H, q, 7.5 Hz), 3.87 (2 H, s), 2.27 (6H, s), 1.17 (3 H, t, <i>J</i> = 7.5 Hz). LCMS (<i>m</i>/<i>z</i>) 233.1 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.76 min.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4-Amino-3-(5,6-dimethylbenzimidazol-2-yl)hydroquinolin-2-one (<b>19b</b>)</h4><div class="NLM_p last">Method A (25% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.48 (1H, s, NH), 8.29 (1 H, d, <i>J</i> = 8.1 Hz), 8.20 (1 H, bs, NH), 7.61 (2 H, dd, <i>J</i> = 8.1, 7.5 Hz), 7.54 (2 H, s), 7.35 (1 H, d, <i>J</i> = 8.1 Hz), 7.23 (1 H, dd, <i>J</i> = 8.1, 7.5 Hz), 2.38 (6 H, bs). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 161.5, 154.9, 146.2, 139.7, 134.3, 133.2, 131.4, 124.6, 122.3, 116.7, 114.3, 113.3, 89.1, 20.6. LCMS (<i>m</i>/<i>z</i>) 305.3 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 2.31 min. HPLC <i>R</i><sub>t</sub> 20.53 min.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 5-Morpholin-4-yl-2-nitrophenylamine (<b>21a</b>): General Method for S<sub>N</sub>Ar Reaction (Method B)</h4><div class="NLM_p last">5-Fluoro-2-nitrophenylamine (30.0 g, 0.19 mol) was dissolved in anhydrous 1-methyl-2-pyrrolidinone (NMP, 40 mL). Triethylamine (58 mL, 0.42 mol, 2.2 equiv) and morpholine (18 mL, 0.21 mol, 1.1 equiv) were added. The reaction vessel was fitted with a reflux condenser and heated at 100 °C for 16 h. The reaction was cooled to room temperature and then poured into 1 L of water. A yellow precipitate formed, which was collected by filtration through a sintered glass funnel, washed with ether, and dried under vacuum to yield <b>21a</b> (38.0 g, 91%) as a yellow solid.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Ethyl 2-(5-Morpholin-4-ylbenzimidazol-2-yl)acetate (<b>23a</b>): General Method for Formation of the Benzimidazole Acetate (Method C)</h4><div class="NLM_p last">A 2 L round-bottom flask was charged with 5-morpholin-4-yl-2-nitrophenylamine (20.0 g, 90 mmol, 1.0 equiv) and anhydrous ethanol (800 mL). Palladium on carbon (10% w/w, 6.6 g) was added, and the reaction vessel was fitted with a 3-way stopcock. The flask was evacuated under vacuum and then filled with hydrogen. The reaction was stirred overnight under a 1 atm of hydrogen gas, with additional hydrogen added as necessary. The reaction was flushed with nitrogen, and ethyl 3-ethoxy-3-iminopropanoate hydrochloride (44.1 g, 220 mmol, 2.4 equiv) was added. The reaction vessel was fitted with a reflux condenser and heated at 90 °C overnight under a positive pressure of nitrogen. The reaction was then cooled to room temperature and filtered through a pad of celite. The filtrate was concentrated under reduced pressure. The resulting residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (500 mL), neutralized with ammonium hydroxide, and washed with water (2 × 100 mL). The organic phase was concentrated and filtered through a plug of silica gel using EtOAc. The filtrate was concentrated in vacuo to afford <b>23a</b> (21.2 g, 81% yield) as a brown solid (product is very hygroscopic). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 7.35 (1 H, d, <i>J</i> = 8.7 Hz), 6.94 (1 H, d, <i>J</i> = 1.8 Hz), 6.89 (1 H, dd, <i>J</i> = 8.7, 1.8 Hz), 4.1 (2 H, q, <i>J</i> = 7.2 Hz), 3.88 (2 H, s), 3.74 (4 H, m), 3.04 (4 H, m), 1.18 (3 H, t, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 168.8, 147.4, 146.8, 138.2, 134.3, 115.8, 112,9, 99.9, 66.2, 60.7, 50.4, 35.1, 14.0. LCMS (<i>m</i>/<i>z</i>): 290.1 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.36 min. HPLC <i>R</i><sub>t</sub> 13.38 min. Anal. calcd for C<sub>15</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub>: C 62.27, H 6.62, N 14.51; found C 62.30, H 6.49, N 14.04.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-Amino-3-(6-morpholin-4-ylbenzimidazol-2-yl)hydroquinolin-2-one (<b>19c</b>)</h4><div class="NLM_p last">Method A (61% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.48 (1 H, s), 9.20 (1 H, bs), 8.31 (1 H, d, <i>J</i> = 8.4 Hz), 8.11 (1 H, bs), 7.81 (1 H, d, <i>J</i> = 8.7 Hz), 7.72 (1 H, d, <i>J</i> = 8.7 Hz), 7.59 (1 H, dd, <i>J</i> = 8.4, 7.2), 7.38 (1 H, d, <i>J</i> = 8.4 Hz), 7.24 (1 H, dd, <i>J</i> = 8.1, 7.2), 4.11 (4H, bs), 3.59 (4H, bs). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 162.4, 155.0, 152.6, 139.9, 139.1, 137.0, 133.8, 132.9, 124.6, 122.3, 116.7, 116.2, 115.2, 113.5, 107.5, 90.0, 64.6, 54.7. LCMS (<i>m</i>/<i>z</i>) 362.1 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.65 min. HPLC <i>R</i><sub>t</sub> 18.16 min; Anal. calcd for C<sub>20</sub>H<sub>19</sub>N<sub>5</sub>O<sub>2</sub> + 0.6 H<sub>2</sub>O: C 64.33, H 5.49, N 18.76; found C 64.21, H 5.37, N 18.37.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 5-(4-Methylpiperazinyl)-2-nitrophenylamine (<b>21b</b>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></h4><div class="NLM_p last">Method B (96% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 7.78 (1 H, dd, <i>J</i> = 9.6, 0.9 Hz), 7.24 (2 H, bs), 6.34 (1 H, dd, <i>J</i> = 9.6, 2.2 Hz), 6.19 (1 H, d, <i>J</i> = 2.2 Hz), 3.27 (4 H, t, <i>J</i> = 4.8 Hz), 2.36 (4H, t, <i>J</i> = 4.8 Hz), 2.17 (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 155.0 (C), 148.3 (C), 127.1 (CH), 122.9 (C), 105.4 (CH), 97.5 (CH), 54.1 (CH<sub>2</sub>), 46.1 (CH<sub>2</sub>), 45.6 (CH<sub>3</sub>). LCMS <i>m</i>/<i>z</i> 237.3 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.23 min. Anal. calcd for C<sub>11</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub>: C, 55.92; H, 6.83; N, 23.71. Found: C, 55.96; H, 6.62, N, 23.68.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Ethyl 2-[6-(4-Methylpiperazinyl)benzimidazol-2-yl]acetate (<b>23b</b>)</h4><div class="NLM_p last">Method C (83% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 7.33 (1 H, d, <i>J</i> = 8.7 Hz), 6.92 (1 H, bs), 6.87 (1 H, d, <i>J</i> = 8.7 Hz), 4.10 (2 H, q, <i>J</i> = 7.2 Hz), 3.87 (2 H, s), 3.06 (4 H, m), 2.45 (4 H, m), 2.20 (3 H, s), 1.18 (3 H, t, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 168.9, 147.5, 146.6, 136.2, 136.0, 118.5, 113.3, 98.1, 60.7, 54.9, 50.06, 45.7, 35.1, 14.0. LCMS (<i>m</i>/<i>z</i>) 303.1 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.15 min. HPLC <i>R</i><sub>t</sub> 9.85 min.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 4-Amino-3-[6-(4-methylpiperazinyl)benzimidazol-2-yl]hydroquinolin-2-one (<b>19d</b>)</h4><div class="NLM_p last">Method A (60% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.47 (1 H, s, NH), 11.32 (1 H, bs, NH), 8.26 (1 H, d, <i>J</i> = 8.1 Hz), 7.63 (2 H, dd, <i>J</i> = 8.4, 8.1 Hz), 7.35 (1 H, d, <i>J</i> = 8.4 Hz), 7.27 (2 H, bs), 7.23 (1 H, d, <i>J</i> = 8.1 Hz), 3.82 (2 H, m), 3.53 (2 H, m), 3.24 (4 H, m), 2.82 (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 161.2, 154.0, 147.3, 146.9, 138.7, 134.1, 132.3, 128.4, 123.9, 121.6, 116.0, 115.5, 114.6, 112.8, 100.5, 89.0, 52.1, 47.0, 41.9. LCMS (<i>m</i>/<i>z</i>) 375.2 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.38 min. HPLC <i>R</i><sub>t</sub> 14.09 min. HRMS found <i>m</i>/<i>z</i> 375.1895; C<sub>21</sub>H<sub>23</sub>N<sub>6</sub>O requires 375.1927. Anal. calcd for C<sub>21</sub>H<sub>22</sub>N<sub>6</sub>O: C67.36, H 5.92, N 22.44; found C67.15, H 5.84, N 22.27.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 5-(4-Methyl(1,4-diazaperhydroepinyl))-2-nitrophenylamine (<b>21c</b>)</h4><div class="NLM_p last">Method B (20% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 7.81 (1 H, d, <i>J</i> = 9.9 Hz), 7.23 (2 H, bs, NH<sub>2</sub>), 6.25 (1 H, dd, <i>J</i> = 9.9, 2.7 Hz), 6.05 (1 H, d, <i>J</i> = 2.7 Hz), 3.56 (2 H, m), 3.49 (2 H, m), 3.62 (2 H, m), 2.48 (2 H, m), 2.28 (3 H, s), 1.88 (2 H, m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 153.7, 148.4, 127.5, 122.1, 104.0, 94.6, 56.7, 55.9, 48.1, 47.9, 45.7, 26.4. LCMS (<i>m</i>/<i>z</i>) 251.3 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.57 min. Anal. calcd for C<sub>12</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub>: C 57.58, H 7.25, N 22.38; found C 57.03, H 7.11, N 22.31.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Ethyl 2-[6-(4-Methyl-1,4-diazaperhydroepinyl)benzimidazol-2-yl]acetate (<b>23c</b>)</h4><div class="NLM_p last">Method C (53% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 7.26 (1 H, m), 6.62 (2 H, m), 4.09 (2 H, q, <i>J</i> = 7.2 Hz), 3.83 (2 H, s), 3.50 (2 H, m), 3.41 (2 H, m), 2.62 (2 H, m), 2.44 (2 H, m), 2.25 (3 H, s), 1.90 (2 H, m), 1.18 (3 H, t, <i>J</i> = 7.2 Hz). LCMS (<i>m</i>/<i>z</i>) 317.4 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.47 min.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 4-Amino-3-[6-(4-methyl(1,4-diazaperhydroepinyl))benzimidazol-2-yl]hydroquinolin-2-one (<b>19e</b>)</h4><div class="NLM_p last">Method A (5% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.67 (1 H, bs, NH), 11.48 (1 H, s, NH), 8.31 (1 H, d, <i>J</i> = 8.1 Hz), 7.64 (1 H, d, <i>J</i> = 9.3 Hz), 7.58 (1 H, dd, <i>J</i> = 8.4, 7.2 Hz), 7.36 (1 H, d, <i>J</i> = 8.4 Hz), 7.27 (2 H, bs), 7.20 (1 H, dd, <i>J</i> = 8.1, 7.2 Hz), 3.96 (2 H, m), 3.60 (3 H, m), 3.44 (2 H, m), 3.23 (1 H, m), 2.78 (3 H, s), 2.41 (1 H, m), 2.30 (1 H, m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 161.7, 154.9, 146.8, 145.5, 139.6, 134.7, 133.2, 127.0, 124.8, 122.3, 116.7, 115.0, 113.7, 113.4, 98.3, 89.2, 55.3, 50.7, 47.1, 43.7, 23.5. LCMS (<i>m</i>/<i>z</i>) 389.4 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.72 min.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (3<i>S</i>)-1-(3-Amino-4-nitrophenyl)pyrrolidin-3-yl]dimethylamine (<b>21d</b>)</h4><div class="NLM_p last">Method B (88% yield); mp 148−149 °C. <sup>1</sup>H NMR (300 MHz, acetone-<i>d</i><sub>6</sub>) 7.90 (1 H, d, <i>J</i> = 9.5 Hz), 6.88 (2 H, bs, NH<sub>2</sub>), 6.09 (1 H, dd, <i>J</i> = 9.5, 2.7), 5.90 (1H, d, <i>J</i> = 2.7 Hz), 3.56 (2 H, m), 3.36 (1 H, m), 3.15 (1 H, app. t, <i>J</i> = 8.4 Hz), 2.81 (1 H, m), 2.24 (6 H, s), 2.22 (1 H, m), 1.88 (1 H, m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 151.8, 148.3, 127.5, 122.4, 104.3, 94.5, 64.5, 51.7, 46.6, 40.3, 29.3. LCMS (<i>m</i>/<i>z</i>): 251.2 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.34 min. HPLC: <i>R</i><sub>t</sub> 13.48 min; [α]<sub>D</sub><sup>22</sup> = −16.3 (<i>c</i> = 0.57, DMSO).</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Ethyl 2-{5-[(3<i>S</i>)-3-(dimethylamino)pyrrolidinyl]benzimidazol-2-yl}acetate (<b>23d</b>)</h4><div class="NLM_p last">Method C (76% yield); mp 135 °C (decomposition). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 7.30 (1 H, d, <i>J</i> = 9.3 Hz), 6.50 (1 H, s), 6.41 (1 H, d, <i>J</i> = 9.3 Hz), 4.12 (2 H, q, <i>J</i> = 7.2 Hz), 3.85 (2 H, s), 3.41 (1 H, m), 3.29 (2 H, m), 3.04 (1 H, m), 2.80 (1 H, m), 2.21 (6 H, s), 2.15 (1 H, m), 1.82 (1 H, m), 1.20 (3 H, t, <i>J</i> = 7.2 Hz). LCMS <i>m</i>/<i>z</i> 317.1 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.45 min. HPLC <i>R</i><sub>t</sub> 11.6 min; [α]<sub>D</sub><sup>22</sup> = −25.3 (<i>c</i> = 1, DMSO).</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 3-{5-[(3<i>S</i>)-3-(Dimethylamino)pyrrolidinyl]benzimidazol-2-yl}-4-aminohydroquinolin-2-one (<b>19f</b>)</h4><div class="NLM_p last">Method A (1.5 g, 43% yield); mp 280 °C (decomposition). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.79 (1 H, bs, NH), 11.46 (1 H, s, NH), 8.27 (1 H, d, <i>J</i> = 7.8 Hz), 8.1 (1 H, bs, NH), 7.61 (1 H, d, <i>J</i> = 9.0 Hz) 7.60 (1 H, app. t, <i>J</i> = 5.4 Hz), 7.34 (1 H, d, <i>J</i> = 7.8 Hz), 7.23 (1 H, app t, <i>J</i> = 7.8 Hz), 6.88 (1 H, d, <i>J</i> = 9.0 Hz), 6.80 (1 H, s), 4.04 (1 H, m), 3.70 (2 H, m), 3.57 (1 H, m), 3.35 (1 H, m), 2.81 (6 H, s), 2.44 (2 H, m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 160.83, 154.02, 144.97, 138.95, 132.44, 123.94, 121.64, 116.03, 114.39, 112.69, 111.61, 94.37, 88.66, 63.82, 49.43, 47.02, 41.26, 40.70, 26.51. LCMS <i>m</i>/<i>z</i> 389.1 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.72 min. HRMS found <i>m</i>/<i>z</i> 389.2050; C<sub>22</sub>H<sub>25</sub>N<sub>6</sub>O requires 389.2084; [α]<sub>D</sub><sup>22</sup> = −21.5 (<i>c</i> = 0.5, DMSO). Anal. calcd for C<sub>22</sub>H<sub>24</sub>N<sub>6</sub>O + 0.5H<sub>2</sub>O: C 66.48, H 6.34, N 21.14; found C 66.15, H 6.01, N 21.05.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 5-(2-Morpholin-4-ylethoxy)-2-nitrophenylamine (<b>24</b>)</h4><div class="NLM_p last">Diisopropyl azodicarboxylate (14 mL, 71.4 mmol) was added dropwise to a stirred solution of 3-amino-4-nitrophenol (10.1 g, 64.9 mmol), triphenylphosphine (18.7 g, 71.4 mmol), and <i>N</i>-(2-hydroxyethyl)morpholine (7.9 mL, 64.9 mmol) in THF (100 mL) at 0 °C. The mixture was allowed to warm to room temperature and left to stir for 18 h. The solvent was then evaporated, and the product was purified by flash chromotography (98:2 CH<sub>2</sub>Cl<sub>2</sub>:MeOH), yielding <b>24</b> as a dark reddish-brown syrup (5.62 g, 32%). LCMS (<i>m</i>/<i>z</i>) 268.0 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.01 min.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 4-(2-Morpholin-4-ylethoxy)benzene-1,2-diamine (<b>25</b>)</h4><div class="NLM_p last">To a solution of 5-(2-morpholin-4-ylethoxy)-2-nitrophenylamine (5.62 g) in EtOH (100 mL), Pd/C (200 mg) was added. The reaction vessel was purged (3×) with nitrogen and then stirred under a H<sub>2</sub> atmosphere for 18 h. The reaction was filtered through a celite plug, and the plug was washed with EtOH. The solution was used immediately in the next step. LC/MS (<i>m/z)</i> 238.3 (MH<sup>+</sup>) <i>R</i><sub>t</sub> 0.295 min.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Ethyl 2-[5-(2-Morpholin-4-ylethoxy)benzimidazol-2-yl]acetate (<b>26</b>)</h4><div class="NLM_p last">To the solution of <b>25</b> in EtOH described above (125 mL), ethyl 3-ethoxy-3-iminopropanoate hydrochloride (4.06 g, 20.8 mmol) was added. This reaction mixture was heated for 18 h at 70 °C, at which time the solvent was evaporated and the residue was taken up in CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was washed once with H<sub>2</sub>O and then purified by flash chromatography (10:1:2 CH<sub>2</sub>Cl<sub>2</sub>:MeOH:EtOAc) to yield <b>26</b> as a dark reddish-brown syrup (4.94 g, 70% yield over two steps). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) 7.4 (1 H, broad s), 6.9 (1 H, broad s), 6.83 (1 H, dd, <i>J</i> = 9.0 Hz), 4.18 (2 H, q), 4.1 (2 H, t, <i>J</i> = 5.4 Hz), 3.96 (2 H, s), 3.71 (4 H, t, <i>J</i> = 5.1 Hz), 2.77 (2 H, t, <i>J</i> = 5.7 Hz), 2.54 (4 H, t, <i>J</i> = 4.8 Hz), 1.25 (3 H, t, <i>J</i> = 7.2 Hz). LCMS (<i>m</i>/<i>z</i>) 334.4 (MH<sup>+</sup>) <i>R</i><sub>t</sub> 1.08 min.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 4-Amino-3-[5-(2-morpholin-4-ylethoxy)-benzimidazol-2-yl]hydroquinolin-2-one (<b>19g</b>)</h4><div class="NLM_p last">Method A (239 mg, 14% yield). <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) 7.83 (d, <i>J</i> = 8.7, 1H), 7.59 (t, <i>J</i> = 7.2, 1H), 7.52 (d, <i>J</i> = 8.7, 1H), 7.24 (t, <i>J</i> = 6.9, 1H), 7.19 (d, <i>J</i> = 7.8, 1H), 7.10 (s, 1H), 6.98 (dd, <i>J</i> = 9, 1H), 4.32 (t, <i>J</i> = 5.1, 2H), 4.11 (2H, broad m), 3.88 (broad m, 2H), 3.64 (t, <i>J</i> = 5.1, 2H), 3.60 (broad m, 2H), 3.33 (broad m, 2H). Note: At 50 °C, the broad multiplets at 3.33, 3.60, 3.88, and 4.11 resolved into two broad multiplets of 4 H each (δ 3.73, 4.28). LCMS (<i>m/</i>z) 406.4 (MH<sup>+</sup>) <i>R</i><sub>t</sub> 1.56 min. HRMS found <i>m</i>/<i>z</i> 406.1850; C<sub>22</sub>H<sub>24</sub>N<sub>5</sub>O<sub>3</sub> requires 406.1873.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-[5-(Methoxycarbonyl)benzimidazol-2-yl]acetate (<b>18c</b>)</h4><div class="NLM_p last">Methyl 3,4-diaminobenzoate (14.85 g, 89.4 mmol, 1 equiv) was stirred with ethyl-3-ethoxy-3-iminopropanoate hydrochloride (26.3 g, 134.9 mmol, 1.5 equiv) in EtOH (300 mL) at 70 °C overnight. The reaction mixture was cooled to room temperature, and the excess unreacted ethyl-3-ethoxy-3-iminopropanoate hydrochloride was removed by filtration. The EtOH was removed under reduced pressure, and the residue was dissolved in water and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent removed under reduced pressure. The solid was triturated with Et<sub>2</sub>O to yield <b>18c</b> as an off-white solid (18.4 g, 78%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 8.15 (1 H, d, <i>J</i> = 1.5 Hz), 7.81 (1 H, dd, <i>J</i> = 8.4, 1.5 Hz), 7.61 (1 H, d, <i>J</i> = 8.4 Hz), 4.14 (2 H, q, <i>J</i> = 7.2 Hz), 4.04 (2 H, s), 3.86 (3 H, s), 1.20 (3 H, t, <i>J</i> = 7.2). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 169.2, 167.5, 151.3, 143.1, 139.3, 123.7, 123.5, 117.7, 115.3, 61.6, 52.6, 35.8, 14.7. LCMS (<i>m</i>/<i>z</i>) 263.3 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.82 min. Anal. calcd for C<sub>13</sub>H<sub>14</sub>N<sub>2</sub>O<sub>4</sub>: C 59.41, H 5.12, N 10.51; found C 59.54, H 5.38, N 10.68.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Methyl 2-(4-Amino-2-<i>oxo</i>-3-hydroquinolyl) benzimidazole-6-carboxylate (<b>19ad</b>)</h4><div class="NLM_p last">Method A (21% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 13.28 (1 H, s), 11.42 (1 H, s), 8.37 (1 H, bs), 8.24 (1 H, d, <i>J</i> = 6.3 Hz), 8.20 (1 H, d, <i>J</i> = 4.6 Hz), 7.80 (1 H, d, <i>J</i> = 8.0 Hz), 7.74 (1 H, dd, <i>J</i> = 8.0, 4.6 Hz), 7.56 (1 H, dd, <i>J</i> = 8.0, 1.0 Hz), 7.34 (1 H, d, <i>J</i> = 8.0 Hz), 7.24 (1 H, dd, <i>J</i> = 8.0, 1.0 Hz), 3.85 (3 H, s).</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-(4-Amino-2-<i>oxo</i>-3-hydroquinolyl)benzimidazole-6-carboxylic acid (<b>19ae</b>)</h4><div class="NLM_p last">The crude material obtained in the previous step was dissolved in a 1:1 mixture of EtOH and 30% aq KOH (10 mL) and stirred overnight at 70 °C. The reaction mixture was cooled and acidified with 1N HCl. A precipitate formed. The solid was filtered, washed with water, and dried to obtain <b>19ae</b> (190 mg, 40%) as a brown solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.46 (1 H, s, NH), 9.40 (1 H, bs, NH), 8.30 (1 H, d, <i>J</i> = 1.5 Hz), 8.28 (1 H, d, <i>J</i> = 8.1 Hz), 7.88 (1 H, dd, <i>J</i> = 8.7. 1.5 Hz), 7.76 (1 H, d, <i>J</i> = 8.7 Hz), 7.60 (1 H, dd, <i>J</i> = 8.1, 7.5 Hz), 7.37 (1 H, d, <i>J</i> = 8.4 Hz), 7.25 (1 H, dd, <i>J</i> = 8.4, 7.5 Hz). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 168.4, 162.5, 155.1, 153.4, 139.5, 139.1, 135.5, 132.9, 125.5, 124.5, 122.3, 116.7, 114.7, 113.5, 90.1. LCMS (<i>m</i>/<i>z</i>) 321.3 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 2.25 min.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 4-Amino-3-{6-[(4-methylpiperazinyl)carbonyl]benzimidazol-2-yl}hydroquinolin-2-one (<b>19h</b>)</h4><div class="NLM_p last">A mixture of <b>19ae</b> (70 mg, 0.22 mmol, 1.0 equiv), 1-methyl piperazine (0.024 mL, 0.22 mmol, 1.0 equiv), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC 50 mg, 0.26 mmol, 1.2 equiv), 1-hydroxy-7-azabenzotriazole (HOAT, 35 mg, 0.26 mmol, 1.2 equiv), and Et<sub>3</sub>N (0.06 mL, 0.44 mmol, 2.5 equiv) in DMF (3 mL) was stirred at 23 °C for 20 h. The reaction mixture was partitioned between H<sub>2</sub>O and EtOAc. The combined organic layers were dried with Na<sub>2</sub>SO<sub>4</sub> and concentrated. Water was added, and the precipitate was filtered and dried. The crude solid was purified by reverse phase HPLC to afford <b>19h</b> (29.8 mg, 34%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 8.20 (1 H, d, <i>J</i> = 8.1 Hz), 7.81 (1 H, d, <i>J</i> = 1.5 Hz), 7.77 (1 H, d, <i>J</i> = 8.4 Hz), 7.59 (1 H, dd, <i>J</i> = 8.1, 7.2 Hz), 7.42 (1 H, dd, <i>J</i> = 8.4, 1.2 Hz), 7.33 (1 H, d, <i>J</i> = 8.4 Hz), 7.23 (1 H, dd, <i>J</i> = 8.4, 7.2 Hz), 4.12 (2 H, m), 3.40 (4 H, m), 3.11 (2 H, m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 169.6, 161.6, 154.4, 151.2, 138.5, 135.7, 134.3, 132.3, 129.1, 124.0, 122.3, 121.6, 116.0, 114.2, 113.6, 112.8, 89.1, 51.9, 42.0, 40.1. LCMS (<i>m</i>/<i>z</i>) 403.3 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.80 min. Anal. calcd for C<sub>22</sub>H<sub>22</sub>N<sub>6</sub>O<sub>2</sub> + 2H<sub>2</sub>O: C 60.26, H 5.98, N 19.17; found C 60.38, H 5.48, N 18.84.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 4-amino-3-(6-(hydroxymethyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)quinolin-2(1<i>H</i>)-one (<b>19af</b>)</h4><div class="NLM_p last">A suspension of methyl 2-(4-amino-2-oxo-3-hydroquinolyl) benzimidazole-6-carboxylate <b>19ad</b> (1.0 g, 3.1 mmol, 1.0 equiv) in toluene (100 mL) was treated with DIBAL-H (10.3 mL of 1.5 M soln in toluene, 15.5 mmol, 5.0 equiv) at room temperature. The reaction mixture was stirred for 10 h and was then treated with NaF (2.6 g, 62 mmol, 20 equiv) followed by water (0.27 mL, 15 mmol, 4.8 equiv). The reaction was stirred at room temperature for an additional 1.5 h, and then DMF was added. The resulting mixture was heated at 100 °C for 1 h and then filtered. The filtrate was evaporated to one-quarter of the original volume and treated with 50 mL of water. The resulting solid was collected and dried to give <b>19af</b> (475 mg, 50% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 13.28 (1 H, s), 11.42 (1 H, s), 8.19 (1 H, d, <i>J</i> = 8.8 Hz), 7.58 (3 H, m), 7.34 (1 H, d, <i>J</i> = 8.8 Hz), 7.26 (2 H, m), 4.58 (2 H, s), 4.5−4.9 (1 H, bs). LCMS (<i>m</i>/<i>z</i>) 307.1 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.47 min.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-(4-Amino-2-<i>oxo</i>-1,2-dihydroquinolin-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole-6-carbaldehyde (<b>19ag</b>)</h4><div class="NLM_p last"><b>19af</b> (320 mg, 1.04 mmol, 1.0 equiv) was dissolved in DMA (4 mL), and MnO<sub>2</sub> (450 mg, 5.2 mmol, 5.0 equiv) was added. The reaction mixture was heated under microwave irradiation at 140 °C for 10 min. The reaction mixture was then filtered through celite, and water was added to the filtrate. The resulting solid was collected and dried to give <b>19ag</b> (310 mg, 97% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 13.28 (1 H, s), 11.42 (1 H, s), 10.00 (1 H, s), 8.42 (1 H, bs), 8.24 (1 H, d, <i>J</i> = 6.3 Hz), 8.19 (1 H, d, <i>J</i> = 4.6 Hz), 7.86 (1 H, d, <i>J</i> = 8.0 Hz), 7.74 (1 H, dd, <i>J</i> = 8.0, 4.6 Hz), 7.58 (1 H, dd, <i>J</i> = 8.0, 1.0 Hz), 7.34 (1 H, d, <i>J</i> = 8.0 Hz), 7.23 (1 H, dd, <i>J</i> = 8.0, 1.0 Hz). LCMS (<i>m</i>/<i>z</i>) 305.1 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 2.47 min.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 4-Amino-3-(6-((4-methylpiperazin-1-yl)methyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)quinolin-2(1<i>H</i>)-one (<b>19i</b>)</h4><div class="NLM_p last"><b>19ag</b> (250 mg, 0.82 mmol, 1.0 equiv) was suspended in MeOH (5 mL). Piperazine (123 mg, 1.23 mmol, 1.5 equiv) and HOAc (0.15 mL, 2.46 mmol, 3.0 equiv) were added followed by NaBH<sub>3</sub>CN (257 mg, 4.1 mmol, 5.0 equiv). The reaction was heated at 90 °C for 6 h in a glass bomb. The solution was cooled and then poured into water and extracted with EtOAc. The organic layer was dried and concentrated, and the resulting oil was purified by reverse phase HPLC. The purified fractions were combined, neutralized with NaHCO<sub>3</sub> (aq, sat.), and extracted with EtOAc (2×). The organic extracts were combined, dried, and concentrated to give <b>19i</b> (160 mg, 50% yield). LCMS (<i>m</i>/<i>z</i>) 389.1 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.46 min.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 4-Amino-3-(6-(methylamino)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)quinolin-2(1<i>H</i>)-one (<b>19ah</b>)</h4><div class="NLM_p last">Method A (63% yield). HRMS found <i>m</i>/<i>z</i> 306.1354; C<sub>17</sub>H<sub>15</sub>N<sub>5</sub>O requires 306.1349.</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-(2-(4-Amino-2-<i>oxo</i>-1,2-dihydroquinolin-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-6-yl)-2-(dimethylamino)-<i>N</i>-methylacetamide (<b>19j</b>)</h4><div class="NLM_p last">To a solution of <b>19ah</b> (75 mg, 0.25 mmol, 1.0 equiv) in DMA (6 mL) was added 2-(dimethylamino)acetic acid (38 mg, 0.37mmol, 1.5 equiv), EDC (57.4, 0.37 mmol, 1.5 equiv), HOBT (50 mg, 0.37 mmol,1.5 equiv), and Et<sub>3</sub>N (0.104 mL, 0.74 mmol, 3 equiv). The reaction mixture was stirred at room temperature for 12 h. The reaction mixture was then concentrated to a thick oil and triturated with water. The resulting solid was collected and purified by reverse phase HPLC. The purified fractions were combined, neutralized with NaHCO<sub>3</sub> (aq, sat.), and extracted with EtOAc (2×). The organic extracts were combined, dried, and concentrated to provide <b>19j</b> (70 mg, 72% yield). LCMS (<i>m</i>/<i>z</i>) 391.2 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.68 min.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 4-Amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)quinolin-2(1<i>H</i>)-one (<b>5</b>)</h4><div class="NLM_p last">Method A (60% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.66 (1H, s, NH), 9.73 (1H, bs, NH), 7.66 (1H, d, <i>J</i> = 9.1 Hz), 7.59 (1H, ddd, <i>J</i> = 8.5, 8.0, 6.0 Hz), 7.29 (1H, dd, <i>J</i> = 9.1, 1.5 Hz), 7.23 (1H, s), 7.15 (1H, d, <i>J</i> = 8.0 Hz), 7.04 (1H, dd, <i>J</i> = 13.8, 8.5 Hz), 3.86 (2H, d, <i>J</i> = 12.7 Hz), 3.56 (2H, d, <i>J</i> = 11.4 Hz), 3.23 (2H, m), 3.07 (2H, m), 2.88 (3H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 162.5, 159.2, 151.9 (d, <i>J</i> = 42.3 Hz), 147.0, 140.2, 136.5, 133.2, 132.9 (d, <i>J</i> = 14.1 Hz), 118.1, 114.7, 113.9, 113.0, 108.6 (d, <i>J</i> = 18.9 Hz), 104.9, 103.3, 99.4, 91.5, 48.4, 43.6. Anal. calcd for C<sub>21</sub>H<sub>21</sub>N<sub>6</sub>OF·1.5H<sub>2</sub>O: C 60.13, H 5.77, N 20.04, F 4.53; found C 60.74, H 5.98, N 18.50, F 4.13. HRMS found <i>m</i>/<i>z</i> 393.1812; C<sub>21</sub>H<sub>22</sub>N<sub>6</sub>OF requires 393.1833.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 4-Amino-5-chloro-3-[6-(4-methylpiperazinyl)benzimidazol-2-yl]hydroquinolin-2-one (<b>19k</b>)</h4><div class="NLM_p last">Method A (8% yield). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 161.2, 154.0, 147.3, 146.9, 138.7, 134.1, 132.3, 127.4, 123.9, 120.4, 116.6, 115.5, 114.6, 100.5, 89.0, 52.1, 47.0, 41.9. HRMS found <i>m</i>/<i>z</i> 409.1550; C<sub>21</sub>H<sub>22</sub>N<sub>6</sub>OCl requires 409.1538.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 4-Amino-5-methyl-3-[6-(4-methylpiperazinyl)benzimidazol-2-yl]hydroquinolin-2-one (<b>19l</b>)</h4><div class="NLM_p last">Method A (8% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.56 (1 H, bs, NH), 11.37 (1 H, s, NH), 7.62 (1 H, d, <i>J</i> = 9.0 Hz), 7.41 (1 H, dd, <i>J</i> = 8.4, 7.5 Hz), 7.26 (1 H, d, <i>J</i> = 2.1 Hz), 7.21 (1 H, d, <i>J</i> = 8.4 Hz), 7.20 (1 H, dd, <i>J</i> = 9.0, 2.1 Hz), 7.00 (1 H, d, <i>J</i> = 7.5 Hz), 3.78 (2 H, m), 3.51 (2 H, m), 3.25 (4 H, m), 2.85 (3 H, s), 2.80 (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 160.6, 157.1, 147.6, 146.9, 139.9, 136.0, 133.7, 131.5, 127.9, 125.8, 115.6, 114.4, 112.8, 100.3, 89.4, 52.0, 47.0, 41.9, 23.2. LCMS (<i>m</i>/<i>z</i>) 389.5 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.88 min. HPLC <i>R</i><sub>t</sub> 15.03 min. HRMS found <i>m</i>/<i>z</i> 389.2053; C<sub>22</sub>H<sub>25</sub>N<sub>6</sub>O requires 389.2084; Anal. calcd for C<sub>22</sub>H<sub>24</sub>N<sub>6</sub>O + 0.5H<sub>2</sub>O: C 66.64, H 6.71, N 20.73; found C 66.36, H 6.14, N 20.00.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 4-Amino-5-(methylamino)-3-(6-(4-methylpiperazin-1-yl)-1<i>H</i>-benzo[d]imidazol-2-yl)quinolin-2(1<i>H</i>)-one (<b>19m</b>)</h4><div class="NLM_p last">Compound <b>5</b> (50 mg, 0.13 mmol, 1.0 equiv) was dissolved in a solution of MeNH<sub>2</sub> (6 M in EtOH, 3 mL, 18 mmol, 140 equiv) and heated at 180 °C in a sealed vessel for 48 h. The reaction mixture was cooled, concentrated, and purified via reverse phase HPLC to provide <b>19m</b> (21 mg, 41% yield) as a yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.12 (1 H, s), 9.8 (1 H, bs), 9.75 (1 H, bs), 7.51 (1 H, d, <i>J</i> = 8.7 Hz), 7.35 (1 H, t, <i>J</i> = 8.1 Hz), 7.24 (1 H, bs), 6.94 (1 H, dd, <i>J</i> = 8.1, 2.4 Hz), 6.78 (1 H, d, <i>J</i> = 8.1 Hz), 6.57 (1 H, d, <i>J</i> = 7.8 Hz), 3.75 (1 H, m), 3.55 (1 H, m), 3.24 (1 H, m), 3.0 (1 H, m), 2.9 (3 H, s), 2.71 (3 H, s).</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 4-Amino-6-fluoro-3-[6-(4-methylpiperazinyl)benzimidazol-2-yl]hydroquinolin-2-one (<b>19n</b>)</h4><div class="NLM_p last">Method A (25% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.51 (1 H, s, NH), 11.30 (1 H, bs, NH), 8.17 (1 H, dd, <i>J</i><sub>H−F</sub> = 10.5, <i>J</i><sub>H−H</sub> = 2.1 Hz), 7.62 (1 H, d, <i>J</i> = 9.0 Hz), 7.58 (1 H, dd, <i>J</i><sub>H−F</sub> = 11.1, <i>J</i><sub>H−H</sub> = 8.7 Hz), 7.37 (1 H, dd, <i>J</i><sub>H−H</sub> = 8.7, <i>J</i><sub>H−F</sub> = 7.4 Hz), 7.26 (1 H, bs), 7.20 (1 H, bd, <i>J</i> = 9.0 Hz), 3.78 (2 H, m), 3.50 (2 H, m), 3.20 (4 H, m), 2.81 (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 161.6, 157.8 (d, <i>J</i><sub>C−F</sub> = 236 Hz, C <i>ipso</i>), 154.2, 147.8, 147.3, 136.4, 134.4, 128.5, 121.3 (d, <i>J</i><sub>C−F</sub> = 24.5 Hz), 118.8, 116.7, 115.3, 114.2 (d, <i>J</i><sub>C−F</sub> = 8.0 Hz), 110.2 (d, <i>J</i><sub>C−F</sub> = 27.0 Hz), 101.1, 90.1 52.7, 47.7, 42.7, 23.5. LCMS (<i>m</i>/<i>z</i>) 393.3 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.84 min. HRMS found <i>m</i>/<i>z</i> 393.1846; C<sub>21</sub>H<sub>22</sub>N<sub>6</sub>OF requires 393.1833. Anal. calcd for C<sub>21</sub>H<sub>21</sub>FN<sub>6</sub>O: C 64.24, H 5.39, N 21.42; found C 64.87, H 5.24, N 20.91.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 4-Amino-6-chloro-3-[6-(4-methylpiperazinyl)benzimidazol-2-yl]hydroquinolin-2-one (<b>19o</b>)</h4><div class="NLM_p last">Method A (46% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.5 (1 H, s), 9.6 (1 H, bs), 8.33 (1 H, d, <i>J</i> = 2.1 Hz), 7.60 (2 H, dd, <i>J</i> = 8.7, 2.1 Hz), 7.34 (1 H, d, <i>J</i> = 8.7 Hz), 7.28 (1 H, s), 6.97 (1 H, dd, <i>J</i> = 9.0, 2.1 Hz), 3.75 (1 H, m), 3.55 (1 H, m), 3.24 (1 H, m), 3.0 (1 H, m), 2.9 (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 161.5, 153.8, 147.6, 147.3, 138.4, 134.4, 132.9, 126.6, 124.0, 118.7, 116.6, 115.2, 114.6, 101.1, 89.9, 52.6, 47.6, 42.7. HRMS found <i>m</i>/<i>z</i> 409.1550; C<sub>21</sub>H<sub>22</sub>N<sub>6</sub>OCl requires 409.1538.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 4,6-Diamino-3-(6-(4-methylpiperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)quinolin-2(1<i>H</i>)-one (<b>19p</b>)</h4><div class="NLM_p last">Method A (45% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.35 (1 H, s), 9.91 (1 H, bs), 7.71 (1 H, s), 7.55 (1 H, d, <i>J</i> = 8.8 Hz), 7.29 (3 H, m), 6.96 (1 H, dd, <i>J</i> = 8.8, 1.8 Hz), 3.75 (1 H, m), 3.55 (1 H, m), 3.24 (1 H, m), 3.0 (1 H, m), 2.9 (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 162.6,159.3, 158.8, 153.1, 151.8, 146.6, 136.1, 130.5, 125.9, 119.1, 117.8, 115.7, 115.2, 114.7, 114.3, 91.7, 53.2, 48.1, 42.8.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 4-Amino-6-(dimethylamino)-3-[6-(4-methylpiperazinyl)benzimidazol-2-yl]hydroquinolin-2-one (<b>19q</b>)</h4><div class="NLM_p last">Method A (48% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.17 (1 H, s), 9.90 (1 H, bs), 7.58 (1 H, d, <i>J</i> = 8.7 Hz), 7.42 (1 H, s), 7.25 (3 H, m), 7.0 (1 H, dd, <i>J</i> = 9.0, 2.4 Hz), 3.75 (1 H, m), 3.55 (1 H, m), 3.24 (1 H, m), 3.0 (1 H, m), 2.9 (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 162.1, 159.6, 159.1, 153.8, 151.4, 146.9, 144.9, 132.4, 122.7, 121.4, 118.8, 117.5, 115.5, 115.0, 114.1, 111.0, 107.9, 101.9, 90.9, 53.2, 48.0, 42.8. HRMS found <i>m</i>/<i>z</i> 418.2360; C<sub>23</sub>H<sub>28</sub>N<sub>7</sub>O requires 418.2349.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>N</i>-(4-Amino-3-(6-(4-methylpiperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-2-<i>oxo</i>-1,2-dihydroquinolin-6-yl)benzamide (<b>19r</b>)</h4><div class="NLM_p last">To a solution of <b>19p</b> (20 mg, 0.05 mmol, 1.0 equiv) in 1.0 mL of <i>N</i>,<i>N</i>-dimethylacetamide (1.0 mL) was added benzoyl chloride (14 mg, 0.10 mmol, 2.0 equiv) followed by Et<sub>3</sub>N (0.23 mL, 1.65 mmol, 5 equiv). The resulting solution was stirred at room temperature for 8 h. The reaction was concentrated and purified by reverse phase HPLC to provide <b>19r</b> (21 mg, 79% yield) as a yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.4 (1 H, s), 10.4 (1 H, s), 9.85 (1 H, bs), 8.5 (1 H, s), 8.0 (2 H, m), 7.73 (2 H, dd, <i>J</i> = 2.4, 9.3 Hz), 7.54 (4 H, m), 7.33 (1 H, d, <i>J</i> = 8.7 Hz), 7.27 (1 H, d, <i>J</i> = 1.8 Hz), 7.01 (1 H, dd, <i>J</i> = 2.1, 8.7 Hz), 3.75 (1 H, m), 3.55 (1 H, m), 3.24 (1 H, m), 3.0 (1 H, m), 2.9 (3 H, s). HRMS found <i>m</i>/<i>z</i> 494.2330; C<sub>28</sub>H<sub>28</sub>N<sub>7</sub>O<sub>2</sub> requires 494.2298.</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 4-Amino-6-(benzylamino)-3-(6-(4-methylpiperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)quinolin-2(1<i>H</i>)-one (<b>19s</b>)</h4><div class="NLM_p last">To a solution of <b>19p</b> (20 mg, 0.05 mmol, 1.0 equiv) in 1.0 mL of MeOH/CH<sub>2</sub>Cl<sub>2</sub>/AcOH (2:2:1) was added benzaldehyde (11 mg, 0.10 mmol, 2.0 equiv) followed by BH<sub>3</sub>/Pyr (0.3 mL of ∼8 M). The resulting solution was stirred at room temperature for 8 h. The reaction mixture was quenched with H<sub>2</sub>O, and the solid was purified by reverse phase HPLC to provide <b>19s</b> (19 mg, 82% yield) as a yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.09 (1 H, s), 9.9 (1 H, bs), 7.75 (1 H, d, <i>J</i> = 8.6 Hz), 7.44 (2 H, m), 7.33 (2 H, m), 7.25 (3 H, m), 7.04 (3 H, m), 4.40 (2 H, s), 3.75 (1 H, m), 3.55 (1 H, m), 3.24 (1 H, m), 3.0 (1 H, m), 2.9 (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 161.9, 159.2, 158.8, 153.7, 146.7, 143.9, 140.1, 130.9, 128.9, 128.5, 127.6, 122.0, 117.5, 114.7, 114.2, 103.2, 90.8, 53.2, 48.1, 48.0, 42.8.</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 4-Aminobenzene-1,3-dicarbonitrile (<b>27d</b>)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></h4><div class="NLM_p last">A dry round-bottom flask was charged with 2-amino-5-bromo benzonitrile (1.5 g, 7.5 mmol, 1.0 equiv) and zinc cyanide (880 mg, 7.5 mmol, 1.0 equiv) and DMF (15 mL). Nitrogen was bubbled through the solution for 5 min, and then Pd[P(Ph)<sub>3</sub>]<sub>4</sub> (693 mg, 0.6 mmol, 8 mol%) was added in one portion. The reaction mixture was stirred at 90 °C overnight. After cooling to room temperature, NaHCO<sub>3</sub> (aq, sat.) was added, and the mixture was extracted with EtOAc. The organic extracts were collected and dried with Na<sub>2</sub>SO<sub>4</sub>. Evaporation of the solvent under reduced pressure and purification by column chromatography on silica gel (2% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) afforded <b>27d</b> (900 mg, 84%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) 7.70 (1 H, d, <i>J</i> = 1.8 Hz), 7.55 (1 H, d, <i>J</i> = 8.7, 1.8 Hz), 6.78 (1 H, d, <i>J</i> = 8.7 Hz), 4.93 (1 H, bs). GC/MS (<i>m/z %</i>) 143 (M<sup>+</sup>, 100%), 116 (M<sup>+</sup>-HCN, 30%), <i>R</i><sub>t</sub> 14.4 min.</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 4-Amino-3-[6-(4-methylpiperazinyl)benzimidazol-2-yl]-2-oxohydroquinoline-6-carbonitrile (<b>19ai</b>)</h4><div class="NLM_p last">Method A (24% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.61 (1 H, bs), 11.09 (1 H, s), 8.88 (1 H, d, <i>J</i> = 1.5 Hz), 7.95 (1 H. dd, <i>J</i> = 8.7, 1.5 Hz), 7.66 (1 H, d, <i>J</i> = 8.7 Hz), 7.47 (1 H, d, <i>J</i> = 9.0 Hz), 7.29 (1 H, s), 7.28 (1 H, d, <i>J</i> = 9.0 Hz), 3.82 (2 H, m), 3.52 (2 H, m), 3.29 (4 H, m), 2.80, (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 161.6, 153.8, 147.6, 146.7, 142.5, 135.3, 134.4, 130.4, 128.6, 119.5, 117.9, 116.9, 115.3, 113.7, 104.4, 101.2, 90.2, 52.5, 47.7, 42.5. LCMS (<i>m</i>/<i>z</i>) 400.4 (MH<sup>+</sup>), R<sub>t</sub> 1.89 min.</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 4-Amino-3-[6-(4-methylpiperazinyl) benzimidazol-2-yl]-2-oxohydroquinoline-6-carboxylic acid (<b>19aj</b>)</h4><div class="NLM_p last">Compound <b>19ai</b> (24 mg, 0.06 mmol, 1.0 equiv) was dissolved in a 1:1 mixture of EtOH and 30% aq NaOH (2 mL). The solution was heated to 100 °C for 2 h. The mixture was cooled to room temperature, concentrated, and neutralized with 1 N HCl. The precipitate was filtered and washed with H<sub>2</sub>O twice and dried to afford the desired <b>19aj</b> in quantitative yield. LCMS (<i>m</i>/<i>z</i>) 419.2 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.35 min.</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> {4-Amino-3-[6-(4-methylpiperazinyl)benzimidazol-2-yl]-2-<i>oxo</i>(6-hydroquinolyl)}-<i>N</i>-benzylcarboxamide (<b>19t</b>)</h4><div class="NLM_p last">Compound <b>19aj</b> (25 mg, 0.06 mmol, 1.0 equiv) was suspended in DMF (2 mL). Triethylamine (0.016 mL, 0.12 mmol, 2.0 equiv) and benzylamine (0.009 mL, 0.08 mmol, 1.2 equiv) were added, followed by EDC (16 mg, 0.08 mmol, 1.2 equiv) and HOAT (11 mg, 0.08 mmol, 1.2 equiv). The reaction mixture was stirred at room temperature for 2 days. Water was then added, and the mixture was extracted with EtOAc. The residue was purified by reverse phase HPLC to give <b>19t</b> (13.8 mg, 45%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.67 (1 H, s), 11.49 (1 H, bs), 9.42 (1 H, app. t, <i>J</i> = 5.4 Hz), 9.27 (1 H, s), 8.50 (1 H, bs), 8.11 (1 H, dd, <i>J</i> = 8.4, 1.2 Hz), 7.65 (1 H, d, <i>J</i> = 9.6 Hz), 7.4−7.1 (7 H, m), 4.49 (2 H, app d, <i>J</i> = 5.7 Hz), 3.82 (2 H, m), 3.51 (2 H, m), 3.24 (4 H, m), 2.80, (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 165.1, 161.1, 154.3, 147.2, 146.4, 140.8, 139.8, 133.5, 131.4, 128.2, 127.4, 127.2, 126.7, 124.1, 116.0, 115.8, 114.5, 112.1, 100.2, 88.9, 52.0, 46.9, 42.6, 41.9. LCMS (<i>m</i>/<i>z</i>) 508.5 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 2.11 min.</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 4-Amino-7-fluoro-3-[6-(4-methylpiperazinyl)benzimidazol-2-yl]hydroquinolin-2-one (<b>19u</b>)</h4><div class="NLM_p last">Method A (46% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.45 (1 H, s), 9.9 (1 H, bs), 8.25 (1 H, dd, <i>J</i> = 8.8, 5.8 Hz), 7.55 (1 H, d, <i>J</i> = 8.8 Hz), 7.38 (1 H, s), 7.1 (2 H, m), 6.95 (1 H, dd, <i>J</i> = 2.1, 8.8 Hz), 3.75 (1 H, m), 3.55 (1 H, m), 3.24 (1 H, m) 3.0 (1 H, m), 2.9 (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 166.5,163.2, 161.8, 154.5, 147.8, 147.5, 141.5, 134.3, 127.9, 127.7, 116.6, 115.1. HRMS found <i>m</i>/<i>z</i> 393.1811; C<sub>21</sub>H<sub>22</sub>N<sub>6</sub>OF requires 393.1833.</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 4-Amino-7-(methylamino)-3-[6-(4-methylpiperazinyl)benzimidazol-2-yl]hydroquinolin-2-one (<b>19v</b>)</h4><div class="NLM_p last">Compound <b>19u</b> (28 mg, 0.07 mmol, 1.0 equiv) was combined with MeNH<sub>2</sub> (8 M) and 1:1 EtOH:NMP (2 mL) and then heated under microwave irradiation 4 times for 5 min at 220 °C. After cooling, water was added and the mixture extracted with EtOAc. The organic extracts were collected and dried over Na<sub>2</sub>SO<sub>4</sub>. Evaporation of the solvent under reduced pressure, and purification of the residue by reverse phase HPLC afforded <b>19v</b> (7.1 mg, 21%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.64 (1 H, bs, NH), 11.11 (1 H, s, NH), 7.99 (1 H, d, <i>J</i> = 9.0 Hz), 7.62 (1 H, d, <i>J</i> = 9.6 Hz), 7.23 (1 H, d, <i>J</i> = 9.6 Hz), 7.22 (1 H, s), 6.56 (1 H, dd, <i>J</i> = 9.0, 1.8 Hz), 6.32 (1 H, d, <i>J</i> = 8.1, 1.8 Hz), 3.79 (2 H, m), 3.50 (2 H, m), 3.24 (4 H, m), 2.79 (3 H, bs), 2.72 (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 162.9, 155.3, 153.5, 148.1, 147.1, 142.2, 133.1, 126.8, 125.8, 116.7, 110.8, 103.2, 100.5, 94.9, 85.7, 52.6, 47.4, 42.5, 30.1. LCMS (<i>m</i>/<i>z</i>) 404.4 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.72 min. HRMS found <i>m</i>/<i>z</i> 404.2189; C<sub>22</sub>H<sub>26</sub>N<sub>7</sub>O requires 404.2193.</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-Amino-3-fluorobenzonitrile (<b>17a</b>)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></h4><div class="NLM_p last">2,3-Difluorobenzonitrile (2.0 g, 14.4 mmol, 1 equiv) was dissolved in anhydrous EtOH (25 mL) in a glass pressure vessel. The solution was saturated with gaseous NH<sub>3</sub>, and the vessel was sealed. The reaction mixture was stirred at 140 °C for 3 days and then cooled to room temperature. Evaporation of the solvent under reduced pressure and purification of the residue by chromatography (3:1 EtOAc:hexanes) on silica gel afforded <b>17a</b> (1.0 g, 51%). GC/MS (<i>m/z %</i>) 136 (M<sup>+</sup>, 100%), 109 (M<sup>+</sup>-HCN, 30%) <i>R</i><sub>t</sub> 7.93 min.</div></div><div id="sec5_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 4-Amino-8-fluoro-3-[6-(4-methylpiperazinyl)benzimidazol-2-yl]hydroquinolin-2-one (<b>19w</b>)</h4><div class="NLM_p last">Method A (45% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.40 (1 H, s, NH) 8.61 (1 H, bs, NH), 8.1 (1 H, d, <i>J</i><sub>H−H</sub> = 8.4 Hz), 7.64 (1 H, d, <i>J</i><sub>H−H</sub> = 9.0 Hz), 7.51 (1 H, dd, <i>J</i><sub>H−F</sub> = 10.7, <i>J</i><sub>H−H</sub> = 7.8 Hz), 7.26 (1 H, d, <i>J</i><sub>H−H</sub> = 2.1 Hz), 7.21 (1 H, dd, <i>J</i><sub>H−H</sub> = 9.0, 2.1 Hz), 7.20 (1 H, ddd, <i>J</i><sub>H−H</sub> = 8.4, 7.8, <i>J</i><sub>H−F</sub> = 3.0 Hz), 3.80 (2 H, m), 3.51 (2 H, m), 3.22 (4 H, m), 2.8 (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 161.7, 154.1, 149.9 (d, <i>J</i><sub>C−F</sub> = 244.0 Hz, C ipso), 147.7, 135.8, 135.0, 128.4 (d, <i>J</i><sub>C−F</sub> = 14.5 Hz), 121.9, 120.3, 117.8, 116.3, 115.7, 115.3, 100.8, 90.4, 52.8, 47.6, 42.5. LCMS (<i>m</i>/<i>z</i>) 393.1 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.48 min. HPLC <i>R</i><sub>t</sub> 14.96 min. HRMS found <i>m</i>/<i>z</i> 393.1802; C<sub>21</sub>H<sub>22</sub>N<sub>6</sub>OF requires 393.1833.</div></div><div id="sec5_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 4-Amino-6,7-difluoro-3-(6-(4-methylpiperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)quinolin-2(1<i>H</i>)-one (<b>19x</b>)</h4><div class="NLM_p last">Synthesized via modified isatoic anhydride route as previously described.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (28% yield for 3 steps). LCMS (<i>m</i>/<i>z</i>) 411.3 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.82 min.</div></div><div id="sec5_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 6-Amino-2,4-difluorobenzenecarbonitrile (<b>17b</b>)<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></h4><div class="NLM_p last">2,4,6-Trifluorobenzonitrile (160 mg, 1 mmol, 1.0 equiv) was dissolved in CH<sub>3</sub>CN and conc NH<sub>4</sub>OH (2:1, 6 mL). The reaction mixture was stirred at room temperature for 3 days. The reaction mixture was then diluted with CH<sub>2</sub>Cl<sub>2</sub>. The organic phase was washed with H<sub>2</sub>O, brine, and then dried with Na<sub>2</sub>SO<sub>4</sub>. Evaporation of the solvent under reduced pressure afforded a mixture of 2-amino-4,6-difluorobenzonitrile (<b>17b</b>) and 4-amino-2,6-difluorobenzonitrile. The two isomers were separated by flash chromatography on silica gel (1:2 EtOAc:hexanes) and the desired 2-amino-4,6-difluorobenzonitrile (<b>17b</b>) in 47% yield (72 mg). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) 6.25 (1H, ddd, <i>J</i><sub>H−F</sub> = 10.8, 9.9, <i>J</i><sub>H−H</sub> = 2.1 Hz) 6.23 (1H, dd, <i>J</i><sub>H−F</sub> = 10.7, <i>J</i><sub>H−H</sub> = 2.1 Hz); GC/MS (<i>m</i>/<i>z</i> %) 154 (M<sup>+</sup>, 100%).</div></div><div id="sec5_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 4-Amino-5,7-difluoro-3-[6-(4-methylpiperazinyl)benzimidazol-2-yl]hydroquinolin-2-one (<b>19y</b>)</h4><div class="NLM_p last">Method A (45% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): 11.75 (1 H, s, NH), 11.50 (1 H, bs, NH), 7.56 (1 H, d, <i>J</i><sub>H−H</sub> = 9.0 Hz), 7.37 (1 H, dd, <i>J</i><sub>H−F</sub> = 11.4, <i>J</i><sub>H−H</sub> = 2.1 Hz), 7.26 (1 H, d, <i>J</i><sub>H−H</sub> = 1.8 Hz), 7.14 (1 H, ddd, <i>J</i><sub>H−F</sub> = 11.4, 9.0, <i>J</i><sub>H−H</sub> = 2.1 Hz), 7.03 (1 H, dd, <i>J</i><sub>H−H</sub> = 9.0, 1.8 Hz), 3.73 (2 H, m), 3.48 (2 H, m), 3.20 (4 H, m), 2.78 (3 H, s). LCMS (<i>m</i>/<i>z</i>) 411.2 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.94 min.</div></div><div id="sec5_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 4-Amino-7-(dimethylamino)-6-fluoro-3-(6-(4-methylpiperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)quinolin-2(1<i>H</i>)-one (<b>19z</b>)</h4><div class="NLM_p last">Compound <b>19x</b> (0.0569 mg, 0.14 mmol, 1.0 equiv) and Me<sub>2</sub>NH (2 M in THF, 1.0 mL, 2.0 mmol, 13.3 equiv) were heated in NMP (2 mL) at 80 °C overnight. After cooling, the reaction mixture was purified by reverse phase HPLC to afford <b>19z</b> (38.7 mg, 47% yield). LCMS (<i>m</i>/<i>z</i>) 436.2 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.85 min. HRMS found <i>m</i>/<i>z</i> 436.2274; C<sub>23</sub>H<sub>27</sub>N<sub>7</sub>OF requires 436.2255.</div></div><div id="sec5_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 2-(4-Methylpiperazinyl)-6-nitrobenzenecarbonitrile<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></h4><div class="NLM_p last">Yield 69%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 7.83 (1 H, dd, <i>J</i> = 8.1, 1.2 Hz), 7.78 (1 H, t, <i>J</i> = 8.1 Hz), 7.58 (1 H, dd, <i>J</i> = 8.1, 1.2 Hz), 3.23 (4 H, t, <i>J</i> = 4.8 Hz), 2.49 (4 H, t, <i>J</i> = 4.8 Hz), 2.22 (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 157.7 (C), 150.4 (C), 134.3 (CH), 125.3 (CH), 117.8 (CH), 114.2 (C), 98.7 (C), 54.4 (CH<sub>2</sub>), 51.2 (CH<sub>2</sub>), 45.6 (CH<sub>3</sub>). LCMS <i>m</i>/<i>z</i> 247.2 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.64 min. Anal. calcd for C<sub>12</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub>: C, 58.53; H, 5.73; N, 22.75; found: C, 58.60; H, 5.74, N, 22.62.</div></div><div id="sec5_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 6-Amino-2-(4-methylpiperazinyl)benzenecarbonitrile (<b>27a</b>)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></h4><div class="NLM_p last">Yield 28%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 7.14 (1 H, t, <i>J</i> = 8.2 Hz), 6.38 (1 H, dd, <i>J</i> = 8.2, 0.9 Hz), 6.19 (1 H, dd, <i>J</i> = 8.2, 0.9 Hz), 3.02 (4 H, t, <i>J</i> = 4.5 Hz), 2.46 (4 H, t, <i>J</i> = 4.5 Hz), 2.22 (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 156.1 (C), 153.2 (C), 134.0 (CH), 117.3 (C), 108.8 (CH), 105.2 (CH), 88.5 (C), 54.7 (CH<sub>2</sub>), 51.2 (CH<sub>2</sub>), 45.7 (CH<sub>3</sub>). LCMS <i>m</i>/<i>z</i> 217.4 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 0.99 min. Anal. calcd for C<sub>12</sub>H<sub>16</sub>N<sub>4</sub>: C, 66.64; H, 7.46; N, 25.90; found: C, 66.68; H, 7.40, N, 25.90.</div></div><div id="sec5_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 4-Amino-3-benzimidazol-2-yl-5-(4-methylpiperazinyl)hydroquinolin-2-one (<b>19aa</b>)</h4><div class="NLM_p last">Method A (15% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.47 (2 H, s), 9.70 (2 H, bs), 7.72 (2 H, dd, <i>J</i> = 6.0, 3.3 Hz), 7.55 (1 H, t, <i>J</i> = 8.0 Hz), 7.34 (2 H, dd, <i>J</i> = 6.0, 3.3 Hz), 7.20 (1 H, d, <i>J</i> = 8.0 Hz), 7.06 (1 H, d, <i>J</i> = 8.0 Hz), 4.80 (6 H, bs), 3.41 (8 H, m,), 2.83 (3 H, d, <i>J</i> = 4.2 Hz). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 160.7 (C), 156.1 (C), 150.4 (C), 149.0 (C), 140.5 (C), 133.8 (C), 132.5 (CH), 123.3 (CH), 113.7 (CH), 113.5 (CH), 106.5 (C), 88.9 (C), 52.2 (CH<sub>2</sub>), 50.2 (CH<sub>2</sub>), 42.2 (CH<sub>3</sub>). LCMS <i>m</i>/<i>z</i> 375.4 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.74 min. HRMS found <i>m</i>/<i>z</i> 375.1897; C<sub>21</sub>H<sub>23</sub>N<sub>6</sub>O requires 375.1927.</div></div><div id="sec5_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 6-Amino-2-(1-methyl(3-piperidyloxy))benzenecarbonitrile (<b>27b</b>)</h4><div class="NLM_p last">3-Hydroxy-1-methylpiperidine (4.1 mL, 35.6 mmol) was added dropwise to hexane-washed NaH (1.03 g, 43.0 mmol) in NMP (30 mL). After 15 min, 2-amino-6-fluorobenzonitrile (4.03 g, 29.6 mmol) was added in portions. The reaction mixture was heated to 100 °C for 2 h. The reaction mixture was poured into H<sub>2</sub>O and extracted with EtOAc (2×). The combined organic layers were washed with H<sub>2</sub>O (3×) and brine. The organic layer was dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by column chromatography on silica gel (50% EtOAc/hex to EtOAc to 5% MeOH/1% Et<sub>3</sub>N/94% CH<sub>2</sub>Cl<sub>2</sub>) to give <b>27b</b> (3.31 g, 49% yield) as a brown solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 7.13 (1 H, t, <i>J</i> = 8.4 Hz), 6.31 (1 H, d, <i>J</i> = 8.4 Hz), 6.24 (1 H, d, <i>J</i> = 8.4 Hz), 5.93 (2 H, s), 4.36 (1 H, sept, <i>J</i> = 4.5 Hz), 2.80 (1 H, m), 2.49 (1 H, m), 2.14 (3 H, s), 1.98 (3 H, m), 1.69 (1 H, m), 1.51 (1 H, m), 1.25 (1 H, m). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 159.6 (C), 153.1 (C), 134.3 (CH), 115.6 (C), 107.3 (CH), 99.8 (CH), 85.4 (C), 73.0 (CH), 59.0 (CH<sub>2</sub>), 54.7 (CH<sub>2</sub>), 45.9 (CH<sub>3</sub>), 29.0 (CH<sub>2</sub>), 22.4 (CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 232.3 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.47 min.</div></div><div id="sec5_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 4-Amino-3-benzimidazol-2-yl-5-(1-methyl(3-piperidyloxy))hydroquinolin-2-one (<b>19ab</b>)</h4><div class="NLM_p last">Method A (8% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 11.55 (1H, bs), 11.50 (1 H, s), 11.43 (1 H, s), 10.57 (1 H, bs), 8.90 (2 H, bs), 7.73 (2 H, p, <i>J</i> = 3.3 Hz), 7.51 (1 H, dt, <i>J</i> = 8.4, 1.8 Hz), 7.36 (2 H, p, <i>J</i> = 3.3 Hz), 7.04 (1 H, d, <i>J</i> = 8.4 Hz), 6.97 (1 H, dd, <i>J</i> = 24.3, 8.4 Hz), 5.15 (1 H, bs), 4.90 (4 H, bs), 3.79 (1 H, m), 3.21 (3 H, m), 2.80 (3 H, s), 2.07 (4 H, m). <sup>13</sup>C NMR of HCl salt (75 MHz, DMSO-<i>d</i><sub>6</sub>) 160.8 (C), 156.1/156.0 (C), 155.7/155.5 (C), 148.5/148.4 (C), 141.0/140.8 (C), 133.8/133.1 (CH), 123.5 (CH), 113.9 (CH), 109.9/109.5 (CH), 106.2/105.9 (CH), 103.9/103.3 (C), 88.5/87.6 (C), 71.7 (CH), 54.1/52.6 (CH<sub>2</sub>), 43.1/42.6 (CH<sub>3</sub>), 27.3/25.4 (CH<sub>2</sub>), 20.3/18.2 (CH<sub>2</sub>). LCMS <i>m</i>/<i>z</i> 390.4 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.98 min. HRMS found <i>m</i>/<i>z</i> 390.1900; C<sub>22</sub>H<sub>24</sub>N<sub>5</sub>O<sub>2</sub> requires 390.1924. Anal. calcd for C<sub>22</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub>: C, 67.85; H, 5.95; N, 17.98; found: C, 67.48; H, 6.01, N, 17.78.</div></div><div id="sec5_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 5-(4-Methylpiperazinyl)-2-nitrobenzenecarbonitrile<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></h4><div class="NLM_p last">Yield 95%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 8.15 (1 H, d, <i>J</i> = 8.2 Hz), 7.52 (1 H, d, <i>J</i> = 2.1 Hz), 7.24 (1 H, dd, <i>J</i> = 8.2, 2.1 Hz), 3.53 (4 H, m), 2.41 (4 H, m), 2.21 (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 153.4 (C), 135.5 (C), 127.9 (CH), 118.9 (CH), 116.2 (C), 115.5 (CH), 109.1 (C), 54.0 (CH<sub>2</sub>), 46.2 (CH<sub>2</sub>), 45.5 (CH<sub>3</sub>). LCMS <i>m</i>/<i>z</i> 247.3 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.62 min.</div></div><div id="sec5_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 2-Amino-5-(4-methylpiperazinyl)benzenecarbonitrile (<b>27c</b>)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></h4><div class="NLM_p last">Yield 91%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 7.07 (1 H, dd, <i>J</i> = 9.0, 2.7 Hz), 6.84 (1 H, d, <i>J</i> = 2.7 Hz), 6.75 (1 H, d, <i>J</i> = 9.0 Hz), 2.92 (4 H, t, <i>J</i> = 4.8 Hz), 2.40 (4 H, t, <i>J</i> = 4.8 Hz), 2.18 (3 H, s). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) 145.7 (C), 142.1 (C), 125.1 (CH), 118.5 (C), 117.7 (CH), 116.7 (CH), 93.7 (C), 54.7 (CH<sub>2</sub>), 49.5 (CH<sub>2</sub>), 45.7 (CH<sub>3</sub>). LCMS <i>m</i>/<i>z</i> 217.4 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 0.70 min.</div></div><div id="sec5_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 4-Amino-3-benzimidazol-2-yl-6-(4-methylpiperazinyl)hydroquinolin-2-one (<b>19ac</b>)</h4><div class="NLM_p last">Method A (1% Yield). LCMS <i>m</i>/<i>z</i> 375.4 (MH<sup>+</sup>), <i>R</i><sub>t</sub> 1.87 min. HRMS found <i>m</i>/<i>z</i> 375.1909; C<sub>21</sub>H<sub>23</sub>N<sub>6</sub>O requires 375.1927.</div></div></div><div id="sec5_1_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Molecular Modeling</h3><div class="NLM_p last">The VEGFR-2 homology model was built using Chemical Computing Group’s MOE software. Default settings were used in the alignment and homology modeling module and the FGFR-1 crystal structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FGI">2FGI</a> from the Brookhaven Protein Data Bank was used as a template. The model was brought into Maestro (version 8.0.308, Schrödinger LLC) and aligned with the CHK-1 crystal structure of the 6-Cl analogue of <b>16c</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GDO">2GDO</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The 4-amino-3-benzimidazol-2-ylhydroquinolin-2-one core was extracted from the CHK-1 structure and placed into the aligned active site of the VEGFR-2 homology model. The complex was prepared for Prime optimization using the Protein Preparation Wizard in Maestro (fixing bond orders, adding hydrogens, optimizing hydrogen bonds, optimizing hydrogens). A Prime optimization (Prime version 1.6) was performed on the core and the residues in a 6 Å sphere around it, resulting in a binding pose of the core with 3 hydrogen bonds to the hinge region (to Glu917-CO, Cys919-NH, Cys919-CO). A Glide grid was subsequently created using default settings (Glide version 45208) around the optimized core, and used to dock ligands like <b>5</b>, after creating their input conformations through LigPrep (version 21207) and using SP precision (GlideScore version SP4.5).</div></div><div id="sec5_1_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> In Vitro Kinase Assays</h3><div class="NLM_p">FGFR-1, PDGFRβ, and VEGFR-2 receptor tyrosine kinases used in isolated enzyme assays were purified from insect cell lysates that were infected with recombinant baculovirus containing the respective human kinase domains. All kinases contained the wild type amino acid sequence.</div><div class="NLM_p">The IC<sub>50</sub> values for the inhibition of RTKs were determined in the Alpha Screen format by measuring the inhibition by compound of phosphate transfer to a peptide substrate by the respective enzyme. Briefly, the respective RTK cytosolic domain was purchased as human recombinant protein (VEGFR-2, Invitrogen no. PV3660, PDGFRβ Invitrogen no. P3082, and FGFR-1 Upstate 14-582) were incubated with serial dilutions of compound in the presence of peptide substrate and ATP at concentrations at or below the Km<sub>(app)</sub> of ATP.</div><div class="NLM_p last">The kinase domain of FGFR-1 was assayed in 50 mM Hepes, pH 7.5, 2 mM MgCl<sub>2</sub>, 5 mM MnCl<sub>2</sub>, 1 mM DTT, 0.1% BSA with 0.2 μM biotinylated peptide substrate (b-GGGGQDGKDYIVLPI-NH<sub>2</sub>), VEGFR-2 in 50 mM Hepes, pH 7.5, 5 mM MnCl<sub>2</sub>, 0.1%BSA, 0.01%Tween-20, 1 mM DTT, and 1 μM of the same biotinylated substrate and PDGFRβ in 50 mM Hepes, pH 7.5, 20 mM MgCl<sub>2</sub>, 1 mM DTT, 0.1% BSA with 0.1 μM biotinylated peptide substrate (b-GGLFDDPSYVNVQNL-NH<sub>2</sub>) at ATP concentrations of 5, 1, and 10 μM, respectively, depending on the ATP Km<sub>(app)</sub> for the respective enzyme. Reactions were incubated at room temperature for 2.5 h and then stopped with buffer (70 mM Tris, pH 7.5, 17.1 mM EDTA, 0.011% Tween-20 for PDGFRβ and FGFR-1; 50 mM Hepes, pH 7.5, 60 mM EDTA, 0.1% BSA, 0.01% Tween-20 for VEGFR-2). Next the stopped reactions were incubated with PY20 Ab/Alpha Screen IgG beads overnight and then read on an Alpha Screen reader. The concentration of compound for 50% inhibition (IC<sub>50</sub>) was calculated by employing nonlinear regression using XL-Fit data analysis software and represents the average of at least 2 experiments. As a control compound, staurosporine is run on every assay plate. Additionally, a <i>Z</i>′ > 0.5 is required to validate results for each plate.</div></div><div id="sec5_1_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Cell Proliferation Assays</h3><div class="NLM_p last">HMVECs (human microvascular endothelial cells) were purchased from Clonetics (San Diego, CA). Cells were grown as monolayers in media (EBM-2MV from Clonetics) and maintained at 37 °C in a humidified atmosphere with 5% CO<sub>2</sub>. To perform the VEGF-mediated proliferation assay, cells were seeded in 96-well plates at 2000 cells per well in assay medium (EBM-2 with 5% FBS). The following day, serial dilutions of compound at 0.2% final DMSO concentration in assay medium with 2.5 ng/mL of VEGF were added to the cells. Control wells contained cells in assay medium without the VEGF. After 72 h, the number of viable cells left was determined using the CellTiter-Glo<sup></sup> assay (Promega, Madison, WI) as described by the manufacturer. Plates were read on a luminometer. The IC<sub>50</sub> values were calculated using nonlinear regression using XL Fit data analysis software and represent the average of two experiments.</div></div><div id="sec5_1_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> Cell Lines</h3><div class="NLM_p last">Human colon tumor cell lines (KM12L4A), prostate (DU145), and acute myelogenous leukemia (AML) FLT-3 ITD cell line (MV4;11) were obtained from American Tissue Culture Collection (Rockville, MD). KM12L4A, or DU145, cells were cultured in RPMI 1640 (Life Technologies, Gaithersburg, MD) supplemented with 10% fetal bovine serum (FBS) and 1% <span class="smallcaps smallerCapital">l</span>-glutamine. MV4;11 cells were grown in Iscoves modified Dulbecco medium (IMBM) supplemented with 10% fetal bovine serum (FBS, Gibco Life Technologies, Gaithersburg, MD) containing 4 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 5 ng/mL granulocyte-macrophage colony stimulating factor (GM-CSF, R&D Systems, Minneapolis, MN), and 1% penicillin and streptomycin. Cells were grown as adherent or suspension cultures and maintained in a humidified atmosphere at 37 °C and 5% CO<sub>2</sub>. Cells were used in exponential growth phase, with viability >98% (assessed using trypan blue staining) and determined free of mycoplasma.</div></div><div id="sec5_1_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> In Vivo bFGF-Mediated Matrigel Angiogenesis Assays</h3><div class="NLM_p last">A mixture of 0.5 mL of Matrigel (Becton Dickinson, Bedford, MA) with 2 μg of bFGF (Chiron Corporation; Emeryville, CA) was implanted subcutaneously into female BDF1 mice (Charles River, Wilmington, MA). Vehicle or doses of <b>5</b> (HCl salt, formulated in 5 mM citrate) ranging from 0 to 200 mg/kg/d was given daily via oral gavage for 8 days. On day 8, 4 h post dose, Matrigel plugs were removed and homogenized in 0.5 mL deionized water using a Polytron homogenizer (Kinematica Littau, Switzerland). Hemoglobin content in Matrigel plugs was quantified by a colorimetric assay using Drabkin’s procedure (Hemoglobin Test Kit, Sigma Diagnostics, St. Louis, MO).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> In Vivo Tumor Efficacy Studies</h3><div class="NLM_p last">Nude (nu/nu) or SCID-NOD mice (6−8 week-old, 18−22 g) were obtained from Charles River (Wilmington, MA) and acclimated for 1 week in a pathogen-free enclosure prior to the start of the study. MV4;11 cells (5 × 10<sup>6</sup> cells/mouse) were reconstituted with 50% Matrigel (Becton Dickinson) and implanted sc into the right flank of SCID-NOD mice. KM12L4A (2 × 10<sup>6</sup> cells) were implanted subcutaneously into the flank of female nude mice. DU145 tumor pieces (2 mm × 2 mm) from a passaged DU145 tumor (500 mm<sup>3</sup>) were implanted subcutaneously using a trocar into male nude mice. Tumors were allowed to grow to a size of approximately 200−500 mm<sup>3</sup> prior to initiation of drug treatment. Mice were randomly assigned into cohorts (typically 10 mice/group) and treated with either vehicle or <b>5</b> (10−100 mg/kg/d) once daily by oral gavage. Tumor volumes and body weights were assessed 2−3 times weekly. Caliper measurements of tumors were converted into mean tumor volume (mm<sup>3</sup>) using the formula: <sup>1</sup>/<sub>2</sub> (length (mm) × [width (mm)]<sup>2</sup>). Percent tumor growth inhibition (TGI) was determined as [1 − (mean tumor volume of each <b>5</b>-treated dose group/mean tumor volume of vehicle-treated group)] × 100. Statistical analyses: Student’s <i>t</i> test was used to measure statistical significance between two treatment groups. Multiple comparisons were done using one-way analysis of variance (ANOVA), and post-tests comparing different treatment means were done using either Student−Newman−Keuls or Dunn’s test (SigmaStat, San Rafael, CA). Differences were considered statistically significant at <i>p</i> < 0.05.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i93"><a href="/doi/suppl/10.1021/jm800790t">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74372" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74372" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis data or high resolution mass spectrometry data for key compounds, MS, HPLC traces, and <sup>1</sup>H NMR for <b>5</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800790t/suppl_file/jm800790t_si_001.pdf">jm800790t_si_001.pdf (417.7 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm800790t" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88010" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88010" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul A. Renhowe</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ec9c8d9980c29e898284839b89ac82839a8d9e98859fc28f8381"><span class="__cf_email__" data-cfemail="661607130a481403080e091103260809100714120f154805090b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sabina Pecchi</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cynthia M. Shafer</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy D. Machajewski</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisa M. Jazan</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clarke Taylor</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William Antonios-McCrea</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher M. McBride</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kelly Frazier</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marion Wiesmann</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gena R. Lapointe</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul H. Feucht</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert L. Warne</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carla C. Heise</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Menezes</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly Aardalen</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Helen Ye</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Molly He</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincent Le</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jayesh Vora</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johanna M. Jansen</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Ellen Wernette-Hammond</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alex L. Harris</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608-2419</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i92">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50832" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50832" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Lara Nordhal and Yan Tang for their excellent technical expertise with the in vivo studies, and Weiping Jia, Keshi Wang, and Dazhi Tang for their analytical support.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Folkman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abernathy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G.</span><span> </span><span class="NLM_article-title">Isolation of a tumor factor responsible for angiogenesis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=1971&pages=275-288&issue=2&author=J.+Folkmanauthor=E.+Merlerauthor=C.+Abernathyauthor=G.+Williams&title=Isolation+of+a+tumor+factor+responsible+for+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26aulast%3DMerler%26aufirst%3DE.%26aulast%3DAbernathy%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DG.%26atitle%3DIsolation%2520of%2520a%2520tumor%2520factor%2520responsible%2520for%2520angiogenesis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1971%26volume%3D133%26issue%3D2%26spage%3D275%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Carmeliet, P.</span><span> </span><span class="NLM_article-title">Mechanisms of angiogenesis and arteriogenesis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1038%2F74651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=10742145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVOrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=389-395&issue=4&author=P.+Carmeliet&title=Mechanisms+of+angiogenesis+and+arteriogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of angiogenesis and arteriogenesis</span></div><div class="casAuthors">Carmeliet, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">389-395</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">A review with 71 refs., on the cellular and mol. mechanisms underlying the formation of endothelium-lined channels (angiogenesis) and their maturation via recruitment of smooth muscle cells (arteriogenesis) during physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC5duTZ_-aV7Vg90H21EOLACvtfcHk0lhvN1mpfqFUPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVOrur4%253D&md5=a8a3874f286a4e46a9eeaaa9ff8b17dc</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F74651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F74651%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DMechanisms%2520of%2520angiogenesis%2520and%2520arteriogenesis%26jtitle%3DNat.%2520Med.%26date%3D2000%26volume%3D6%26issue%3D4%26spage%3D389%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Penault-Llorca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelaiede, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquemier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLapeyriere, O.</span><span> </span><span class="NLM_article-title">Expression of FGF and FGF receptor genes in human breast cancer</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1002%2Fijc.2910610205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=7705943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADyaK2MXlsVCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1995&pages=170-176&issue=2&author=F.+Penault-Llorcaauthor=F.+Bertucciauthor=J.+Adelaiedeauthor=P.+Parcauthor=F.+Coulierauthor=J.+Jacquemierauthor=D.+Birnbaumauthor=O.+DeLapeyriere&title=Expression+of+FGF+and+FGF+receptor+genes+in+human+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of FGF and FGF receptor genes in human breast cancer</span></div><div class="casAuthors">Penault-Llorca, Frederique; Bertucci, Francois; Adelaiede, Jose; Parc, Patricia; Coulier, Francois; Jacquemier, Jocelyne; Birnbaum, Daniel; DeLapeyriere, Odile</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">170-6</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">The family of FGF growth factors is involved in several biol. processes and might play an important role in tumorigenesis.  The authors have studied the resp. expression of 8 of the 9 characterized FGF genes, and of the 4 known FGF receptor genes, in a panel of 10 tumor-cell lines and 103 breast-tumor samples, using RT-PCR and Northern-blot analyses.  FGF1 and FGF2 were expressed in almost all samples, whereas expression of FGF5, FGF6, FGF7 and FGF9 was more restricted.  FGFR1, FGFR2, and FGFR4 were expressed at high levels in resp. 22%, 4%, and 32% of tumors.  FGFR3 expression was not detected.  The transcript encoding an FGFR1 isoform with 2 Ig-like domains was the most prevalent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM4Ndkn4BdcLVg90H21EOLACvtfcHk0lhvN1mpfqFUPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsVCmt7g%253D&md5=ce0eda6c49f3504d032c36d6cfb805e5</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910610205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910610205%26sid%3Dliteratum%253Aachs%26aulast%3DPenault-Llorca%26aufirst%3DF.%26aulast%3DBertucci%26aufirst%3DF.%26aulast%3DAdelaiede%26aufirst%3DJ.%26aulast%3DParc%26aufirst%3DP.%26aulast%3DCoulier%26aufirst%3DF.%26aulast%3DJacquemier%26aufirst%3DJ.%26aulast%3DBirnbaum%26aufirst%3DD.%26aulast%3DDeLapeyriere%26aufirst%3DO.%26atitle%3DExpression%2520of%2520FGF%2520and%2520FGF%2520receptor%2520genes%2520in%2520human%2520breast%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1995%26volume%3D61%26issue%3D2%26spage%3D170%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kyzas, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batistatou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnantis, N. J.</span><span> </span><span class="NLM_article-title">Potential autocrine function of vascular endothelial growth factor in head and neck cancer via vascular endothelial growth factor receptor-2</span> <span class="citation_source-journal">Mod. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1038%2Fmodpathol.3800295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=15475932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVSht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=485-494&issue=4&author=P.+A.+Kyzasauthor=D.+Stefanouauthor=A.+Batistatouauthor=N.+J.+Agnantis&title=Potential+autocrine+function+of+vascular+endothelial+growth+factor+in+head+and+neck+cancer+via+vascular+endothelial+growth+factor+receptor-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Potential autocrine function of vascular endothelial growth factor in head and neck cancer via vascular endothelial growth factor receptor-2</span></div><div class="casAuthors">Kyzas, Panayiotis A.; Stefanou, Dimitrios; Batistatou, Anna; Agnantis, Niki J.</div><div class="citationInfo"><span class="NLM_cas:title">Modern Pathology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">485-494</span>CODEN:
                <span class="NLM_cas:coden">MODPEO</span>;
        ISSN:<span class="NLM_cas:issn">0893-3952</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Vascular endothelial growth factor is a peptide with well-defined actions on the vasculature and fundamental role in tumor angiogenesis.  Its action in vascular endothelium is exerted in a paracrine manner.  The immunohistochem. expression of this protein by cancer cells in head and neck squamous cell carcinoma was correlated with increased tumor aggressiveness and poor survival in previous studies.  In the past years, an increasing amt. of studies demonstrated potential autocrine action of vascular endothelial growth factor in various neoplasms.  However, the existence and the impact of such autocrine action in head and neck cancer have not been demonstrated yet.  In this retrospective study, we evaluated the expression of vascular endothelial growth factor and its receptors in neoplastic cells, in a cohort of patients with head and neck squamous cell carcinoma, and compared this expression with tumor aggressiveness, clinicopathol. parameters and outcome.  High expression of vascular endothelial growth factor was strongly correlated with high expression of vascular endothelial growth factor receptor-2 (but not vascular endothelial growth factor receptor-1) on the cancer cells (P<0.001).  The co-overexpression of both the protein and vascular endothelial growth factor receptor-2 was assocd. with higher tumor proliferation rate (P<0.001).  The above co-overexpression also correlated with worse survival (log rank P<0.05) in patients with oral-larynx squamous cell carcinoma.  Our results suggest that an autocrine vascular endothelial growth factor loop, mediated via vascular endothelial growth factor receptor-2, probably exists in head and neck squamous cell carcinoma.  These observations support the hypothesis that the use of vascular endothelial growth factor receptor-2 inhibitors as adjuvant antiangiogenic therapy might have beneficial effects for these patients, by disrupting both paracrine (endothelial-dependent) and autocrine actions of vascular endothelial growth factor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWBHGb6re0ybVg90H21EOLACvtfcHk0ljwDOepQniO9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVSht7g%253D&md5=29dc98d41d914a6b64703b1d2a16130b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fmodpathol.3800295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmodpathol.3800295%26sid%3Dliteratum%253Aachs%26aulast%3DKyzas%26aufirst%3DP.%2BA.%26aulast%3DStefanou%26aufirst%3DD.%26aulast%3DBatistatou%26aufirst%3DA.%26aulast%3DAgnantis%26aufirst%3DN.%2BJ.%26atitle%3DPotential%2520autocrine%2520function%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520in%2520head%2520and%2520neck%2520cancer%2520via%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%26jtitle%3DMod.%2520Pathol.%26date%3D2005%26volume%3D18%26issue%3D4%26spage%3D485%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Oestman, A.</span><span> </span><span class="NLM_article-title">PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma</span> <span class="citation_source-journal">Cytokine Growth Factor Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1016%2Fj.cytogfr.2004.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=15207817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltVKhtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=275-286&issue=4&author=A.+Oestman&title=PDGF+receptors-mediators+of+autocrine+tumor+growth+and+regulators+of+tumor+vasculature+and+stroma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma</span></div><div class="casAuthors">Oestman, Arne</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & Growth Factor Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">275-286</span>CODEN:
                <span class="NLM_cas:coden">CGFRFB</span>;
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with refs.  PDGFs and their cognate tyrosine kinase α- and β-receptors are involved in multiple tumor-assocd. processes including autocrine growth stimulation of tumor cells, stimulation of tumor angiogenesis and recruitment and regulation of tumor fibroblasts.  The recent development of clin. useful PDGF antagonists, like STI571/Glivec, has increased the interest in PDGF receptors as cancer drug targets.  Autocrine PDGF receptor signaling occurs in certain malignancies characterized by mutational activation of PDGF or PDGF receptors, for instance, dermatofibrosarcoma protuberans, gastrointestinal stromal tumors, and hypereosinophilic syndrome.  The roles of PDGF in regulation of tumor angiogenesis and tumor fibroblasts are more general, and probably occur in most common solid tumors.  Concerning tumor angiogenesis recent studies have predominantly focused on the importance of PDGF receptor signaling for tumor pericyte recruitment.  PDGF receptors in the tumor stroma have also attracted attention as interesting drug targets because of their function as regulators of tumor interstitial fluid pressure, tumor trans-vascular transport and tumor drug uptake.  In summary, the improved understanding of the role of PDGF signaling in tumor biol., and the introduction of PDGF antagonists, has set the stage for a continued development of PDGF antagonists as novel cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8-4CVipxax7Vg90H21EOLACvtfcHk0ljwDOepQniO9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltVKhtLw%253D&md5=1acb20873a7a3b8e18799bb255792a46</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cytogfr.2004.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cytogfr.2004.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DOestman%26aufirst%3DA.%26atitle%3DPDGF%2520receptors-mediators%2520of%2520autocrine%2520tumor%2520growth%2520and%2520regulators%2520of%2520tumor%2520vasculature%2520and%2520stroma%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2004%26volume%3D15%26issue%3D4%26spage%3D275%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Patel, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaganti, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motzer, R. J.</span><span> </span><span class="NLM_article-title">Targeted therapy for metastatic renal cell carcinoma</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=16465192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVyjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=614-619&issue=5&author=P.+H.+Patelauthor=R.+S.+Chagantiauthor=R.+J.+Motzer&title=Targeted+therapy+for+metastatic+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted therapy for metastatic renal cell carcinoma</span></div><div class="casAuthors">Patel, P. H.; Chaganti, R. S. K.; Motzer, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">614-619</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Metastatic renal cell carcinoma (RCC) has historically been refractory to cytotoxic and hormonal agents; only interleukin 2 and interferon alpha provide response in a minority of patients.  We reviewed RCC biol. and explored the ways in which this understanding led to development of novel, effective targeted therapies.  Small mol. tyrosine kinase inhibitors, monoclonal antibodies and novel agents are all being studied, and phase II studies show promising activity of sunitinib, sorafenib and bevacizumab.  The results of phase III studies will det. the role of these agents in metastatic RCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWE44JTS3olLVg90H21EOLACvtfcHk0ljwDOepQniO9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVyjsbk%253D&md5=fc726443c9e627eb2453ba04b93f2def</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DP.%2BH.%26aulast%3DChaganti%26aufirst%3DR.%2BS.%26aulast%3DMotzer%26aufirst%3DR.%2BJ.%26atitle%3DTargeted%2520therapy%2520for%2520metastatic%2520renal%2520cell%2520carcinoma%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D94%26issue%3D5%26spage%3D614%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Liao, J. J.-L.</span><span> </span><span class="NLM_article-title">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=409-424&issue=3&author=J.+J.-L.+Liao&title=Molecular+Recognition+of+Protein+Kinase+Binding+Pockets+for+Design+of+Potent+and+Selective+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span></div><div class="casAuthors">Liao, Jeffrey Jie-Lou</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-424</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Many kinase inhibitors have failed in preclin. or clin. development because of the lack of such selectivity that induces intolerable side effects, mostly because the catalytic cleft is highly conserved in sequence and conformation.  Systematic anal. of the crystal structures of protein kinases can offer insight into the design of highly selective kinase inhibitors to overcome these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDTl2SBUfbbVg90H21EOLACvtfcHk0lhs-ZZe7F2UkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D&md5=77542d3ba589bd834a0d2b97a24eea05</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm0608107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608107%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%2BJ.-L.%26atitle%3DMolecular%2520Recognition%2520of%2520Protein%2520Kinase%2520Binding%2520Pockets%2520for%2520Design%2520of%2520Potent%2520and%2520Selective%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D3%26spage%3D409%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Albert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magoc, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, R.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghoreishi-Haack, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukofzer, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavropoulos, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartandi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niquette, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCall, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donawho, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelides, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span> </span><span class="NLM_article-title">Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">1006</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1158%2F1535-7163.MCT-05-0410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=16648571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFCkt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=995-1006&issue=4&author=D.+H.+Albertauthor=P.+Tapangauthor=T.+J.+Magocauthor=L.+J.+Peaseauthor=D.+R.+Reuterauthor=R.-Q.+Weiauthor=J.+Liauthor=J.+Guoauthor=P.+F.+Bousquetauthor=N.+S.+Ghoreishi-Haackauthor=B.+Wangauthor=G.+T.+Bukofzerauthor=Y.-C.+Wangauthor=J.+A.+Stavropoulosauthor=K.+Hartandiauthor=A.+L.+Niquetteauthor=N.+Soniauthor=E.+F.+Johnsonauthor=J.+O.+McCallauthor=J.+J.+Bouskaauthor=Y.+Luoauthor=C.+K.+Donawhoauthor=Y.+Daiauthor=P.+A.+Marcotteauthor=K.+B.+Glaserauthor=M.+R.+Michaelidesauthor=S.+K.+Davidsen&title=Preclinical+activity+of+ABT-869%2C+a+multitargeted+receptor+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor</span></div><div class="casAuthors">Albert, Daniel H.; Tapang, Paul; Magoc, Terrance J.; Pease, Lori J.; Reuter, David R.; Wei, Ru-Qi; Li, Junling; Guo, Jun; Bousquet, Peter F.; Ghoreishi-Haack, Nayereh S.; Wang, Baole; Bukofzer, Gail T.; Wang, Yi-Chun; Stavropoulos, Jason A.; Hartandi, Kresna; Niquette, Amanda L.; Soni, Nirupama; Johnson, Eric F.; McCall, J. Owen; Bouska, Jennifer J.; Luo, Yanping; Donawho, Cherrie K.; Dai, Yujia; Marcotte, Patrick A.; Glaser, Keith B.; Michaelides, Michael R.; Davidsen, Steven K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">995-1006</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">ABT-869 is a structurally novel, receptor tyrosine kinase (RTK) inhibitor that is a potent inhibitor of members of the vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptor families (e.g., KDR IC50 = 4 nmol/L) but has much less activity (IC50s > 1 μmol/L) against unrelated RTKs, sol. tyrosine kinases, or serine/threonine kinases.  The inhibition profile of ABT-869 is evident in cellular assays of RTK phosphorylation (IC50 = 2, 4, and 7 nmol/L for PDGFR-β, KDR, and CSF-1R, resp.) and VEGF-stimulated proliferation (IC50 = 0.2 nmol/L for human endothelial cells).  ABT-869 is not a general antiproliferative agent because, in most cancer cells, >1,000-fold higher concns. of ABT-869 are required for inhibition of proliferation.  However, ABT-869 exhibits potent antiproliferative and apoptotic effects on cancer cells whose proliferation is dependent on mutant kinases, such as FLT3.  In vivo ABT-869 is effective orally in the mechanism-based murine models of VEGF-induced uterine edema (ED50 = 0.5 mg/kg) and corneal angiogenesis (>50% inhibition, 15 mg/kg).  In tumor growth studies, ABT-869 exhibits efficacy in human fibrosarcoma and breast, colon, and small cell lung carcinoma xenograft models (ED50 = 1.5-5 mg/kg, twice daily) and is also effective (>50% inhibition) in orthotopic breast and glioma models.  Redn. in tumor size and tumor regression was obsd. in epidermoid carcinoma and leukemia xenograft models, resp.  In combination, ABT-869 produced at least additive effects when given with cytotoxic therapies.  Based on pharmacokinetic anal. from tumor growth studies, efficacy correlated more strongly with time over a threshold value (cellular KDR IC50 cor. for blood plasma protein binding = 0.08 μg/mL, ≥7 h) than with plasma area under the curve or Cmax.  These results support clin. assessment of ABT-869 as a therapeutic agent for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkn2KBvMa4wrVg90H21EOLACvtfcHk0lhs-ZZe7F2UkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFCkt7g%253D&md5=a5a60b591b4da7a3c589f1618d9cffb9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0410%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DTapang%26aufirst%3DP.%26aulast%3DMagoc%26aufirst%3DT.%2BJ.%26aulast%3DPease%26aufirst%3DL.%2BJ.%26aulast%3DReuter%26aufirst%3DD.%2BR.%26aulast%3DWei%26aufirst%3DR.-Q.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DBousquet%26aufirst%3DP.%2BF.%26aulast%3DGhoreishi-Haack%26aufirst%3DN.%2BS.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DBukofzer%26aufirst%3DG.%2BT.%26aulast%3DWang%26aufirst%3DY.-C.%26aulast%3DStavropoulos%26aufirst%3DJ.%2BA.%26aulast%3DHartandi%26aufirst%3DK.%26aulast%3DNiquette%26aufirst%3DA.%2BL.%26aulast%3DSoni%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DMcCall%26aufirst%3DJ.%2BO.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DDonawho%26aufirst%3DC.%2BK.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DMarcotte%26aufirst%3DP.%2BA.%26aulast%3DGlaser%26aufirst%3DK.%2BB.%26aulast%3DMichaelides%26aufirst%3DM.%2BR.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26atitle%3DPreclinical%2520activity%2520of%2520ABT-869%252C%2520a%2520multitargeted%2520receptor%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26issue%3D4%26spage%3D995%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">George, D. J.</span><span> </span><span class="NLM_article-title">Phase 2 Studies of Sunitinib and AG013736 in Patients with Cytokine-Refractory Renal Cell Carcinoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">2, Pt. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">753s</span><span class="NLM_x">–</span> <span class="NLM_lpage">757s</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=753s-757s&issue=2%2C+Pt.+2&author=D.+J.+George&title=Phase+2+Studies+of+Sunitinib+and+AG013736+in+Patients+with+Cytokine-Refractory+Renal+Cell+Carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DD.%2BJ.%26atitle%3DPhase%25202%2520Studies%2520of%2520Sunitinib%2520and%2520AG013736%2520in%2520Patients%2520with%2520Cytokine-Refractory%2520Renal%2520Cell%2520Carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26issue%3D2%252C%2520Pt.%25202%26spage%3D753s%26epage%3D757s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lee, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes de Menezes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vora, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordahl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aukerman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C.</span><span> </span><span class="NLM_article-title">In Vivo Target Modulation and Biological Activity of CHIR-258, a Multitargeted Growth Factor Receptor Kinase Inhibitor, in Colon Cancer Models</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">3633</span><span class="NLM_x">–</span> <span class="NLM_lpage">3641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1158%2F1078-0432.CCR-04-2129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=15897558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFyrsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=3633-3641&issue=10&author=S.+H.+Leeauthor=D.+Lopes+de+Menezesauthor=J.+Voraauthor=A.+Harrisauthor=H.+Yeauthor=L.+Nordahlauthor=E.+Garrettauthor=E.+Samaraauthor=S.+L.+Aukermanauthor=A.+B.+Gelbauthor=C.+Heise&title=In+Vivo+Target+Modulation+and+Biological+Activity+of+CHIR-258%2C+a+Multitargeted+Growth+Factor+Receptor+Kinase+Inhibitor%2C+in+Colon+Cancer+Models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo Target Modulation and Biological Activity of CHIR-258, a Multitargeted Growth Factor Receptor Kinase Inhibitor, in Colon Cancer Models</span></div><div class="casAuthors">Lee, Sang Hoon; Lopes de Menezes, Daniel; Vora, Jayesh; Harris, Alex; Ye, Helen; Nordahl, Lara; Garrett, Evelyn; Samara, Emil; Aukerman, Sharon Lea; Gelb, Arnold B.; Heise, Carla</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3633-3641</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: To evaluate the therapeutic and biol. effects of CHIR-258, an orally bioavailable, potent inhibitor of class III-V receptor tyrosine kinases, in colon cancer models.  Exptl. Design: The pharmacol. activity of CHIR-258 was characterized by monitoring target modulation as well as by evaluating the antitumor and antiangiogenic effects in human colon xenograft models.  Results: CHIR-258 inhibits vascular endothelial growth factor receptor 1/2, fibroblast growth factor receptor 1/3, and platelet-derived growth factor receptor β (PDGFRβ) and shows both antitumor and antiangiogenic activities in vivo.  Treatment of KM12L4a human colon cancer cells with CHIR-258 resulted in a dose-dependent inhibition of vascular endothelial growth factor receptor 1 and PDGFRβ phosphorylation and redn. of phosphorylated extracellular signal-regulated kinase (ERK) levels, indicating modulation of target receptors and downstream signaling.  In vivo administration of CHIR-258 resulted in significant tumor growth inhibition and tumor regressions, including large, established tumors (500-1,000 mm3).  Immunohistochem. anal. showed a redn. of phosphorylated PDGFRβ and phosphorylated ERK in tumor cells after oral dosing with CHIR-258 compared with control tumors.  These changes were accompanied by decreased tumor cell proliferation rate and reduced intratumoral microvessel d.  CHIR-258 inhibited the phosphorylation of PDGFRβ and ERK phosphorylation in tumors within 2 h following dosing and the inhibitory activity was sustained for >24 h.  Significant antitumor activity was obsd. with intermittent dosing schedules, indicating a sustained biol. activity.  Conclusion: These studies provide evidence that biol. activity of CHIR-258 in tumors correlates with efficacy and aids in the identification of potential biomarkers of this multitargeted receptor tyrosine kinase inhibitor.  CHIR-258 exhibits properties that make it a promising candidate for clin. development in a variety of solid and hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBYM9bzT_QQLVg90H21EOLACvtfcHk0ljzKPJuZvLwwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFyrsb4%253D&md5=eeca79fe190dcdc2db251d6e836ec4ab</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-2129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-2129%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DLopes%2Bde%2BMenezes%26aufirst%3DD.%26aulast%3DVora%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DA.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DNordahl%26aufirst%3DL.%26aulast%3DGarrett%26aufirst%3DE.%26aulast%3DSamara%26aufirst%3DE.%26aulast%3DAukerman%26aufirst%3DS.%2BL.%26aulast%3DGelb%26aufirst%3DA.%2BB.%26aulast%3DHeise%26aufirst%3DC.%26atitle%3DIn%2520Vivo%2520Target%2520Modulation%2520and%2520Biological%2520Activity%2520of%2520CHIR-258%252C%2520a%2520Multitargeted%2520Growth%2520Factor%2520Receptor%2520Kinase%2520Inhibitor%252C%2520in%2520Colon%2520Cancer%2520Models%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26issue%3D10%26spage%3D3633%26epage%3D3641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Lopes de Menezes, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shephard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldbeck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aukerman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C.</span><span> </span><span class="NLM_article-title">CHIR-258: A Potent Inhibitor of FLT3 Kinase in Experimental Tumor Xenograft Models of Human Acute Myelogenous Leukemia</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">5281</span><span class="NLM_x">–</span> <span class="NLM_lpage">5291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1158%2F1078-0432.CCR-05-0358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=16033847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt12qurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=5281-5291&issue=14&author=D.+E.+Lopes+de+Menezesauthor=J.+Pengauthor=E.+N.+Garrettauthor=S.+G.+Louieauthor=S.+H.+Leeauthor=M.+Wiesmannauthor=Y.+Tangauthor=L.+Shephardauthor=C.+Goldbeckauthor=Y.+Oeiauthor=H.+Yeauthor=S.+L.+Aukermanauthor=C.+Heise&title=CHIR-258%3A+A+Potent+Inhibitor+of+FLT3+Kinase+in+Experimental+Tumor+Xenograft+Models+of+Human+Acute+Myelogenous+Leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">CHIR-258: A Potent Inhibitor of FLT3 Kinase in Experimental Tumor Xenograft Models of Human Acute Myelogenous Leukemia</span></div><div class="casAuthors">Lopes de Menezes, Daniel E.; Peng, Jing; Garrett, Evelyn N.; Louie, Sharianne G.; Lee, Sang H.; Wiesmann, Marion; Tang, Yan; Shephard, Lee; Goldbeck, Cheryl; Oei, Yoko; Ye, Helen; Aukerman, Sharon L.; Heise, Carla</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5281-5291</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Fms-like tyrosine kinase 3 (FLT3) encodes a receptor tyrosine kinase (RTK) for which activating mutations have been identified in a proportion of acute myelogenous leukemia (AML) patients and assocd. with poor clin. prognosis.  Given the relevance of FLT3 mutations in AML, we investigated the activity of CHIR-258, an orally active, multitargeted small mol., with potent activity against FLT3 kinase and class III, IV, and V RTKs involved in endothelial and tumor cell proliferation in AML models.  Exptl. Design: CHIR-258 was tested on two human leukemic cell lines in vitro and in vivo with differing FLT3 mutational status [MV4;11 cells express FLT3 internal tandem duplications (ITD) vs. RS4;11 cells with wild-type (WT) FLT3].  Results: Antiproliferative activity of CHIR-258 against MV4;11 was ∼24-fold greater compared with RS4;11, indicating more potent inhibition against cells with constitutively activated FLT3 ITD.  Dose-dependent down modulation of receptor phosphorylation and downstream signaling [signal transducer and activator of transcription 5 (STAT5) and extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase] in MV4;11 cells with CHIR-258 confirmed the mol. mechanism of action.  Target modulation of phospho-FLT3, phospho-STAT5, and phospho-ERK in MV4;11 tumors was achieved at biol. active doses of CHIR-258.  Tumor regressions and eradication of AML cells from the bone marrow were shown in s.c. and bone marrow engraftment leukemic xenograft models.  Tumor responses were characterized by decreased cellular proliferation and pos. immunohistochem. staining for active caspase-3 and cleaved poly(ADP-ribose) polymerase, suggesting cell death was mediated in part via apoptosis.  Conclusions: These data indicate that CHIR-258 may be an effective therapy in FLT3-assocd. AML and warrants clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqguTG7oB17arVg90H21EOLACvtfcHk0lgxEoJFyYUwfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt12qurc%253D&md5=81dc564d120f28420fdd69f685f877c2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0358%26sid%3Dliteratum%253Aachs%26aulast%3DLopes%2Bde%2BMenezes%26aufirst%3DD.%2BE.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DGarrett%26aufirst%3DE.%2BN.%26aulast%3DLouie%26aufirst%3DS.%2BG.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DWiesmann%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DShephard%26aufirst%3DL.%26aulast%3DGoldbeck%26aufirst%3DC.%26aulast%3DOei%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DAukerman%26aufirst%3DS.%2BL.%26aulast%3DHeise%26aufirst%3DC.%26atitle%3DCHIR-258%253A%2520A%2520Potent%2520Inhibitor%2520of%2520FLT3%2520Kinase%2520in%2520Experimental%2520Tumor%2520Xenograft%2520Models%2520of%2520Human%2520Acute%2520Myelogenous%2520Leukemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26issue%3D14%26spage%3D5281%26epage%3D5291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Trudel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reece, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. K.</span><span> </span><span class="NLM_article-title">CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2941</span><span class="NLM_x">–</span> <span class="NLM_lpage">2948</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=2941-2948&issue=7&author=S.+Trudelauthor=Z.+H.+Liauthor=E.+Weiauthor=M.+Wiesmannauthor=H.+Changauthor=C.+Chenauthor=D.+Reeceauthor=C.+Heiseauthor=A.+K.+Stewart&title=CHIR-258%2C+a+novel%2C+multitargeted+tyrosine+kinase+inhibitor+for+the+potential+treatment+of+t%284%3B14%29+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrudel%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DZ.%2BH.%26aulast%3DWei%26aufirst%3DE.%26aulast%3DWiesmann%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DReece%26aufirst%3DD.%26aulast%3DHeise%26aufirst%3DC.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26atitle%3DCHIR-258%252C%2520a%2520novel%252C%2520multitargeted%2520tyrosine%2520kinase%2520inhibitor%2520for%2520the%2520potential%2520treatment%2520of%2520t%25284%253B14%2529%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26issue%3D7%26spage%3D2941%26epage%3D2948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ukrainets, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezuglyi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treskach, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turov, A. V.</span><span> </span><span class="NLM_article-title">2-(Carbethoxymethyl)-4<i>H</i>-3,1-benzoxazin-4-one. 3. Condensation with <i>o</i>-phenylenediamine</span> <span class="citation_source-journal">Khim. Geterotsikl. Soedin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&pages=239-241&issue=2&author=I.+V.+Ukrainetsauthor=P.+A.+Bezuglyiauthor=V.+I.+Treskachauthor=A.+V.+Turov&title=2-%28Carbethoxymethyl%29-4H-3%2C1-benzoxazin-4-one.+3.+Condensation+with+o-phenylenediamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUkrainets%26aufirst%3DI.%2BV.%26aulast%3DBezuglyi%26aufirst%3DP.%2BA.%26aulast%3DTreskach%26aufirst%3DV.%2BI.%26aulast%3DTurov%26aufirst%3DA.%2BV.%26atitle%3D2-%2528Carbethoxymethyl%2529-4H-3%252C1-benzoxazin-4-one.%25203.%2520Condensation%2520with%2520o-phenylenediamine%26jtitle%3DKhim.%2520Geterotsikl.%2520Soedin.%26date%3D1992%26issue%3D2%26spage%3D239%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Ukrainets, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taran, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turov, A. V.</span><span> </span><span class="NLM_article-title">4-Hydroxy-2-quinolones. 16. Condensation of 2-carboxymalonanilic acid <i>N</i>-<i>R</i>-substituted amides with <i>o</i>-phenylenediamine</span> <span class="citation_source-journal">Khim. Geterotsikl. Soedin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1105</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&pages=1105-1108&issue=8&author=I.+V.+Ukrainetsauthor=S.+G.+Taranauthor=A.+V.+Turov&title=4-Hydroxy-2-quinolones.+16.+Condensation+of+2-carboxymalonanilic+acid+N-R-substituted+amides+with+o-phenylenediamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUkrainets%26aufirst%3DI.%2BV.%26aulast%3DTaran%26aufirst%3DS.%2BG.%26aulast%3DTurov%26aufirst%3DA.%2BV.%26atitle%3D4-Hydroxy-2-quinolones.%252016.%2520Condensation%2520of%25202-carboxymalonanilic%2520acid%2520N-R-substituted%2520amides%2520with%2520o-phenylenediamine%26jtitle%3DKhim.%2520Geterotsikl.%2520Soedin.%26date%3D1993%26issue%3D8%26spage%3D1105%26epage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ukrainets, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezugly, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taran, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorokhova, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turov, A. V.</span><span> </span><span class="NLM_article-title">Effective Synthesis of 3-(Benzimidazol-2-yl)-4-hydroxy-2-<i>oxo</i>-1,2-dihydroquinolines</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">42</span><span class="NLM_x">) </span> <span class="NLM_fpage">7747</span><span class="NLM_x">–</span> <span class="NLM_lpage">7748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=7747-7748&issue=42&author=I.+V.+Ukrainetsauthor=P.+A.+Bezuglyauthor=S.+G.+Taranauthor=O.+V.+Gorokhovaauthor=A.+V.+Turov&title=Effective+Synthesis+of+3-%28Benzimidazol-2-yl%29-4-hydroxy-2-oxo-1%2C2-dihydroquinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUkrainets%26aufirst%3DI.%2BV.%26aulast%3DBezugly%26aufirst%3DP.%2BA.%26aulast%3DTaran%26aufirst%3DS.%2BG.%26aulast%3DGorokhova%26aufirst%3DO.%2BV.%26aulast%3DTurov%26aufirst%3DA.%2BV.%26atitle%3DEffective%2520Synthesis%2520of%25203-%2528Benzimidazol-2-yl%2529-4-hydroxy-2-oxo-1%252C2-dihydroquinolines%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26issue%3D42%26spage%3D7747%26epage%3D7748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ukrainets, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezugly, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorokhova, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treskach, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turov, A. V.</span><span> </span><span class="NLM_article-title">4-Hydroxy-2-quinolones. 7. Synthesis and biological properties of 1-<i>R</i>-3-(benzimidazolyl-2)-4-hydroxy-2-quinolones</span> <span class="citation_source-journal">Khim. Geterotsikl. Soedin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&pages=105-108&issue=1&author=I.+V.+Ukrainetsauthor=P.+A.+Bezuglyauthor=O.+V.+Gorokhovaauthor=V.+I.+Treskachauthor=A.+V.+Turov&title=4-Hydroxy-2-quinolones.+7.+Synthesis+and+biological+properties+of+1-R-3-%28benzimidazolyl-2%29-4-hydroxy-2-quinolones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUkrainets%26aufirst%3DI.%2BV.%26aulast%3DBezugly%26aufirst%3DP.%2BA.%26aulast%3DGorokhova%26aufirst%3DO.%2BV.%26aulast%3DTreskach%26aufirst%3DV.%2BI.%26aulast%3DTurov%26aufirst%3DA.%2BV.%26atitle%3D4-Hydroxy-2-quinolones.%25207.%2520Synthesis%2520and%2520biological%2520properties%2520of%25201-R-3-%2528benzimidazolyl-2%2529-4-hydroxy-2-quinolones%26jtitle%3DKhim.%2520Geterotsikl.%2520Soedin.%26date%3D1993%26issue%3D1%26spage%3D105%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Matei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coltea, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grecu, R.</span><span> </span><span class="NLM_article-title">Condensation of ethyl 2-benzimidazoleacetate with carbonyl compounds</span> <span class="citation_source-journal">Rev. Chim. (Bucharest, Rom.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADyaL38XlvVahu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1982&pages=527-530&issue=6&author=S.+Mateiauthor=J.+Russuauthor=P.+Colteaauthor=R.+Grecu&title=Condensation+of+ethyl+2-benzimidazoleacetate+with+carbonyl+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Condensation of ethyl 2-benzimidazoleacetate with carbonyl compounds</span></div><div class="casAuthors">Matei, Simion; Russu, Jana; Coltea, Petronela; Grecu, Rodica</div><div class="citationInfo"><span class="NLM_cas:title">Revistade Chimie (Bucharest, Romania)</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">527-30</span>CODEN:
                <span class="NLM_cas:coden">RCBUAU</span>;
        ISSN:<span class="NLM_cas:issn">0034-7752</span>.
    </div><div class="casAbstract">I (R = H, Me; R1 = H, Cl, Me) reacted with PhCHO to give II; III (Z = O, NH) were obtained from I (R1 = H) and 2-HOC6H4CHO or 2-H2NC6H4CHO resp.  I (R = R1 = H), PhCHO, and piperidine in EtOH was refluxed to give II (R = R1 = H).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZNxnFmXjrzrVg90H21EOLACvtfcHk0lgM7jR8RzboRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XlvVahu78%253D&md5=0e5a6c60475629e05afa5f598787fc00</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatei%26aufirst%3DS.%26aulast%3DRussu%26aufirst%3DJ.%26aulast%3DColtea%26aufirst%3DP.%26aulast%3DGrecu%26aufirst%3DR.%26atitle%3DCondensation%2520of%2520ethyl%25202-benzimidazoleacetate%2520with%2520carbonyl%2520compounds%26jtitle%3DRev.%2520Chim.%2520%2528Bucharest%252C%2520Rom.%2529%26date%3D1982%26volume%3D33%26issue%3D6%26spage%3D527%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Ni, Z.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsanti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brammeier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diebes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poon, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfister, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renhowe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramurthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagman, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussiere, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesner, T. G.</span><span> </span><span class="NLM_article-title">4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3121</span><span class="NLM_x">–</span> <span class="NLM_lpage">3124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3121-3124&issue=12&author=Z.-J.+Niauthor=P.+Barsantiauthor=N.+Brammeierauthor=A.+Diebesauthor=D.+J.+Poonauthor=S.+Ngauthor=S.+Pecchiauthor=K.+Pfisterauthor=P.+A.+Renhoweauthor=S.+Ramurthyauthor=A.+S.+Wagmanauthor=D.+E.+Bussiereauthor=V.+Leauthor=Y.+Zhouauthor=J.+M.+Jansenauthor=S.+Maauthor=T.+G.+Gesner&title=4-%28Aminoalkylamino%29-3-benzimidazole-quinolinones+as+potent+CHK-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DZ.-J.%26aulast%3DBarsanti%26aufirst%3DP.%26aulast%3DBrammeier%26aufirst%3DN.%26aulast%3DDiebes%26aufirst%3DA.%26aulast%3DPoon%26aufirst%3DD.%2BJ.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DPecchi%26aufirst%3DS.%26aulast%3DPfister%26aufirst%3DK.%26aulast%3DRenhowe%26aufirst%3DP.%2BA.%26aulast%3DRamurthy%26aufirst%3DS.%26aulast%3DWagman%26aufirst%3DA.%2BS.%26aulast%3DBussiere%26aufirst%3DD.%2BE.%26aulast%3DLe%26aufirst%3DV.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DJansen%26aufirst%3DJ.%2BM.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DGesner%26aufirst%3DT.%2BG.%26atitle%3D4-%2528Aminoalkylamino%2529-3-benzimidazole-quinolinones%2520as%2520potent%2520CHK-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D12%26spage%3D3121%26epage%3D3124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Antonios-McCrea, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazier, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jazan, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machajewski, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renhowe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C.</span><span> </span><span class="NLM_article-title">LHMDS mediated tandem acylation-cyclization of 2-aminobenzenecarbonitriles with 2-benzymidazol-2-yl acetates: a short and efficient route to the synthesis of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=657-660&issue=5&author=W.+R.+Antonios-McCreaauthor=K.+A.+Frazierauthor=E.+M.+Jazanauthor=T.+D.+Machajewskiauthor=C.+M.+McBrideauthor=S.+Pecchiauthor=P.+A.+Renhoweauthor=C.+M.+Shaferauthor=C.+Taylor&title=LHMDS+mediated+tandem+acylation-cyclization+of+2-aminobenzenecarbonitriles+with+2-benzymidazol-2-yl+acetates%3A+a+short+and+efficient+route+to+the+synthesis+of+4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAntonios-McCrea%26aufirst%3DW.%2BR.%26aulast%3DFrazier%26aufirst%3DK.%2BA.%26aulast%3DJazan%26aufirst%3DE.%2BM.%26aulast%3DMachajewski%26aufirst%3DT.%2BD.%26aulast%3DMcBride%26aufirst%3DC.%2BM.%26aulast%3DPecchi%26aufirst%3DS.%26aulast%3DRenhowe%26aufirst%3DP.%2BA.%26aulast%3DShafer%26aufirst%3DC.%2BM.%26aulast%3DTaylor%26aufirst%3DC.%26atitle%3DLHMDS%2520mediated%2520tandem%2520acylation-cyclization%2520of%25202-aminobenzenecarbonitriles%2520with%25202-benzymidazol-2-yl%2520acetates%253A%2520a%2520short%2520and%2520efficient%2520route%2520to%2520the%2520synthesis%2520of%25204-amino-3-benzimidazol-2-ylhydroquinolin-2-ones%26jtitle%3DTetrahedron%2520Lett.%26date%3D2006%26volume%3D47%26issue%3D5%26spage%3D657%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Church, T. J.; Cutshall, N. S.; Gangloff, A. R.; Jenkins, T. E.; Linsell, M. S.; Litvak, J.; Rice, K. D.; Spencer, J. R.; Wang, V. R.</span><span> </span><span class="NLM_article-title">Preparation of compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity</span> Patent 9845275,<span class="NLM_x"> </span><span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=T.+J.+Church&author=N.+S.+Cutshall&author=A.+R.+Gangloff&author=T.+E.+Jenkins&author=M.+S.+Linsell&author=J.+Litvak&author=K.+D.+Rice&author=J.+R.+Spencer&author=V.+R.+Wang&title=Preparation+of+compounds+and+compositions+for+treating+diseases+associated+with+serine+protease%2C+particularly+tryptase%2C+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChurch%26aufirst%3DT.%2BJ.%26atitle%3DPreparation%2520of%2520compounds%2520and%2520compositions%2520for%2520treating%2520diseases%2520associated%2520with%2520serine%2520protease%252C%2520particularly%2520tryptase%252C%2520activity%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Klaubert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellstedt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guinosso, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capetola, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, S. C.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Aminophenyl)oxamic acids and esters as potent, orally active antiallergy agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00138a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1981&pages=742-748&issue=6&author=D.+H.+Klaubertauthor=J.+H.+Sellstedtauthor=C.+J.+Guinossoauthor=R.+J.+Capetolaauthor=S.+C.+Bell&title=N-%28Aminophenyl%29oxamic+acids+and+esters+as+potent%2C+orally+active+antiallergy+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00138a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00138a020%26sid%3Dliteratum%253Aachs%26aulast%3DKlaubert%26aufirst%3DD.%2BH.%26aulast%3DSellstedt%26aufirst%3DJ.%2BH.%26aulast%3DGuinosso%26aufirst%3DC.%2BJ.%26aulast%3DCapetola%26aufirst%3DR.%2BJ.%26aulast%3DBell%26aufirst%3DS.%2BC.%26atitle%3DN-%2528Aminophenyl%2529oxamic%2520acids%2520and%2520esters%2520as%2520potent%252C%2520orally%2520active%2520antiallergy%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1981%26volume%3D24%26issue%3D6%26spage%3D742%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Elslager, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werbel, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worth, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davoll, J.</span><span> </span><span class="NLM_article-title">Antimalarial drugs. 25. Folate antagonists. 3. 2,4-Diamino-6-(heterocyclic)quinazolines, a novel class of antimetabolites with potent antimalarial and antibacterial activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">836</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00278a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1972&pages=827-836&issue=8&author=E.+F.+Elslagerauthor=J.+Clarkeauthor=L.+M.+Werbelauthor=D.+F.+Worthauthor=J.+Davoll&title=Antimalarial+drugs.+25.+Folate+antagonists.+3.+2%2C4-Diamino-6-%28heterocyclic%29quinazolines%2C+a+novel+class+of+antimetabolites+with+potent+antimalarial+and+antibacterial+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm00278a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00278a008%26sid%3Dliteratum%253Aachs%26aulast%3DElslager%26aufirst%3DE.%2BF.%26aulast%3DClarke%26aufirst%3DJ.%26aulast%3DWerbel%26aufirst%3DL.%2BM.%26aulast%3DWorth%26aufirst%3DD.%2BF.%26aulast%3DDavoll%26aufirst%3DJ.%26atitle%3DAntimalarial%2520drugs.%252025.%2520Folate%2520antagonists.%25203.%25202%252C4-Diamino-6-%2528heterocyclic%2529quinazolines%252C%2520a%2520novel%2520class%2520of%2520antimetabolites%2520with%2520potent%2520antimalarial%2520and%2520antibacterial%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1972%26volume%3D15%26issue%3D8%26spage%3D827%26epage%3D836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><div class="note"><p class="first last">At pH 7, the solubility of <b>8c</b> was <0.030 μg/mL while the solubility of <b>16c</b> was 107 μg/mL</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=At+pH+7%2C+the+solubility+of+8c+was+%3C0.030+%CE%BCg%2FmL+while+the+solubility+of+16c+was+107+%CE%BCg%2FmL."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><div class="note"><p class="first last">Unpublished results</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Features of Selective Kinase Inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&issue=6&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+Selective+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0li0AaKjqCz9eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520Selective%2520Kinase%2520Inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26issue%3D6%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Wiesmann, M.; Lee, S. H.; LaPointe, G.; Javandel, M.; Heise, C.; Renhowe, P.; Wernette-Hammond, M.-E.; Gesner, T.; Harrison, S.; Harris, A. L.</span> In  <span class="citation_source-book">In Vitro Characterization of a Potent Tyrosine Kinase Inhibitor, CHIR258, That Modulates Angiogenesis and Proliferation of Selected Cancer Cell Lines</span>, <span class="NLM_publisher-name">American Association of Cancer Research</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=M.+Wiesmann&author=S.+H.+Lee&author=G.+LaPointe&author=M.+Javandel&author=C.+Heise&author=P.+Renhowe&author=M.-E.+Wernette-Hammond&author=T.+Gesner&author=S.+Harrison&author=A.+L.+Harris&title=In+Vitro+Characterization+of+a+Potent+Tyrosine+Kinase+Inhibitor%2C+CHIR258%2C+That+Modulates+Angiogenesis+and+Proliferation+of+Selected+Cancer+Cell+Lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWiesmann%26aufirst%3DM.%26btitle%3DIn%2520Vitro%2520Characterization%2520of%2520a%2520Potent%2520Tyrosine%2520Kinase%2520Inhibitor%252C%2520CHIR258%252C%2520That%2520Modulates%2520Angiogenesis%2520and%2520Proliferation%2520of%2520Selected%2520Cancer%2520Cell%2520Lines%26pub%3DAmerican%2520Association%2520of%2520Cancer%2520Research%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><div class="note"><p class="first last">Additional modeling information can be found in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Additional+modeling+information+can+be+found+in+the+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Cowan-Jacob, S. W.</span><span> </span><span class="NLM_article-title">Structural biology of protein tyrosine kinases</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">2608</span><span class="NLM_x">–</span> <span class="NLM_lpage">2625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1007%2Fs00018-006-6202-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=17041812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWqtr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2006&pages=2608-2625&issue=22&author=S.+W.+Cowan-Jacob&title=Structural+biology+of+protein+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structural biology of protein tyrosine kinases</span></div><div class="casAuthors">Cowan-Jacob, S. W.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2608-2625</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  The current understanding of the structure, reaction mechanism, and modes of regulation of the protein tyrosine kinase family owes a great deal to structural biol.  Structures are now available for >20 different tyrosine kinase domains, many of these in multiple conformational states.  They form the basis for the design of expts. to further investigate the role of different structural elements in the normal function and regulation of the protein and in the pathogenesis of many human diseases.  Once thought to be too similar to be specifically inhibited by a small mol., structural differences between kinases allow the design of compds. which inhibit only an acceptable few.  Here, the author provides a general overview of protein tyrosine kinase structural biol., including a discussion of the strengths and limitations of the investigative methods involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2S0MIZlhimLVg90H21EOLACvtfcHk0lg9tXShqmP8Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWqtr%252FF&md5=a21a90ccdda010e192aef7519d717e10</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs00018-006-6202-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-006-6202-8%26sid%3Dliteratum%253Aachs%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26atitle%3DStructural%2520biology%2520of%2520protein%2520tyrosine%2520kinases%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2006%26volume%3D63%26issue%3D22%26spage%3D2608%26epage%3D2625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Vogtherr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimme, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieborr, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescatore, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delarbre, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, K. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwalbe, H.</span><span> </span><span class="NLM_article-title">NMR characterization of kinase p38 dynamics in free and ligand-bound forms</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=993-997&issue=6&author=M.+Vogtherrauthor=K.+Saxenaauthor=S.+Hoelderauthor=S.+Grimmeauthor=M.+Betzauthor=U.+Schieborrauthor=B.+Pescatoreauthor=M.+Robinauthor=L.+Delarbreauthor=T.+Langerauthor=K.+U.+Wendtauthor=H.+Schwalbe&title=NMR+characterization+of+kinase+p38+dynamics+in+free+and+ligand-bound+forms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVogtherr%26aufirst%3DM.%26aulast%3DSaxena%26aufirst%3DK.%26aulast%3DHoelder%26aufirst%3DS.%26aulast%3DGrimme%26aufirst%3DS.%26aulast%3DBetz%26aufirst%3DM.%26aulast%3DSchieborr%26aufirst%3DU.%26aulast%3DPescatore%26aufirst%3DB.%26aulast%3DRobin%26aufirst%3DM.%26aulast%3DDelarbre%26aufirst%3DL.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DWendt%26aufirst%3DK.%2BU.%26aulast%3DSchwalbe%26aufirst%3DH.%26atitle%3DNMR%2520characterization%2520of%2520kinase%2520p38%2520dynamics%2520in%2520free%2520and%2520ligand-bound%2520forms%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26issue%3D6%26spage%3D993%26epage%3D997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bold, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guagnano, V.</span><span> </span><span class="NLM_article-title">Aromatic Interactions with Phenylalanine 691 and Cysteine 828: A Concept for FMS-like Tyrosine Kinase-3 Inhibition. Application to the Discovery of a New Class of Potential Antileukemia Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4451</span><span class="NLM_x">–</span> <span class="NLM_lpage">4454</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060368s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4451-4454&issue=15&author=P.+Furetauthor=G.+Boldauthor=T.+Meyerauthor=J.+Roeselauthor=V.+Guagnano&title=Aromatic+Interactions+with+Phenylalanine+691+and+Cysteine+828%3A+A+Concept+for+FMS-like+Tyrosine+Kinase-3+Inhibition.+Application+to+the+Discovery+of+a+New+Class+of+Potential+Antileukemia+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm060368s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060368s%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DBold%26aufirst%3DG.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DRoesel%26aufirst%3DJ.%26aulast%3DGuagnano%26aufirst%3DV.%26atitle%3DAromatic%2520Interactions%2520with%2520Phenylalanine%2520691%2520and%2520Cysteine%2520828%253A%2520A%2520Concept%2520for%2520FMS-like%2520Tyrosine%2520Kinase-3%2520Inhibition.%2520Application%2520to%2520the%2520Discovery%2520of%2520a%2520New%2520Class%2520of%2520Potential%2520Antileukemia%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D15%26spage%3D4451%26epage%3D4454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><div class="note"><p class="first last">Compound <b>5</b> was analyzed in plasma using a qualified LC/MS/MS method with a calibration range of 1−8000 ng/mL, as described previously (Lee, S. H. et al. <i>Clin. Cancer Res.</i><b>2005</b>, <i>11</i>, 3633−3641). Average concentration−time data was subject to PK analyses using standard noncompartmental methods using WinNonlin software (Pharsight Corporation, Mountain View, CA)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Compound+5+was+analyzed+in+plasma+using+a+qualified+LC%2FMS%2FMS+method+with+a+calibration+range+of+1%E2%88%928000+ng%2FmL%2C+as+described+previously+%28Lee%2C+S.+H.+et+al.+Clin.+Cancer+Res.2005%2C+11%2C+3633%E2%88%923641%29.+Average+concentration%E2%88%92time+data+was+subject+to+PK+analyses+using+standard+noncompartmental+methods+using+WinNonlin+software+%28Pharsight+Corporation%2C+Mountain+View%2C+CA%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Harris, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowden, K.</span><span> </span><span class="NLM_article-title">Antifolate and antibacterial activities of 6-substituted 2,4-diaminoquinazolines</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1992&pages=7-18&issue=1&author=N.+V.+Harrisauthor=C.+Smithauthor=K.+Bowden&title=Antifolate+and+antibacterial+activities+of+6-substituted+2%2C4-diaminoquinazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DN.%2BV.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DBowden%26aufirst%3DK.%26atitle%3DAntifolate%2520and%2520antibacterial%2520activities%2520of%25206-substituted%25202%252C4-diaminoquinazolines%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1992%26volume%3D27%26issue%3D1%26spage%3D7%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase inhibitors for potential use in Alzheimer’s disease: molecular modeling, synthesis and kinetic evaluation of 11<i>H</i>-indeno-[1,2-<i>b</i>]-quinolin-10-ylamine derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2000&pages=497-506&issue=3&author=A.+Rampaauthor=A.+Bisiauthor=F.+Bellutiauthor=S.+Gobbiauthor=P.+Valentiauthor=V.+Andrisanoauthor=V.+Cavriniauthor=A.+Cavalliauthor=M.+Recanatini&title=Acetylcholinesterase+inhibitors+for+potential+use+in+Alzheimer%E2%80%99s+disease%3A+molecular+modeling%2C+synthesis+and+kinetic+evaluation+of+11H-indeno-%5B1%2C2-b%5D-quinolin-10-ylamine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3DAcetylcholinesterase%2520inhibitors%2520for%2520potential%2520use%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520molecular%2520modeling%252C%2520synthesis%2520and%2520kinetic%2520evaluation%2520of%252011H-indeno-%255B1%252C2-b%255D-quinolin-10-ylamine%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2000%26volume%3D8%26issue%3D3%26spage%3D497%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Badawey, E. S. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rida, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soliman, F. S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kappe, T.</span><span> </span><span class="NLM_article-title">Benzimidazole condensed ring systems. 4. New approaches to the synthesis of substituted pyrimido[1,6-<i>a</i>]benzimidazole-1,3(2<i>H</i>,5<i>H</i>)-diones</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1989&pages=405-408&issue=2&author=E.+S.+A.+M.+Badaweyauthor=S.+M.+Ridaauthor=F.+S.+G.+Solimanauthor=T.+Kappe&title=Benzimidazole+condensed+ring+systems.+4.+New+approaches+to+the+synthesis+of+substituted+pyrimido%5B1%2C6-a%5Dbenzimidazole-1%2C3%282H%2C5H%29-diones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBadawey%26aufirst%3DE.%2BS.%2BA.%2BM.%26aulast%3DRida%26aufirst%3DS.%2BM.%26aulast%3DSoliman%26aufirst%3DF.%2BS.%2BG.%26aulast%3DKappe%26aufirst%3DT.%26atitle%3DBenzimidazole%2520condensed%2520ring%2520systems.%25204.%2520New%2520approaches%2520to%2520the%2520synthesis%2520of%2520substituted%2520pyrimido%255B1%252C6-a%255Dbenzimidazole-1%252C3%25282H%252C5H%2529-diones%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1989%26volume%3D26%26issue%3D2%26spage%3D405%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Self, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillings, M. R.</span><span> </span><span class="NLM_article-title">Cine and tele substitutions in the reaction of 2,3-dinitroaniline with secondary amines</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1980&pages=281-282&issue=6&author=D.+P.+Selfauthor=D.+E.+Westauthor=M.+R.+Stillings&title=Cine+and+tele+substitutions+in+the+reaction+of+2%2C3-dinitroaniline+with+secondary+amines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSelf%26aufirst%3DD.%2BP.%26aulast%3DWest%26aufirst%3DD.%2BE.%26aulast%3DStillings%26aufirst%3DM.%2BR.%26atitle%3DCine%2520and%2520tele%2520substitutions%2520in%2520the%2520reaction%2520of%25202%252C3-dinitroaniline%2520with%2520secondary%2520amines%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1980%26issue%3D6%26spage%3D281%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Crosby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moilliet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parratt, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. J.</span><span> </span><span class="NLM_article-title">Regioselective hydrolysis of aromatic dinitriles using a whole cell catalyst</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1679</span><span class="NLM_x">–</span> <span class="NLM_lpage">1687</span><div class="note"><p class="first last">1972−1999.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1994&pages=1679-1687&author=J.+Crosbyauthor=J.+Moillietauthor=J.+S.+Parrattauthor=N.+J.+Turner&title=Regioselective+hydrolysis+of+aromatic+dinitriles+using+a+whole+cell+catalyst"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrosby%26aufirst%3DJ.%26aulast%3DMoilliet%26aufirst%3DJ.%26aulast%3DParratt%26aufirst%3DJ.%2BS.%26aulast%3DTurner%26aufirst%3DN.%2BJ.%26atitle%3DRegioselective%2520hydrolysis%2520of%2520aromatic%2520dinitriles%2520using%2520a%2520whole%2520cell%2520catalyst%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1994%26volume%3D13%26spage%3D1679%26epage%3D1687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Adachi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugasawa, T.</span><span> </span><span class="NLM_article-title">Exclusive ortho cyanation and alkylthiocarbonylation of anilines and phenols using boron trichloride</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1080%2F00397919008054617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADyaK3cXhvFOkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1990&pages=71-84&issue=1&author=M.+Adachiauthor=T.+Sugasawa&title=Exclusive+ortho+cyanation+and+alkylthiocarbonylation+of+anilines+and+phenols+using+boron+trichloride"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Exclusive ortho cyanation and alkylthiocarbonylation of anilines and phenols using boron trichloride</span></div><div class="casAuthors">Adachi, Makoto; Sugasawa, Tsutomu</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-84</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">BCl3 with or without an addnl. Lewis acid is used in a one-pot synthesis of 2-cyano- and 2-alkylthiocarbonylanilines and -phenols.  Thus, treating RC6H4NHR1 (R = H, 3-Me, 4-Cl, 3-F, 4-OMe, R1 = H, Me, Ph, CH2Ph) with BCl3 in the presence of AlCl3, followed by reaction with Cl3CCN or R2SCN (R2 = Me, CH2Ph, Bu) and work-up with 4N NaOH or water, gave 2-cyanoanilines I or 2-(alkylthiocarbonyl)anilines II, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5VPl0R71i-7Vg90H21EOLACvtfcHk0lgNNpxQ5ZPXzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhvFOkurw%253D&md5=e6da99387aba222829878184b42b2503</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1080%2F00397919008054617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919008054617%26sid%3Dliteratum%253Aachs%26aulast%3DAdachi%26aufirst%3DM.%26aulast%3DSugasawa%26aufirst%3DT.%26atitle%3DExclusive%2520ortho%2520cyanation%2520and%2520alkylthiocarbonylation%2520of%2520anilines%2520and%2520phenols%2520using%2520boron%2520trichloride%26jtitle%3DSynth.%2520Commun.%26date%3D1990%26volume%3D20%26issue%3D1%26spage%3D71%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Achab, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morral, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banos, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivas, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">4657</span><span class="NLM_x">–</span> <span class="NLM_lpage">4666</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000980y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4657-4666&issue=24&author=P.+Campsauthor=R.+El+Achabauthor=J.+Morralauthor=D.+Munoz-Torreroauthor=A.+Badiaauthor=J.+E.+Banosauthor=N.+M.+Vivasauthor=X.+Barrilauthor=M.+Orozcoauthor=F.+J.+Luque&title=New+tacrine-huperzine+A+hybrids+%28huprines%29%3A+highly+potent+tight-binding+acetylcholinesterase+inhibitors+of+interest+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm000980y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000980y%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DEl%2BAchab%26aufirst%3DR.%26aulast%3DMorral%26aufirst%3DJ.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DBanos%26aufirst%3DJ.%2BE.%26aulast%3DVivas%26aufirst%3DN.%2BM.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DNew%2520tacrine-huperzine%2520A%2520hybrids%2520%2528huprines%2529%253A%2520highly%2520potent%2520tight-binding%2520acetylcholinesterase%2520inhibitors%2520of%2520interest%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D24%26spage%3D4657%26epage%3D4666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 101 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yujiao Wei, Yanting Tang, Yunyun Zhou, Yuyu Yang, Yetong Cui, Xuan Wang, Yubo Wang, Yulin Liu, Ning Liu, Qianqian Wang, Chong Li, Hao Ruan, Honggang Zhou, Mingming Wei, Guang Yang, <span class="NLM_string-name hlFld-ContribAuthor">Cheng Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of a Novel 2H-Pyrazolo[3,4-d]pyrimidine Derivative as a Potent Irreversible Pan-Fibroblast Growth Factor Receptor Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 9078-9099. <a href="https://doi.org/10.1021/acs.jmedchem.1c00174" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00174%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252Ba%252BNovel%252B2H-Pyrazolo%25255B3%25252C4-d%25255Dpyrimidine%252BDerivative%252Bas%252Ba%252BPotent%252BIrreversible%252BPan-Fibroblast%252BGrowth%252BFactor%252BReceptor%252BInhibitor%26aulast%3DWei%26aufirst%3DYujiao%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D31012021%26date%3D15062021%26volume%3D64%26issue%3D13%26spage%3D9078%26epage%3D9099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Juan Tang, Xue Chen, Chao-qun Zhao, Wen-jing Li, Shun Li, Xue-li Zheng, Mao-lin Yuan, Hai-yan Fu, Rui-xiang Li, <span class="NLM_string-name hlFld-ContribAuthor">Hua Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Iodination/Amidation of the N-Alkyl (Iso)quinolinium Salts. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (1)
                                     , 716-730. <a href="https://doi.org/10.1021/acs.joc.0c02321" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02321</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02321%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIodination%25252FAmidation%252Bof%252Bthe%252BN-Alkyl%252B%252528Iso%252529quinolinium%252BSalts%26aulast%3DTang%26aufirst%3DJuan%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D30092020%26date%3D02122020%26volume%3D86%26issue%3D1%26spage%3D716%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuming Wang, Lijun Li, Jun Fan, Yang Dai, Alan Jiang, Meiyu Geng, Jing Ai, <span class="NLM_string-name hlFld-ContribAuthor">Wenhu Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent Irreversible Pan-Fibroblast Growth Factor Receptor (FGFR) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9085-9104. <a href="https://doi.org/10.1021/acs.jmedchem.7b01843" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01843</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01843%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252BIrreversible%252BPan-Fibroblast%252BGrowth%252BFactor%252BReceptor%252B%252528FGFR%252529%252BInhibitors%26aulast%3DWang%26aufirst%3DYuming%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D14122017%26date%3D16032018%26date%3D09032018%26volume%3D61%26issue%3D20%26spage%3D9085%26epage%3D9104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ken A.  Brameld</span>, <span class="hlFld-ContribAuthor ">Timothy D.  Owens</span>, <span class="hlFld-ContribAuthor ">Erik  Verner</span>, <span class="hlFld-ContribAuthor ">Eleni  Venetsanakos</span>, <span class="hlFld-ContribAuthor ">J. Michael  Bradshaw</span>, <span class="hlFld-ContribAuthor ">Vernon T.  Phan</span>, <span class="hlFld-ContribAuthor ">Danny  Tam</span>, <span class="hlFld-ContribAuthor ">Kwan  Leung</span>, <span class="hlFld-ContribAuthor ">Jin  Shu</span>, <span class="hlFld-ContribAuthor ">Jacob  LaStant</span>, <span class="hlFld-ContribAuthor ">David G.  Loughhead</span>, <span class="hlFld-ContribAuthor ">Tony  Ton</span>, <span class="hlFld-ContribAuthor ">Dane E.  Karr</span>, <span class="hlFld-ContribAuthor ">Mary E.  Gerritsen</span>, <span class="hlFld-ContribAuthor ">David M.  Goldstein</span>, and <span class="hlFld-ContribAuthor ">Jens Oliver  Funk</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of the Irreversible Covalent FGFR Inhibitor 8-(3-(4-Acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (PRN1371) for the Treatment of Solid Tumors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (15)
                                     , 6516-6527. <a href="https://doi.org/10.1021/acs.jmedchem.7b00360" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00360</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00360%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthe%252BIrreversible%252BCovalent%252BFGFR%252BInhibitor%252B8-%2525283-%2525284-Acryloylpiperazin-1-yl%252529propyl%252529-6-%2525282%25252C6-dichloro-3%25252C5-dimethoxyphenyl%252529-2-%252528methylamino%252529pyrido%25255B2%25252C3-d%25255Dpyrimidin-7%2525288H%252529-one%252B%252528PRN1371%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BSolid%252BTumors%26aulast%3DBrameld%26aufirst%3DKen%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D07032017%26date%3D25072017%26date%3D10082017%26date%3D30062017%26volume%3D60%26issue%3D15%26spage%3D6516%26epage%3D6527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (22)
                                     , 10030-10066. <a href="https://doi.org/10.1021/acs.jmedchem.6b00618" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BBrain%252BCancer%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21042016%26date%3D03082016%26date%3D23112016%26date%3D14072016%26volume%3D59%26issue%3D22%26spage%3D10030%26epage%3D10066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeshma  Kovvuri</span>, <span class="hlFld-ContribAuthor ">Burri  Nagaraju</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>, and <span class="hlFld-ContribAuthor ">Ajay K.  Srivastava</span>  . </span><span class="cited-content_cbyCitation_article-title">An Efficient Synthesis of 2-Substituted Benzimidazoles via Photocatalytic Condensation of o-Phenylenediamines and Aldehydes. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2016,</strong> <em>18 </em>
                                    (10)
                                     , 644-650. <a href="https://doi.org/10.1021/acscombsci.6b00107" title="DOI URL">https://doi.org/10.1021/acscombsci.6b00107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.6b00107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.6b00107%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DAn%252BEfficient%252BSynthesis%252Bof%252B2-Substituted%252BBenzimidazoles%252Bvia%252BPhotocatalytic%252BCondensation%252Bof%252Bo-Phenylenediamines%252Band%252BAldehydes%26aulast%3DKovvuri%26aufirst%3DJeshma%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D15072016%26date%3D10092016%26date%3D26092016%26date%3D10102016%26date%3D15092016%26volume%3D18%26issue%3D10%26spage%3D644%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Yan</span>, <span class="hlFld-ContribAuthor ">Xinyi  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Dai</span>, <span class="hlFld-ContribAuthor ">Bin  Zhao</span>, <span class="hlFld-ContribAuthor ">Xinying  Yang</span>, <span class="hlFld-ContribAuthor ">Jun  Fan</span>, <span class="hlFld-ContribAuthor ">Yinglei  Gao</span>, <span class="hlFld-ContribAuthor ">Fanwang  Meng</span>, <span class="hlFld-ContribAuthor ">Yuming  Wang</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, and <span class="hlFld-ContribAuthor ">Wenhu  Duan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-(5′-Substituted)-Benzimidazole-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors: Design, Synthesis, and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (14)
                                     , 6690-6708. <a href="https://doi.org/10.1021/acs.jmedchem.6b00056" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00056%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-%2525285%2525E2%252580%2525B2-Substituted%252529-Benzimidazole-5-%2525281-%2525283%25252C5-dichloropyridin-4-yl%252529ethoxy%252529-1H-indazoles%252Bas%252BPotent%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252BInhibitors%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%26aulast%3DYan%26aufirst%3DWei%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D13012016%26date%3D06072016%26date%3D28072016%26date%3D27062016%26volume%3D59%26issue%3D14%26spage%3D6690%26epage%3D6708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K. Harsha  Vardhan Reddy</span>, <span class="hlFld-ContribAuthor ">Jean-Daniel  Brion</span>, <span class="hlFld-ContribAuthor ">Samir  Messaoudi</span>, and <span class="hlFld-ContribAuthor ">Mouad  Alami</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Biheterocycles Based on Quinolinone, Chromone, and Coumarin Scaffolds by Palladium-Catalyzed Decarboxylative Couplings. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (2)
                                     , 424-432. <a href="https://doi.org/10.1021/acs.joc.5b02103" title="DOI URL">https://doi.org/10.1021/acs.joc.5b02103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b02103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b02103%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BBiheterocycles%252BBased%252Bon%252BQuinolinone%25252C%252BChromone%25252C%252Band%252BCoumarin%252BScaffolds%252Bby%252BPalladium-Catalyzed%252BDecarboxylative%252BCouplings%26aulast%3DVardhan%2BReddy%26aufirst%3DK.%2BHarsha%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D08092015%26date%3D28122015%26date%3D15012016%26date%3D21122015%26volume%3D81%26issue%3D2%26spage%3D424%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Musumeci</span>, <span class="hlFld-ContribAuthor ">Marco  Radi</span>, <span class="hlFld-ContribAuthor ">Chiara  Brullo</span>, and <span class="hlFld-ContribAuthor ">Silvia  Schenone</span>  . </span><span class="cited-content_cbyCitation_article-title">Vascular Endothelial Growth Factor (VEGF) Receptors: Drugs and New Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (24)
                                     , 10797-10822. <a href="https://doi.org/10.1021/jm301085w" title="DOI URL">https://doi.org/10.1021/jm301085w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301085w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301085w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DVascular%252BEndothelial%252BGrowth%252BFactor%252B%252528VEGF%252529%252BReceptors%25253A%252BDrugs%252Band%252BNew%252BInhibitors%26aulast%3DMusumeci%26aufirst%3DFrancesca%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D25072012%26date%3D06112012%26date%3D27122012%26date%3D25102012%26volume%3D55%26issue%3D24%26spage%3D10797%26epage%3D10822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Werner  Ginzinger</span>, <span class="hlFld-ContribAuthor ">Gerhard  Mühlgassner</span>, <span class="hlFld-ContribAuthor ">Vladimir B.  Arion</span>, <span class="hlFld-ContribAuthor ">Michael A.  Jakupec</span>, <span class="hlFld-ContribAuthor ">Alexander  Roller</span>, <span class="hlFld-ContribAuthor ">Markus  Galanski</span>, <span class="hlFld-ContribAuthor ">Michael  Reithofer</span>, <span class="hlFld-ContribAuthor ">Walter  Berger</span>, and <span class="hlFld-ContribAuthor ">Bernhard K.  Keppler</span>  . </span><span class="cited-content_cbyCitation_article-title">A SAR Study of Novel Antiproliferative Ruthenium and Osmium Complexes with Quinoxalinone Ligands in Human Cancer Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (7)
                                     , 3398-3413. <a href="https://doi.org/10.1021/jm3000906" title="DOI URL">https://doi.org/10.1021/jm3000906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3000906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3000906%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BSAR%252BStudy%252Bof%252BNovel%252BAntiproliferative%252BRuthenium%252Band%252BOsmium%252BComplexes%252Bwith%252BQuinoxalinone%252BLigands%252Bin%252BHuman%252BCancer%252BCell%252BLines%26aulast%3DGinzinger%26aufirst%3DWerner%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D20012012%26date%3D27032012%26date%3D12042012%26date%3D15032012%26volume%3D55%26issue%3D7%26spage%3D3398%26epage%3D3413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vito  Guagnano</span>, <span class="hlFld-ContribAuthor ">Pascal  Furet</span>, <span class="hlFld-ContribAuthor ">Carsten  Spanka</span>, <span class="hlFld-ContribAuthor ">Vincent  Bordas</span>, <span class="hlFld-ContribAuthor ">Mickaël  Le Douget</span>, <span class="hlFld-ContribAuthor ">Christelle  Stamm</span>, <span class="hlFld-ContribAuthor ">Josef  Brueggen</span>, <span class="hlFld-ContribAuthor ">Michael R.  Jensen</span>, <span class="hlFld-ContribAuthor ">Christian  Schnell</span>, <span class="hlFld-ContribAuthor ">Herbert  Schmid</span>, <span class="hlFld-ContribAuthor ">Markus  Wartmann</span>, <span class="hlFld-ContribAuthor ">Joerg  Berghausen</span>, <span class="hlFld-ContribAuthor ">Peter  Drueckes</span>, <span class="hlFld-ContribAuthor ">Alfred  Zimmerlin</span>, <span class="hlFld-ContribAuthor ">Dirksen  Bussiere</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, and <span class="hlFld-ContribAuthor ">Diana  Graus Porta</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (20)
                                     , 7066-7083. <a href="https://doi.org/10.1021/jm2006222" title="DOI URL">https://doi.org/10.1021/jm2006222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2006222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2006222%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-%2525282%25252C6-Dichloro-3%25252C5-dimethoxy-phenyl%252529-1-%25257B6-%25255B4-%2525284-ethyl-piperazin-1-yl%252529-phenylamino%25255D-pyrimidin-4-yl%25257D-1-methyl-urea%252B%252528NVP-BGJ398%252529%25252C%252BA%252BPotent%252Band%252BSelective%252BInhibitor%252Bof%252Bthe%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252BFamily%252Bof%252BReceptor%252BTyrosine%252BKinase%26aulast%3DGuagnano%26aufirst%3DVito%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D17052011%26date%3D21092011%26date%3D27102011%26volume%3D54%26issue%3D20%26spage%3D7066%26epage%3D7083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaclyn L.  Henderson</span> and <span class="hlFld-ContribAuthor ">Stephen L.  Buchwald</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Pd-Catalyzed Amination Reactions for Heterocycle Functionalization. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2010,</strong> <em>12 </em>
                                    (20)
                                     , 4442-4445. <a href="https://doi.org/10.1021/ol101929v" title="DOI URL">https://doi.org/10.1021/ol101929v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol101929v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol101929v%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DEfficient%252BPd-Catalyzed%252BAmination%252BReactions%252Bfor%252BHeterocycle%252BFunctionalization%26aulast%3DHenderson%26aufirst%3DJaclyn%2BL.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D16%252008%25202010%26date%3D22092010%26date%3D15102010%26volume%3D12%26issue%3D20%26spage%3D4442%26epage%3D4445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhong</span>, <span class="hlFld-ContribAuthor ">Yueshan  Li</span>, <span class="hlFld-ContribAuthor ">Liang  Xiong</span>, <span class="hlFld-ContribAuthor ">Wenjing  Wang</span>, <span class="hlFld-ContribAuthor ">Ming  Wu</span>, <span class="hlFld-ContribAuthor ">Ting  Yuan</span>, <span class="hlFld-ContribAuthor ">Wei  Yang</span>, <span class="hlFld-ContribAuthor ">Chenyu  Tian</span>, <span class="hlFld-ContribAuthor ">Zhuang  Miao</span>, <span class="hlFld-ContribAuthor ">Tianqi  Wang</span>, <span class="hlFld-ContribAuthor ">Shengyong  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2021,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-021-00572-w" title="DOI URL">https://doi.org/10.1038/s41392-021-00572-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-021-00572-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-021-00572-w%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DSmall%252Bmolecules%252Bin%252Btargeted%252Bcancer%252Btherapy%25253A%252Badvances%25252C%252Bchallenges%25252C%252Band%252Bfuture%252Bperspectives%26aulast%3DZhong%26aufirst%3DLei%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangyan  Du</span>, <span class="hlFld-ContribAuthor ">Jie  Jiang</span>, <span class="hlFld-ContribAuthor ">Qibiao  Wu</span>, <span class="hlFld-ContribAuthor ">Nathaniel J.  Henning</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Donovan</span>, <span class="hlFld-ContribAuthor ">Hong  Yue</span>, <span class="hlFld-ContribAuthor ">Jianwei  Che</span>, <span class="hlFld-ContribAuthor ">Wenchao  Lu</span>, <span class="hlFld-ContribAuthor ">Eric S.  Fischer</span>, <span class="hlFld-ContribAuthor ">Nabeel  Bardeesy</span>, <span class="hlFld-ContribAuthor ">Tinghu  Zhang</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (29)
                                     , 16041-16047. <a href="https://doi.org/10.1002/ange.202101328" title="DOI URL">https://doi.org/10.1002/ange.202101328</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202101328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202101328%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BDegrader%252Bfor%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252B1%25252F2%26aulast%3DDu%26aufirst%3DGuangyan%26date%3D2021%26date%3D2021%26volume%3D133%26issue%3D29%26spage%3D16041%26epage%3D16047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangyan  Du</span>, <span class="hlFld-ContribAuthor ">Jie  Jiang</span>, <span class="hlFld-ContribAuthor ">Qibiao  Wu</span>, <span class="hlFld-ContribAuthor ">Nathaniel J.  Henning</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Donovan</span>, <span class="hlFld-ContribAuthor ">Hong  Yue</span>, <span class="hlFld-ContribAuthor ">Jianwei  Che</span>, <span class="hlFld-ContribAuthor ">Wenchao  Lu</span>, <span class="hlFld-ContribAuthor ">Eric S.  Fischer</span>, <span class="hlFld-ContribAuthor ">Nabeel  Bardeesy</span>, <span class="hlFld-ContribAuthor ">Tinghu  Zhang</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (29)
                                     , 15905-15911. <a href="https://doi.org/10.1002/anie.202101328" title="DOI URL">https://doi.org/10.1002/anie.202101328</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202101328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202101328%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BDegrader%252Bfor%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252B1%25252F2%26aulast%3DDu%26aufirst%3DGuangyan%26date%3D2021%26date%3D2021%26volume%3D60%26issue%3D29%26spage%3D15905%26epage%3D15911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Cheng  Yuan</span>, <span class="hlFld-ContribAuthor ">Jian  Zuo</span>, <span class="hlFld-ContribAuthor ">Shu-Pei  Yuan</span>, <span class="hlFld-ContribAuthor ">Jian-Qiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhen-Hua  Wang</span>, <span class="hlFld-ContribAuthor ">Yong  You</span>. </span><span class="cited-content_cbyCitation_article-title">Ring expansion and ring opening of 3-halooxindoles with
              N
              -alkoxycarbonyl-
              O
              -tosylhydroxylamines for divergent access to 4-aminoquinolin-2-ones and
              N
              -Cbz-
              N’
              -arylureas. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>8 </em>
                                    (4)
                                     , 784-791. <a href="https://doi.org/10.1039/D0QO01335H" title="DOI URL">https://doi.org/10.1039/D0QO01335H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO01335H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO01335H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DRing%252Bexpansion%252Band%252Bring%252Bopening%252Bof%252B3-halooxindoles%252Bwith%252BN%252B-alkoxycarbonyl-%252BO%252B-tosylhydroxylamines%252Bfor%252Bdivergent%252Baccess%252Bto%252B4-aminoquinolin-2-ones%252Band%252BN%252B-Cbz-%252BN%2525E2%252580%252599%252B-arylureas%26aulast%3DYuan%26aufirst%3DWei-Cheng%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D4%26spage%3D784%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hossam  Nada</span>, <span class="hlFld-ContribAuthor ">Ahmed  Elkamhawy</span>, <span class="hlFld-ContribAuthor ">Kyeong  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Structure Activity Relationship of Key Heterocyclic Anti-Angiogenic Leads of Promising Potential in the Fight against Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (3)
                                     , 553. <a href="https://doi.org/10.3390/molecules26030553" title="DOI URL">https://doi.org/10.3390/molecules26030553</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26030553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26030553%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructure%252BActivity%252BRelationship%252Bof%252BKey%252BHeterocyclic%252BAnti-Angiogenic%252BLeads%252Bof%252BPromising%252BPotential%252Bin%252Bthe%252BFight%252Bagainst%252BCancer%26aulast%3DNada%26aufirst%3DHossam%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D3%26spage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yevheniia  Velihina</span>, <span class="hlFld-ContribAuthor ">Thomas  Scattolin</span>, <span class="hlFld-ContribAuthor ">Denys  Bondar</span>, <span class="hlFld-ContribAuthor ">Stepan  Pil'o</span>, <span class="hlFld-ContribAuthor ">Nataliya  Obernikhina</span>, <span class="hlFld-ContribAuthor ">Olesksiy  Kachkovskyi</span>, <span class="hlFld-ContribAuthor ">Ivan  Semenyuta</span>, <span class="hlFld-ContribAuthor ">Isabella  Caligiuri</span>, <span class="hlFld-ContribAuthor ">Flavio  Rizzolio</span>, <span class="hlFld-ContribAuthor ">Volodymyr  Brovarets</span>, <span class="hlFld-ContribAuthor ">Yevgen  Karpichev</span>, <span class="hlFld-ContribAuthor ">Steven P.  Nolan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis,
              in silico
              and
              in vitro
              Evaluation of Novel Oxazolopyrimidines as Promising Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Helvetica Chimica Acta</span><span> <strong>2020,</strong> <em>103 </em>
                                    (12)
                                     <a href="https://doi.org/10.1002/hlca.202000169" title="DOI URL">https://doi.org/10.1002/hlca.202000169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hlca.202000169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhlca.202000169%26sid%3Dliteratum%253Aachs%26jtitle%3DHelvetica%2520Chimica%2520Acta%26atitle%3DSynthesis%25252C%252Bin%252Bsilico%252Band%252Bin%2525E2%252580%252585vitro%252BEvaluation%252Bof%252BNovel%252BOxazolopyrimidines%252Bas%252BPromising%252BAnticancer%252BAgents%26aulast%3DVelihina%26aufirst%3DYevheniia%26date%3D2020%26date%3D2020%26volume%3D103%26issue%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yazala Jyothsna  Pragathi</span>, <span class="hlFld-ContribAuthor ">Deekala  Veronica</span>, <span class="hlFld-ContribAuthor ">Kowthalam  Anitha</span>, <span class="hlFld-ContribAuthor ">Mandava Venkata Basaveswara  Rao</span>, <span class="hlFld-ContribAuthor ">Rudraraju Ramesh  Raju</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of chalcone derivatives of 1,2,4-thiadiazol-benzo[d]imidazol-2-yl)quinolin-2(1H)-one as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Chemical Data Collections</span><span> <strong>2020,</strong> <em>30 </em>, 100556. <a href="https://doi.org/10.1016/j.cdc.2020.100556" title="DOI URL">https://doi.org/10.1016/j.cdc.2020.100556</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cdc.2020.100556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cdc.2020.100556%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Data%2520Collections%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bchalcone%252Bderivatives%252Bof%252B1%25252C2%25252C4-thiadiazol-benzo%25255Bd%25255Dimidazol-2-yl%252529quinolin-2%2525281H%252529-one%252Bas%252Banticancer%252Bagents%26aulast%3DPragathi%26aufirst%3DYazala%2BJyothsna%26date%3D2020%26volume%3D30%26spage%3D100556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoling  Song</span>, <span class="hlFld-ContribAuthor ">Yunping  Hu</span>, <span class="hlFld-ContribAuthor ">Yongsheng  Li</span>, <span class="hlFld-ContribAuthor ">Rong  Shao</span>, <span class="hlFld-ContribAuthor ">Fatao  Liu</span>, <span class="hlFld-ContribAuthor ">Yingbin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of current targeted therapy in gallbladder cancer. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2020,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-020-00324-2" title="DOI URL">https://doi.org/10.1038/s41392-020-00324-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-020-00324-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-020-00324-2%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DOverview%252Bof%252Bcurrent%252Btargeted%252Btherapy%252Bin%252Bgallbladder%252Bcancer%26aulast%3DSong%26aufirst%3DXiaoling%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heba A.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Hanan M.  Refaat</span>. </span><span class="cited-content_cbyCitation_article-title">Versatile mechanisms of 2-substituted benzimidazoles in targeted cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Future Journal of Pharmaceutical Sciences</span><span> <strong>2020,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s43094-020-00048-8" title="DOI URL">https://doi.org/10.1186/s43094-020-00048-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s43094-020-00048-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs43094-020-00048-8%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DVersatile%252Bmechanisms%252Bof%252B2-substituted%252Bbenzimidazoles%252Bin%252Btargeted%252Bcancer%252Btherapy%26aulast%3DIbrahim%26aufirst%3DHeba%2BA.%26date%3D2020%26date%3D2020%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio  Sacco</span>, <span class="hlFld-ContribAuthor ">Cinzia  Federico</span>, <span class="hlFld-ContribAuthor ">Arianna  Giacomini</span>, <span class="hlFld-ContribAuthor ">Cinzia  Caprio</span>, <span class="hlFld-ContribAuthor ">Federica  Maccarinelli</span>, <span class="hlFld-ContribAuthor ">Katia  Todoerti</span>, <span class="hlFld-ContribAuthor ">Vanessa  Favasuli</span>, <span class="hlFld-ContribAuthor ">Antonella  Anastasia</span>, <span class="hlFld-ContribAuthor ">Marina  Motta</span>, <span class="hlFld-ContribAuthor ">Domenico  Russo</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Rossi</span>, <span class="hlFld-ContribAuthor ">Nicole  Bozza</span>, <span class="hlFld-ContribAuthor ">Riccardo  Castelli</span>, <span class="hlFld-ContribAuthor ">Antonino  Neri</span>, <span class="hlFld-ContribAuthor ">Roberto  Ronca</span>, <span class="hlFld-ContribAuthor ">Chiara  Cattaneo</span>, <span class="hlFld-ContribAuthor ">Alessandra  Tucci</span>, <span class="hlFld-ContribAuthor ">Marco  Mor</span>, <span class="hlFld-ContribAuthor ">Marco  Presta</span>, <span class="hlFld-ContribAuthor ">Aldo M  Roccaro</span>. </span><span class="cited-content_cbyCitation_article-title">Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88.. </span><span class="cited-content_cbyCitation_journal-name">Blood</span><span> <strong>2020,</strong> <em> </em><a href="https://doi.org/10.1182/blood.2020008414" title="DOI URL">https://doi.org/10.1182/blood.2020008414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/blood.2020008414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fblood.2020008414%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%26atitle%3DHalting%252Bthe%252BFGF%25252FFGFR%252Baxis%252Bleads%252Bto%252Banti-tumor%252Bactivity%252Bin%252BWaldenstr%2525C3%2525B6m%252527s%252BMacroglobulinemia%252Bby%252Bsilencing%252BMYD88.%26aulast%3DSacco%26aufirst%3DAntonio%26date%3D2020%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isadora C.  Silveira</span>, <span class="hlFld-ContribAuthor ">Anna Cecília D.M.  Carneiro</span>, <span class="hlFld-ContribAuthor ">Lorraine S.  Hiss</span>, <span class="hlFld-ContribAuthor ">Virgínia O.  Crema</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-Proliferative Role of the Tyrosine Kinase Inhibitors TKI-258 on Oral Squamous Cell Carcinoma In Vitro. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Agents in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (6)
                                     , 751-755. <a href="https://doi.org/10.2174/1871520620666200213110944" title="DOI URL">https://doi.org/10.2174/1871520620666200213110944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1871520620666200213110944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1871520620666200213110944%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Agents%2520in%2520Medicinal%2520Chemistry%26atitle%3DAnti-Proliferative%252BRole%252Bof%252Bthe%252BTyrosine%252BKinase%252BInhibitors%252BTKI-258%252Bon%252BOral%252BSquamous%252BCell%252BCarcinoma%252BIn%252BVitro%26aulast%3DSilveira%26aufirst%3DIsadora%2BC.%26date%3D2020%26volume%3D20%26issue%3D6%26spage%3D751%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ikumi  Kuriwaki</span>, <span class="hlFld-ContribAuthor ">Minoru  Kameda</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Hisamichi</span>, <span class="hlFld-ContribAuthor ">Shigetoshi  Kikuchi</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Iikubo</span>, <span class="hlFld-ContribAuthor ">Yuichiro  Kawamoto</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Moritomo</span>, <span class="hlFld-ContribAuthor ">Yutaka  Kondoh</span>, <span class="hlFld-ContribAuthor ">Yasushi  Amano</span>, <span class="hlFld-ContribAuthor ">Yukihiro  Tateishi</span>, <span class="hlFld-ContribAuthor ">Yuka  Echizen</span>, <span class="hlFld-ContribAuthor ">Yoshinori  Iwai</span>, <span class="hlFld-ContribAuthor ">Atsushi  Noda</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Tomiyama</span>, <span class="hlFld-ContribAuthor ">Tomoyuki  Suzuki</span>, <span class="hlFld-ContribAuthor ">Masaaki  Hirano</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (10)
                                     , 115453. <a href="https://doi.org/10.1016/j.bmc.2020.115453" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115453</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115453%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdrug%252Bdesign%252Bof%252B1%25252C3%25252C5-triazine%252Band%252Bpyrimidine%252Bderivatives%252Bas%252Bnovel%252BFGFR3%252Binhibitors%252Bwith%252Bhigh%252Bselectivity%252Bover%252BVEGFR2%26aulast%3DKuriwaki%26aufirst%3DIkumi%26date%3D2020%26volume%3D28%26issue%3D10%26spage%3D115453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nishant K.  Rasal</span>, <span class="hlFld-ContribAuthor ">Rahul B.  Sonawane</span>, <span class="hlFld-ContribAuthor ">Sangeeta V.  Jagtap</span>. </span><span class="cited-content_cbyCitation_article-title">Potential 2,4-dimethyl-1H-pyrrole-3-carboxamide bearing benzimidazole template: Design, synthesis, in vitro anticancer and in silico ADME study. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>97 </em>, 103660. <a href="https://doi.org/10.1016/j.bioorg.2020.103660" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103660</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103660%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DPotential%252B2%25252C4-dimethyl-1H-pyrrole-3-carboxamide%252Bbearing%252Bbenzimidazole%252Btemplate%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Bin%252Bvitro%252Banticancer%252Band%252Bin%252Bsilico%252BADME%252Bstudy%26aulast%3DRasal%26aufirst%3DNishant%2BK.%26date%3D2020%26volume%3D97%26spage%3D103660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandra  Canonici</span>, <span class="hlFld-ContribAuthor ">Alacoque L.  Browne</span>, <span class="hlFld-ContribAuthor ">Mohamed F. K.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Kevin P.  Fanning</span>, <span class="hlFld-ContribAuthor ">Sandra  Roche</span>, <span class="hlFld-ContribAuthor ">Neil T.  Conlon</span>, <span class="hlFld-ContribAuthor ">Fiona  O’Neill</span>, <span class="hlFld-ContribAuthor ">Justine  Meiller</span>, <span class="hlFld-ContribAuthor ">Mattia  Cremona</span>, <span class="hlFld-ContribAuthor ">Clare  Morgan</span>, <span class="hlFld-ContribAuthor ">Bryan T.  Hennessy</span>, <span class="hlFld-ContribAuthor ">Alex J.  Eustace</span>, <span class="hlFld-ContribAuthor ">Flavio  Solca</span>, <span class="hlFld-ContribAuthor ">Norma  O’Donovan</span>, <span class="hlFld-ContribAuthor ">John  Crown</span>. </span><span class="cited-content_cbyCitation_article-title">Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Therapeutic Advances in Medical Oncology</span><span> <strong>2020,</strong> <em>12 </em>, 175883591989754. <a href="https://doi.org/10.1177/1758835919897546" title="DOI URL">https://doi.org/10.1177/1758835919897546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1758835919897546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1758835919897546%26sid%3Dliteratum%253Aachs%26jtitle%3DTherapeutic%2520Advances%2520in%2520Medical%2520Oncology%26atitle%3DCombined%252Btargeting%252BEGFR%252Band%252BSRC%252Bas%252Ba%252Bpotential%252Bnovel%252Btherapeutic%252Bapproach%252Bfor%252Bthe%252Btreatment%252Bof%252Btriple%252Bnegative%252Bbreast%252Bcancer%26aulast%3DCanonici%26aufirst%3DAlexandra%26date%3D2020%26date%3D2020%26volume%3D12%26spage%3D175883591989754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe  Marseglia</span>, <span class="hlFld-ContribAuthor ">Alessio  Lodola</span>, <span class="hlFld-ContribAuthor ">Marco  Mor</span>, <span class="hlFld-ContribAuthor ">Riccardo  Castelli</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast growth factor receptor inhibitors: patent review (2015–2019). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2019,</strong> <em>29 </em>
                                    (12)
                                     , 965-977. <a href="https://doi.org/10.1080/13543776.2019.1688300" title="DOI URL">https://doi.org/10.1080/13543776.2019.1688300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2019.1688300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2019.1688300%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DFibroblast%252Bgrowth%252Bfactor%252Breceptor%252Binhibitors%25253A%252Bpatent%252Breview%252B%2525282015%2525E2%252580%2525932019%252529%26aulast%3DMarseglia%26aufirst%3DGiuseppe%26date%3D2019%26date%3D2019%26volume%3D29%26issue%3D12%26spage%3D965%26epage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yousef  Najajreh</span>. </span><span class="cited-content_cbyCitation_article-title">Benzimidazoles: From Antiproliferative to Multitargeted Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,<a href="https://doi.org/10.5772/intechopen.86249" title="DOI URL">https://doi.org/10.5772/intechopen.86249</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.86249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.86249%26sid%3Dliteratum%253Aachs%26atitle%3DBenzimidazoles%25253A%252BFrom%252BAntiproliferative%252Bto%252BMultitargeted%252BAnticancer%252BAgents%26aulast%3DNajajreh%26aufirst%3DYousef%26date%3D2019%26date%3D2019%26pub%3DIntechOpen%26atitle%3DChemistry%252Band%252BApplications%252Bof%252BBenzimidazole%252Band%252Bits%252BDerivatives%26aulast%3DMarinescu%26aufirst%3DMaria%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Han  Chiu</span>, <span class="hlFld-ContribAuthor ">Yi-Yen  Lee</span>, <span class="hlFld-ContribAuthor ">Kuo-Chin  Huang</span>, <span class="hlFld-ContribAuthor ">Cheng-Chi  Liu</span>, <span class="hlFld-ContribAuthor ">Chen-Si  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Dovitinib Triggers Apoptosis and Autophagic Cell Death by Targeting SHP-1/
              p
              -STAT3 Signaling in Human Breast Cancers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Oncology</span><span> <strong>2019,</strong> <em>2019 </em>, 1-14. <a href="https://doi.org/10.1155/2019/2024648" title="DOI URL">https://doi.org/10.1155/2019/2024648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2019/2024648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2019%2F2024648%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Oncology%26atitle%3DDovitinib%252BTriggers%252BApoptosis%252Band%252BAutophagic%252BCell%252BDeath%252Bby%252BTargeting%252BSHP-1%25252F%252Bp%252B-STAT3%252BSignaling%252Bin%252BHuman%252BBreast%252BCancers%26aulast%3DChiu%26aufirst%3DYi-Han%26date%3D2019%26volume%3D2019%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdolkarim  Farrokhzadeh</span>, <span class="hlFld-ContribAuthor ">Farideh Badichi  Akher</span>, <span class="hlFld-ContribAuthor ">Fisayo A.  Olotu</span>, <span class="hlFld-ContribAuthor ">Mahmoud E. S.  Soliman</span>, <span class="hlFld-ContribAuthor ">Fanie R.  Van Heerden</span>. </span><span class="cited-content_cbyCitation_article-title">Revealing the distinct mechanistic binding and activity of 5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-3-(5-(4-methylpiperazin-1-yl)-1
              H
              -benzo[
              d
              ]imidazol-2-yl)-1
              H
              -indazole enantiomers against FGFR1. </span><span class="cited-content_cbyCitation_journal-name">Physical Chemistry Chemical Physics</span><span> <strong>2019,</strong> <em>21 </em>
                                    (27)
                                     , 15120-15132. <a href="https://doi.org/10.1039/C9CP02112D" title="DOI URL">https://doi.org/10.1039/C9CP02112D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CP02112D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CP02112D%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Chemistry%2520Chemical%2520Physics%26atitle%3DRevealing%252Bthe%252Bdistinct%252Bmechanistic%252Bbinding%252Band%252Bactivity%252Bof%252B5-%2525281-%2525283%25252C5-dichloropyridin-4-yl%252529ethoxy%252529-3-%2525285-%2525284-methylpiperazin-1-yl%252529-1%252BH%252B-benzo%25255B%252Bd%252B%25255Dimidazol-2-yl%252529-1%252BH%252B-indazole%252Benantiomers%252Bagainst%252BFGFR1%26aulast%3DFarrokhzadeh%26aufirst%3DAbdolkarim%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D27%26spage%3D15120%26epage%3D15132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asuncion  Martinez-Anton</span>, <span class="hlFld-ContribAuthor ">Delphine  Gras</span>, <span class="hlFld-ContribAuthor ">Arnaud  Bourdin</span>, <span class="hlFld-ContribAuthor ">Patrice  Dubreuil</span>, <span class="hlFld-ContribAuthor ">Pascal  Chanez</span>. </span><span class="cited-content_cbyCitation_article-title">KIT as a therapeutic target for non-oncological diseases. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2019,</strong> <em>197 </em>, 11-37. <a href="https://doi.org/10.1016/j.pharmthera.2018.12.008" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2018.12.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2018.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2018.12.008%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DKIT%252Bas%252Ba%252Btherapeutic%252Btarget%252Bfor%252Bnon-oncological%252Bdiseases%26aulast%3DMartinez-Anton%26aufirst%3DAsuncion%26date%3D2019%26volume%3D197%26spage%3D11%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hany S.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Mohamed E.  Albakri</span>, <span class="hlFld-ContribAuthor ">Walaa R.  Mahmoud</span>, <span class="hlFld-ContribAuthor ">Heba Abdelrasheed  Allam</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  Reda</span>, <span class="hlFld-ContribAuthor ">Hatem A.  Abdel-Aziz</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of some novel thiobenzimidazole derivatives as anti-renal cancer agents through inhibition of c-MET kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>85 </em>, 337-348. <a href="https://doi.org/10.1016/j.bioorg.2019.01.006" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.01.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.01.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bsome%252Bnovel%252Bthiobenzimidazole%252Bderivatives%252Bas%252Banti-renal%252Bcancer%252Bagents%252Bthrough%252Binhibition%252Bof%252Bc-MET%252Bkinase%26aulast%3DIbrahim%26aufirst%3DHany%2BS.%26date%3D2019%26volume%3D85%26spage%3D337%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amany S.  Mostafa</span>, <span class="hlFld-ContribAuthor ">Rania M.  Gomaa</span>, <span class="hlFld-ContribAuthor ">Mohammad A.  Elmorsy</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of 2‐phenyl benzimidazole derivatives as
              VEGFR
              ‐2 inhibitors with anti‐breast cancer activity. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2019,</strong> <em>93 </em>
                                    (4)
                                     , 454-463. <a href="https://doi.org/10.1111/cbdd.13433" title="DOI URL">https://doi.org/10.1111/cbdd.13433</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13433%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252B2%2525E2%252580%252590phenyl%252Bbenzimidazole%252Bderivatives%252Bas%252BVEGFR%252B%2525E2%252580%2525902%252Binhibitors%252Bwith%252Banti%2525E2%252580%252590breast%252Bcancer%252Bactivity%26aulast%3DMostafa%26aufirst%3DAmany%2BS.%26date%3D2019%26date%3D2018%26volume%3D93%26issue%3D4%26spage%3D454%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Farideh  Badichi Akher</span>, <span class="hlFld-ContribAuthor ">Abdolkarim  Farrokhzadeh</span>, <span class="hlFld-ContribAuthor ">Fisayo A.  Olotu</span>, <span class="hlFld-ContribAuthor ">Clement  Agoni</span>, <span class="hlFld-ContribAuthor ">Mahmoud E. S.  Soliman</span>. </span><span class="cited-content_cbyCitation_article-title">The irony of chirality – unveiling the distinct mechanistic binding and activities of 1-(3-(4-amino-5-(7-methoxy-5-methylbenzo[
              b
              ]thiophen-2-yl)-7
              H
              -pyrrolo[2,3-
              d
              ]pyrimidin-7-yl)pyrrolidin-1-yl)prop-2-en-1-one enantiomers as irreversible covalent FGFR4 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (5)
                                     , 1176-1190. <a href="https://doi.org/10.1039/C8OB02811G" title="DOI URL">https://doi.org/10.1039/C8OB02811G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB02811G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB02811G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DThe%252Birony%252Bof%252Bchirality%252B%2525E2%252580%252593%252Bunveiling%252Bthe%252Bdistinct%252Bmechanistic%252Bbinding%252Band%252Bactivities%252Bof%252B1-%2525283-%2525284-amino-5-%2525287-methoxy-5-methylbenzo%25255B%252Bb%252B%25255Dthiophen-2-yl%252529-7%252BH%252B-pyrrolo%25255B2%25252C3-%252Bd%252B%25255Dpyrimidin-7-yl%252529pyrrolidin-1-yl%252529prop-2-en-1-one%252Benantiomers%252Bas%252Birreversible%252Bcovalent%252BFGFR4%252Binhibitors%26aulast%3DBadichi%2BAkher%26aufirst%3DFarideh%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D5%26spage%3D1176%26epage%3D1190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bing-Lin  Zhu</span>, <span class="hlFld-ContribAuthor ">Yan  Long</span>, <span class="hlFld-ContribAuthor ">Wei  Luo</span>, <span class="hlFld-ContribAuthor ">Zhen  Yan</span>, <span class="hlFld-ContribAuthor ">Yu-Jie  Lai</span>, <span class="hlFld-ContribAuthor ">Li-Ge  Zhao</span>, <span class="hlFld-ContribAuthor ">Wei-Hui  Zhou</span>, <span class="hlFld-ContribAuthor ">Yan-Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Lin-Lin  Shen</span>, <span class="hlFld-ContribAuthor ">Lu  Liu</span>, <span class="hlFld-ContribAuthor ">Xiao-Juan  Deng</span>, <span class="hlFld-ContribAuthor ">Xue-Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Fei  Sun</span>, <span class="hlFld-ContribAuthor ">Guo-Jun  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation. </span><span class="cited-content_cbyCitation_journal-name">Brain</span><span> <strong>2019,</strong> <em>142 </em>
                                    (1)
                                     , 176-192. <a href="https://doi.org/10.1093/brain/awy305" title="DOI URL">https://doi.org/10.1093/brain/awy305</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/brain/awy305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fbrain%2Fawy305%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%26atitle%3DMMP13%252Binhibition%252Brescues%252Bcognitive%252Bdecline%252Bin%252BAlzheimer%252Btransgenic%252Bmice%252Bvia%252BBACE1%252Bregulation%26aulast%3DZhu%26aufirst%3DBing-Lin%26date%3D2019%26date%3D2018%26volume%3D142%26issue%3D1%26spage%3D176%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Partha Kumar  Samanta</span>, <span class="hlFld-ContribAuthor ">Rumeli  Banerjee</span>, <span class="hlFld-ContribAuthor ">Ryan M.  Richards</span>, <span class="hlFld-ContribAuthor ">Papu  Biswas</span>. </span><span class="cited-content_cbyCitation_article-title">Mesoporous silica supported ytterbium as catalyst for synthesis of 1,2-disubstituted benzimidazoles and 2-substituted benzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">Applied Organometallic Chemistry</span><span> <strong>2018,</strong> <em>32 </em>
                                    (10)
                                     , e4507. <a href="https://doi.org/10.1002/aoc.4507" title="DOI URL">https://doi.org/10.1002/aoc.4507</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/aoc.4507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Faoc.4507%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Organometallic%2520Chemistry%26atitle%3DMesoporous%252Bsilica%252Bsupported%252Bytterbium%252Bas%252Bcatalyst%252Bfor%252Bsynthesis%252Bof%252B1%25252C2-disubstituted%252Bbenzimidazoles%252Band%252B2-substituted%252Bbenzimidazoles%26aulast%3DSamanta%26aufirst%3DPartha%2BKumar%26date%3D2018%26date%3D2018%26volume%3D32%26issue%3D10%26spage%3De4507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qianjin  Li</span>, <span class="hlFld-ContribAuthor ">Omar Awad  Alsaidan</span>, <span class="hlFld-ContribAuthor ">Yongjie  Ma</span>, <span class="hlFld-ContribAuthor ">Sungjin  Kim</span>, <span class="hlFld-ContribAuthor ">Junchen  Liu</span>, <span class="hlFld-ContribAuthor ">Thomas  Albers</span>, <span class="hlFld-ContribAuthor ">Kebin  Liu</span>, <span class="hlFld-ContribAuthor ">Zanna  Beharry</span>, <span class="hlFld-ContribAuthor ">Shaying  Zhao</span>, <span class="hlFld-ContribAuthor ">Fen  Wang</span>, <span class="hlFld-ContribAuthor ">Iryna  Lebedyeva</span>, <span class="hlFld-ContribAuthor ">Houjian  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2018,</strong> <em>293 </em>
                                    (17)
                                     , 6434-6448. <a href="https://doi.org/10.1074/jbc.RA117.000940" title="DOI URL">https://doi.org/10.1074/jbc.RA117.000940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA117.000940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA117.000940%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DPharmacologically%252Btargeting%252Bthe%252Bmyristoylation%252Bof%252Bthe%252Bscaffold%252Bprotein%252BFRS2%2525CE%2525B1%252Binhibits%252BFGF%25252FFGFR-mediated%252Boncogenic%252Bsignaling%252Band%252Btumor%252Bprogression%26aulast%3DLi%26aufirst%3DQianjin%26date%3D2018%26volume%3D293%26issue%3D17%26spage%3D6434%26epage%3D6448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heba A  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Fadi M  Awadallah</span>, <span class="hlFld-ContribAuthor ">Hanan M  Refaat</span>, <span class="hlFld-ContribAuthor ">Kamilia M  Amin</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and molecular modeling study for some new 2-substituted benzimidazoles as dual inhibitors for VEGFR-2 and c-Met. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (5)
                                     , 493-509. <a href="https://doi.org/10.4155/fmc-2017-0174" title="DOI URL">https://doi.org/10.4155/fmc-2017-0174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0174%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bmolecular%252Bmodeling%252Bstudy%252Bfor%252Bsome%252Bnew%252B2-substituted%252Bbenzimidazoles%252Bas%252Bdual%252Binhibitors%252Bfor%252BVEGFR-2%252Band%252Bc-Met%26aulast%3DIbrahim%26aufirst%3DHeba%2BA%26date%3D2018%26volume%3D10%26issue%3D5%26spage%3D493%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincent A.  de Weger</span>, <span class="hlFld-ContribAuthor ">Sanjay  Goel</span>, <span class="hlFld-ContribAuthor ">Roger  von Moos</span>, <span class="hlFld-ContribAuthor ">Jan H. M.  Schellens</span>, <span class="hlFld-ContribAuthor ">Nicholas  Mach</span>, <span class="hlFld-ContribAuthor ">Eugene  Tan</span>, <span class="hlFld-ContribAuthor ">Suraj  Anand</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Scott</span>, <span class="hlFld-ContribAuthor ">Ulrik  Lassen</span>. </span><span class="cited-content_cbyCitation_article-title">A drug–drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2018,</strong> <em>81 </em>
                                    (1)
                                     , 73-80. <a href="https://doi.org/10.1007/s00280-017-3469-4" title="DOI URL">https://doi.org/10.1007/s00280-017-3469-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-017-3469-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-017-3469-4%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DA%252Bdrug%2525E2%252580%252593drug%252Binteraction%252Bstudy%252Bto%252Bassess%252Bthe%252Beffect%252Bof%252Bthe%252BCYP1A2%252Binhibitor%252Bfluvoxamine%252Bon%252Bthe%252Bpharmacokinetics%252Bof%252Bdovitinib%252B%252528TKI258%252529%252Bin%252Bpatients%252Bwith%252Badvanced%252Bsolid%252Btumors%26aulast%3Dde%2BWeger%26aufirst%3DVincent%2BA.%26date%3D2018%26date%3D2017%26volume%3D81%26issue%3D1%26spage%3D73%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaokun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Discovery of FGF/FGFR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 339-383. <a href="https://doi.org/10.1016/B978-0-12-816142-5.00006-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-816142-5.00006-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816142-5.00006-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816142-5.00006-0%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Band%252BDiscovery%252Bof%252BFGF%25252FFGFR%252BInhibitors%26aulast%3DLi%26aufirst%3DXiaokun%26date%3D2018%26spage%3D339%26epage%3D383%26pub%3DElsevier%26atitle%3DFibroblast%252BGrowth%252BFactors%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vakhid A.  Mamedov</span>, <span class="hlFld-ContribAuthor ">Elena A.  Khafizova</span>, <span class="hlFld-ContribAuthor ">Victor V.  Syakaev</span>, <span class="hlFld-ContribAuthor ">Olga B.  Bazanova</span>, <span class="hlFld-ContribAuthor ">Anastasiya I.  Zamaletdinova</span>, <span class="hlFld-ContribAuthor ">Il’dar Kh.  Rizvanov</span>, <span class="hlFld-ContribAuthor ">Shamil K.  Latypov</span>, <span class="hlFld-ContribAuthor ">Oleg G.  Sinyashin</span>. </span><span class="cited-content_cbyCitation_article-title">Reductive acid-catalyzed rearrangement of 3-(2-nitrobenzyl)quinoxalin-2(1Н)-ones in the presence of Na2S2O4 – effective method for the synthesis of 2-(indol-2-yl)benzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2017,</strong> <em>53 </em>
                                    (9)
                                     , 1033-1044. <a href="https://doi.org/10.1007/s10593-017-2166-x" title="DOI URL">https://doi.org/10.1007/s10593-017-2166-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-017-2166-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-017-2166-x%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DReductive%252Bacid-catalyzed%252Brearrangement%252Bof%252B3-%2525282-nitrobenzyl%252529quinoxalin-2%2525281%2525D0%25259D%252529-ones%252Bin%252Bthe%252Bpresence%252Bof%252BNa2S2O4%252B%2525E2%252580%252593%252Beffective%252Bmethod%252Bfor%252Bthe%252Bsynthesis%252Bof%252B2-%252528indol-2-yl%252529benzimidazoles%26aulast%3DMamedov%26aufirst%3DVakhid%2BA.%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D9%26spage%3D1033%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna Cecília Dias Maciel  Carneiro</span>, <span class="hlFld-ContribAuthor ">Isadora Caixeta da  Silveira</span>, <span class="hlFld-ContribAuthor ">Arthur Silva  Rezende</span>, <span class="hlFld-ContribAuthor ">Bruna Raphaela Oliveira  Silva</span>, <span class="hlFld-ContribAuthor ">Virgínia Oliveira  Crema</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine kinase inhibitor TKI-258 inhibits cell motility in oral squamous cell carcinoma
              in vitro. </span><span class="cited-content_cbyCitation_journal-name">Journal of Oral Pathology & Medicine</span><span> <strong>2017,</strong> <em>46 </em>
                                    (7)
                                     , 484-488. <a href="https://doi.org/10.1111/jop.12511" title="DOI URL">https://doi.org/10.1111/jop.12511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jop.12511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjop.12511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Oral%2520Pathology%2520%2526%2520Medicine%26atitle%3DTyrosine%252Bkinase%252Binhibitor%252BTKI-258%252Binhibits%252Bcell%252Bmotility%252Bin%252Boral%252Bsquamous%252Bcell%252Bcarcinoma%252Bin%252Bvitro%26aulast%3DCarneiro%26aufirst%3DAnna%2BCec%25C3%25ADlia%2BDias%2BMaciel%26date%3D2017%26date%3D2016%26volume%3D46%26issue%3D7%26spage%3D484%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feiyue  Hao</span>, <span class="hlFld-ContribAuthor ">Haruyasu  Asahara</span>, <span class="hlFld-ContribAuthor ">Nagatoshi  Nishiwaki</span>. </span><span class="cited-content_cbyCitation_article-title">Direct amino-halogenation and aziridination of the 2-quinolone framework by sequential treatment of 3-nitro-2-quinolone with amine and N-halosuccinimide. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2017,</strong> <em>73 </em>
                                    (9)
                                     , 1255-1264. <a href="https://doi.org/10.1016/j.tet.2017.01.028" title="DOI URL">https://doi.org/10.1016/j.tet.2017.01.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.01.028%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DDirect%252Bamino-halogenation%252Band%252Baziridination%252Bof%252Bthe%252B2-quinolone%252Bframework%252Bby%252Bsequential%252Btreatment%252Bof%252B3-nitro-2-quinolone%252Bwith%252Bamine%252Band%252BN-halosuccinimide%26aulast%3DHao%26aufirst%3DFeiyue%26date%3D2017%26volume%3D73%26issue%3D9%26spage%3D1255%26epage%3D1264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kurt G.  Pike</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of the Fibroblast Growth Factor Receptor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 141-141. <a href="https://doi.org/10.1007/7355_2017_13" title="DOI URL">https://doi.org/10.1007/7355_2017_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2017_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2017_13%26sid%3Dliteratum%253Aachs%26atitle%3DInhibitors%252Bof%252Bthe%252BFibroblast%252BGrowth%252BFactor%252BReceptor%26aulast%3DPike%26aufirst%3DKurt%2BG.%26date%3D2017%26spage%3D141%26epage%3D141%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DCancer%252BII%26aulast%3DWaring%26aufirst%3DMichael%2BJ.%26date%3D2018%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niklas  Schäfer</span>, <span class="hlFld-ContribAuthor ">Gerrit H.  Gielen</span>, <span class="hlFld-ContribAuthor ">Sied  Kebir</span>, <span class="hlFld-ContribAuthor ">Anja  Wieland</span>, <span class="hlFld-ContribAuthor ">Andreas  Till</span>, <span class="hlFld-ContribAuthor ">Frederic  Mack</span>, <span class="hlFld-ContribAuthor ">Christina  Schaub</span>, <span class="hlFld-ContribAuthor ">Theophilos  Tzaridis</span>, <span class="hlFld-ContribAuthor ">Roman  Reinartz</span>, <span class="hlFld-ContribAuthor ">Michael  Niessen</span>, <span class="hlFld-ContribAuthor ">Rolf  Fimmers</span>, <span class="hlFld-ContribAuthor ">Matthias  Simon</span>, <span class="hlFld-ContribAuthor ">Christoph  Coch</span>, <span class="hlFld-ContribAuthor ">Christine  Fuhrmann</span>, <span class="hlFld-ContribAuthor ">Ulrich  Herrlinger</span>, <span class="hlFld-ContribAuthor ">Björn  Scheffler</span>, <span class="hlFld-ContribAuthor ">Martin  Glas</span>. </span><span class="cited-content_cbyCitation_article-title">Phase I trial of dovitinib (TKI258) in recurrent glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cancer Research and Clinical Oncology</span><span> <strong>2016,</strong> <em>142 </em>
                                    (7)
                                     , 1581-1589. <a href="https://doi.org/10.1007/s00432-016-2161-0" title="DOI URL">https://doi.org/10.1007/s00432-016-2161-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00432-016-2161-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00432-016-2161-0%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cancer%2520Research%2520and%2520Clinical%2520Oncology%26atitle%3DPhase%252BI%252Btrial%252Bof%252Bdovitinib%252B%252528TKI258%252529%252Bin%252Brecurrent%252Bglioblastoma%26aulast%3DSch%25C3%25A4fer%26aufirst%3DNiklas%26date%3D2016%26date%3D2016%26volume%3D142%26issue%3D7%26spage%3D1581%26epage%3D1589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Fan</span>, <span class="hlFld-ContribAuthor ">Yang  Dai</span>, <span class="hlFld-ContribAuthor ">Jingwei  Shao</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Chen  Wang</span>, <span class="hlFld-ContribAuthor ">Sufen  Cao</span>, <span class="hlFld-ContribAuthor ">Bin  Zhao</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Wenhu  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of pyrazolylaminoquinazoline derivatives as highly potent pan-fibroblast growth factor receptor inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (11)
                                     , 2594-2599. <a href="https://doi.org/10.1016/j.bmcl.2016.04.028" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.04.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.04.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.04.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyrazolylaminoquinazoline%252Bderivatives%252Bas%252Bhighly%252Bpotent%252Bpan-fibroblast%252Bgrowth%252Bfactor%252Breceptor%252Binhibitors%26aulast%3DFan%26aufirst%3DJun%26date%3D2016%26volume%3D26%26issue%3D11%26spage%3D2594%26epage%3D2599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.A.  Gryshchenko</span>, <span class="hlFld-ContribAuthor ">S.S.  Tarnavskiy</span>, <span class="hlFld-ContribAuthor ">K.V.  Levchenko</span>, <span class="hlFld-ContribAuthor ">V.G.  Bdzhola</span>, <span class="hlFld-ContribAuthor ">G.P.  Volynets</span>, <span class="hlFld-ContribAuthor ">A.G.  Golub</span>, <span class="hlFld-ContribAuthor ">T.P.  Ruban</span>, <span class="hlFld-ContribAuthor ">K.V.  Vygranenko</span>, <span class="hlFld-ContribAuthor ">L.L.  Lukash</span>, <span class="hlFld-ContribAuthor ">S.M.  Yarmoluk</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 5-amino-4-(1H-benzoimidazol-2-yl)-phenyl-1,2-dihydro-pyrrol-3-ones as inhibitors of protein kinase FGFR1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (9)
                                     , 2053-2059. <a href="https://doi.org/10.1016/j.bmc.2016.03.036" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.03.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.03.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.03.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B5-amino-4-%2525281H-benzoimidazol-2-yl%252529-phenyl-1%25252C2-dihydro-pyrrol-3-ones%252Bas%252Binhibitors%252Bof%252Bprotein%252Bkinase%252BFGFR1%26aulast%3DGryshchenko%26aufirst%3DA.A.%26date%3D2016%26volume%3D24%26issue%3D9%26spage%3D2053%26epage%3D2059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chengcai  Xia</span>, <span class="hlFld-ContribAuthor ">Zhenjiang  Wei</span>, <span class="hlFld-ContribAuthor ">Yong  Yang</span>, <span class="hlFld-ContribAuthor ">Wenbo  Yu</span>, <span class="hlFld-ContribAuthor ">Hanxiao  Liao</span>, <span class="hlFld-ContribAuthor ">Chao  Shen</span>, <span class="hlFld-ContribAuthor ">Pengfei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Thioetherification of Quinolone Derivatives via Decarboxylative C−S Cross-Couplings. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - An Asian Journal</span><span> <strong>2016,</strong> <em>11 </em>
                                    (3)
                                     , 360-366. <a href="https://doi.org/10.1002/asia.201500808" title="DOI URL">https://doi.org/10.1002/asia.201500808</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/asia.201500808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fasia.201500808%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520An%2520Asian%2520Journal%26atitle%3DPalladium-Catalyzed%252BThioetherification%252Bof%252BQuinolone%252BDerivatives%252Bvia%252BDecarboxylative%252BC%2525E2%252588%252592S%252BCross-Couplings%26aulast%3DXia%26aufirst%3DChengcai%26date%3D2016%26date%3D2015%26volume%3D11%26issue%3D3%26spage%3D360%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saiharish  Raghavan</span>, <span class="hlFld-ContribAuthor ">Prasath  Manogaran</span>, <span class="hlFld-ContribAuthor ">Krishna Kumari  Gadepalli Narasimha</span>, <span class="hlFld-ContribAuthor ">Balasubramanian  Kalpattu Kuppusami</span>, <span class="hlFld-ContribAuthor ">Palanivelu  Mariyappan</span>, <span class="hlFld-ContribAuthor ">Anjana  Gopalakrishnan</span>, <span class="hlFld-ContribAuthor ">Ganesh  Venkatraman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer activity of novel curcumin–quinolone hybrids. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (17)
                                     , 3601-3605. <a href="https://doi.org/10.1016/j.bmcl.2015.06.068" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.06.068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.06.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.06.068%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Banticancer%252Bactivity%252Bof%252Bnovel%252Bcurcumin%2525E2%252580%252593quinolone%252Bhybrids%26aulast%3DRaghavan%26aufirst%3DSaiharish%26date%3D2015%26volume%3D25%26issue%3D17%26spage%3D3601%26epage%3D3605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leandro H.  Gallo</span>, <span class="hlFld-ContribAuthor ">Katelyn N.  Nelson</span>, <span class="hlFld-ContribAuthor ">April N.  Meyer</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Donoghue</span>. </span><span class="cited-content_cbyCitation_article-title">Functions of Fibroblast Growth Factor Receptors in cancer defined by novel translocations and mutations. </span><span class="cited-content_cbyCitation_journal-name">Cytokine & Growth Factor Reviews</span><span> <strong>2015,</strong> <em>26 </em>
                                    (4)
                                     , 425-449. <a href="https://doi.org/10.1016/j.cytogfr.2015.03.003" title="DOI URL">https://doi.org/10.1016/j.cytogfr.2015.03.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cytogfr.2015.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cytogfr.2015.03.003%26sid%3Dliteratum%253Aachs%26jtitle%3DCytokine%2520%2526%2520Growth%2520Factor%2520Reviews%26atitle%3DFunctions%252Bof%252BFibroblast%252BGrowth%252BFactor%252BReceptors%252Bin%252Bcancer%252Bdefined%252Bby%252Bnovel%252Btranslocations%252Band%252Bmutations%26aulast%3DGallo%26aufirst%3DLeandro%2BH.%26date%3D2015%26volume%3D26%26issue%3D4%26spage%3D425%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rangappa S.  Keri</span>, <span class="hlFld-ContribAuthor ">Asha  Hiremathad</span>, <span class="hlFld-ContribAuthor ">Srinivasa  Budagumpi</span>, <span class="hlFld-ContribAuthor ">Bhari Mallanna  Nagaraja</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive Review in Current Developments of Benzimidazole-Based Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2015,</strong> <em>86 </em>
                                    (1)
                                     , 19-65. <a href="https://doi.org/10.1111/cbdd.12462" title="DOI URL">https://doi.org/10.1111/cbdd.12462</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12462%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DComprehensive%252BReview%252Bin%252BCurrent%252BDevelopments%252Bof%252BBenzimidazole-Based%252BMedicinal%252BChemistry%26aulast%3DKeri%26aufirst%3DRangappa%2BS.%26date%3D2015%26date%3D2014%26volume%3D86%26issue%3D1%26spage%3D19%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gottfried E  Konecny</span>, <span class="hlFld-ContribAuthor ">Neil  Finkler</span>, <span class="hlFld-ContribAuthor ">Agustin A  Garcia</span>, <span class="hlFld-ContribAuthor ">Domenica  Lorusso</span>, <span class="hlFld-ContribAuthor ">Paula S  Lee</span>, <span class="hlFld-ContribAuthor ">Rodney P  Rocconi</span>, <span class="hlFld-ContribAuthor ">Peter C  Fong</span>, <span class="hlFld-ContribAuthor ">Matt  Squires</span>, <span class="hlFld-ContribAuthor ">Kaushal  Mishra</span>, <span class="hlFld-ContribAuthor ">Allison  Upalawanna</span>, <span class="hlFld-ContribAuthor ">Yongyu  Wang</span>, <span class="hlFld-ContribAuthor ">Rebecca  Kristeleit</span>. </span><span class="cited-content_cbyCitation_article-title">Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study. </span><span class="cited-content_cbyCitation_journal-name">The Lancet Oncology</span><span> <strong>2015,</strong> <em>16 </em>
                                    (6)
                                     , 686-694. <a href="https://doi.org/10.1016/S1470-2045(15)70159-2" title="DOI URL">https://doi.org/10.1016/S1470-2045(15)70159-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S1470-2045(15)70159-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS1470-2045%2815%2970159-2%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Lancet%2520Oncology%26atitle%3DSecond-line%252Bdovitinib%252B%252528TKI258%252529%252Bin%252Bpatients%252Bwith%252BFGFR2-mutated%252Bor%252BFGFR2-non-mutated%252Badvanced%252Bor%252Bmetastatic%252Bendometrial%252Bcancer%25253A%252Ba%252Bnon-randomised%25252C%252Bopen-label%25252C%252Btwo-group%25252C%252Btwo-stage%25252C%252Bphase%252B2%252Bstudy%26aulast%3DKonecny%26aufirst%3DGottfried%2BE%26date%3D2015%26volume%3D16%26issue%3D6%26spage%3D686%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuanbing  Zang</span>, <span class="hlFld-ContribAuthor ">Jan  Eucker</span>, <span class="hlFld-ContribAuthor ">Piet  Habbel</span>, <span class="hlFld-ContribAuthor ">Christian  Neumann</span>, <span class="hlFld-ContribAuthor ">Carsten-Oliver  Schulz</span>, <span class="hlFld-ContribAuthor ">Nikola  Bangemann</span>, <span class="hlFld-ContribAuthor ">Lutz  Kissner</span>, <span class="hlFld-ContribAuthor ">Hanno  Riess</span>, <span class="hlFld-ContribAuthor ">Hongyu  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting multiple tyrosine kinase receptors with Dovitinib blocks invasion and the interaction between tumor cells and cancer-associated fibroblasts in breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Cell Cycle</span><span> <strong>2015,</strong> <em>14 </em>
                                    (8)
                                     , 1291-1299. <a href="https://doi.org/10.4161/15384101.2014.995050" title="DOI URL">https://doi.org/10.4161/15384101.2014.995050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4161/15384101.2014.995050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4161%2F15384101.2014.995050%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Cycle%26atitle%3DTargeting%252Bmultiple%252Btyrosine%252Bkinase%252Breceptors%252Bwith%252BDovitinib%252Bblocks%252Binvasion%252Band%252Bthe%252Binteraction%252Bbetween%252Btumor%252Bcells%252Band%252Bcancer-associated%252Bfibroblasts%252Bin%252Bbreast%252Bcancer%26aulast%3DZang%26aufirst%3DChuanbing%26date%3D2015%26date%3D2015%26volume%3D14%26issue%3D8%26spage%3D1291%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-Hui  Deng</span>, <span class="hlFld-ContribAuthor ">Dan  Xu</span>, <span class="hlFld-ContribAuthor ">Ye-Xiang  Su</span>, <span class="hlFld-ContribAuthor ">Yi-Juan  Cheng</span>, <span class="hlFld-ContribAuthor ">Yan-Li  Yang</span>, <span class="hlFld-ContribAuthor ">Xiu-Yun  Wang</span>, <span class="hlFld-ContribAuthor ">Juan  Zhang</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, <span class="hlFld-ContribAuthor ">Li-Ping  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Novel Oxazolo[5,4-
              d
              ]pyrimidines as Potent VEGFR-2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2015,</strong> <em>12 </em>
                                    (4)
                                     , 528-537. <a href="https://doi.org/10.1002/cbdv.201400270" title="DOI URL">https://doi.org/10.1002/cbdv.201400270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201400270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201400270%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BOxazolo%25255B5%25252C4-%252Bd%252B%25255Dpyrimidines%252Bas%252BPotent%252BVEGFR-2%252BInhibitors%26aulast%3DDeng%26aufirst%3DYa-Hui%26date%3D2015%26date%3D2015%26volume%3D12%26issue%3D4%26spage%3D528%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cong-min  Kang</span>, <span class="hlFld-ContribAuthor ">Dong-qing  Liu</span>, <span class="hlFld-ContribAuthor ">Xin-yu  Wang</span>, <span class="hlFld-ContribAuthor ">Ying-jie  Dai</span>, <span class="hlFld-ContribAuthor ">Jia-gao  Cheng</span>, <span class="hlFld-ContribAuthor ">Ying-tao  Lv</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and docking study on 3-benzimidazol-2-ylhydroquinolin-2-one derivatives as VEGFR-2 tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2015,</strong> <em>24 </em>
                                    (3)
                                     , 934-943. <a href="https://doi.org/10.1007/s00044-014-1161-3" title="DOI URL">https://doi.org/10.1007/s00044-014-1161-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-014-1161-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-014-1161-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3D3D-QSAR%252Band%252Bdocking%252Bstudy%252Bon%252B3-benzimidazol-2-ylhydroquinolin-2-one%252Bderivatives%252Bas%252BVEGFR-2%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DKang%26aufirst%3DCong-min%26date%3D2015%26date%3D2014%26volume%3D24%26issue%3D3%26spage%3D934%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tom D.  Bunney</span>, <span class="hlFld-ContribAuthor ">Shunzhou  Wan</span>, <span class="hlFld-ContribAuthor ">Nethaji  Thiyagarajan</span>, <span class="hlFld-ContribAuthor ">Ludovico  Sutto</span>, <span class="hlFld-ContribAuthor ">Sarah V.  Williams</span>, <span class="hlFld-ContribAuthor ">Paul  Ashford</span>, <span class="hlFld-ContribAuthor ">Hans  Koss</span>, <span class="hlFld-ContribAuthor ">Margaret A.  Knowles</span>, <span class="hlFld-ContribAuthor ">Francesco L.  Gervasio</span>, <span class="hlFld-ContribAuthor ">Peter V.  Coveney</span>, <span class="hlFld-ContribAuthor ">Matilda  Katan</span>. </span><span class="cited-content_cbyCitation_article-title">The Effect of Mutations on Drug Sensitivity and Kinase Activity of Fibroblast Growth Factor Receptors: A Combined Experimental and Theoretical Study. </span><span class="cited-content_cbyCitation_journal-name">EBioMedicine</span><span> <strong>2015,</strong> <em>2 </em>
                                    (3)
                                     , 194-204. <a href="https://doi.org/10.1016/j.ebiom.2015.02.009" title="DOI URL">https://doi.org/10.1016/j.ebiom.2015.02.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ebiom.2015.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ebiom.2015.02.009%26sid%3Dliteratum%253Aachs%26jtitle%3DEBioMedicine%26atitle%3DThe%252BEffect%252Bof%252BMutations%252Bon%252BDrug%252BSensitivity%252Band%252BKinase%252BActivity%252Bof%252BFibroblast%252BGrowth%252BFactor%252BReceptors%25253A%252BA%252BCombined%252BExperimental%252Band%252BTheoretical%252BStudy%26aulast%3DBunney%26aufirst%3DTom%2BD.%26date%3D2015%26volume%3D2%26issue%3D3%26spage%3D194%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haiquan  Liu</span>, <span class="hlFld-ContribAuthor ">Jiaming  Tang</span>, <span class="hlFld-ContribAuthor ">Liu  Jiang</span>, <span class="hlFld-ContribAuthor ">Tingting  Zheng</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Lv</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient domino synthesis of benzimidazole derivatives: copper catalysis versus transition metal-free conditions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (13)
                                     , 1624-1630. <a href="https://doi.org/10.1016/j.tetlet.2015.01.197" title="DOI URL">https://doi.org/10.1016/j.tetlet.2015.01.197</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2015.01.197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2015.01.197%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DEfficient%252Bdomino%252Bsynthesis%252Bof%252Bbenzimidazole%252Bderivatives%25253A%252Bcopper%252Bcatalysis%252Bversus%252Btransition%252Bmetal-free%252Bconditions%26aulast%3DLiu%26aufirst%3DHaiquan%26date%3D2015%26volume%3D56%26issue%3D13%26spage%3D1624%26epage%3D1630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James W.  Mier</span>, <span class="hlFld-ContribAuthor ">Rupal S.  Bhatt</span>, <span class="hlFld-ContribAuthor ">David J.  Panka</span>, <span class="hlFld-ContribAuthor ">Michael B.  Atkins</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Resistance to Targeted Therapy: Preclinical Findings and Clinical Relevance. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 319-348. <a href="https://doi.org/10.1007/978-1-4939-1622-1_16" title="DOI URL">https://doi.org/10.1007/978-1-4939-1622-1_16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-1622-1_16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-1622-1_16%26sid%3Dliteratum%253Aachs%26atitle%3DDevelopment%252Bof%252BResistance%252Bto%252BTargeted%252BTherapy%25253A%252BPreclinical%252BFindings%252Band%252BClinical%252BRelevance%26aulast%3DMier%26aufirst%3DJames%2BW.%26date%3D2015%26date%3D2014%26spage%3D319%26epage%3D348%26pub%3DSpringer%2520New%2520York%26atitle%3DRenal%252BCell%252BCarcinoma%26aulast%3DBukowski%26aufirst%3DRonald%2BM.%26date%3D2015%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anita Kailas  Sanap</span>, <span class="hlFld-ContribAuthor ">Ganapati Subray  Shankarling</span>. </span><span class="cited-content_cbyCitation_article-title">Environmentally benign synthesis of 4-aminoquinoline-2-ones using recyclable choline hydroxide. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2015,</strong> <em>39 </em>
                                    (1)
                                     , 206-212. <a href="https://doi.org/10.1039/C4NJ01281J" title="DOI URL">https://doi.org/10.1039/C4NJ01281J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4NJ01281J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4NJ01281J%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DEnvironmentally%252Bbenign%252Bsynthesis%252Bof%252B4-aminoquinoline-2-ones%252Busing%252Brecyclable%252Bcholine%252Bhydroxide%26aulast%3DSanap%26aufirst%3DAnita%2BKailas%26date%3D2015%26date%3D2015%26volume%3D39%26issue%3D1%26spage%3D206%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathias  O. Senge</span>, <span class="hlFld-ContribAuthor ">Keith  J. Flanagan</span>, <span class="hlFld-ContribAuthor ">Yasser  M. Shaker</span>, <span class="hlFld-ContribAuthor ">Ahmed  Temirak</span>, <span class="hlFld-ContribAuthor ">Hoda  I. El Diwani</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal Structures of 2-Furylbenzimidazoles with Antiangiogenic Inhibition of VEGF in Cell Line MCF-7. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2015,</strong> <em>91 </em>
                                    (8)
                                     , 1603. <a href="https://doi.org/10.3987/COM-15-13258" title="DOI URL">https://doi.org/10.3987/COM-15-13258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-15-13258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-15-13258%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DCrystal%252BStructures%252Bof%252B2-Furylbenzimidazoles%252Bwith%252BAntiangiogenic%252BInhibition%252Bof%252BVEGF%252Bin%252BCell%252BLine%252BMCF-7%26aulast%3DO.%2BSenge%26aufirst%3DMathias%26date%3D2015%26volume%3D91%26issue%3D8%26spage%3D1603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ju-Hyung  Park</span>, <span class="hlFld-ContribAuthor ">Geun Mook  Park</span>, <span class="hlFld-ContribAuthor ">Jin-Kyung  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Zerumbone, Sesquiterpene Photochemical from Ginger, Inhibits Angiogenesis. </span><span class="cited-content_cbyCitation_journal-name">The Korean Journal of Physiology & Pharmacology</span><span> <strong>2015,</strong> <em>19 </em>
                                    (4)
                                     , 335. <a href="https://doi.org/10.4196/kjpp.2015.19.4.335" title="DOI URL">https://doi.org/10.4196/kjpp.2015.19.4.335</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4196/kjpp.2015.19.4.335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4196%2Fkjpp.2015.19.4.335%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Korean%2520Journal%2520of%2520Physiology%2520%2526%2520Pharmacology%26atitle%3DZerumbone%25252C%252BSesquiterpene%252BPhotochemical%252Bfrom%252BGinger%25252C%252BInhibits%252BAngiogenesis%26aulast%3DPark%26aufirst%3DJu-Hyung%26date%3D2015%26volume%3D19%26issue%3D4%26spage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E.  Lesca</span>, <span class="hlFld-ContribAuthor ">A.  Lammens</span>, <span class="hlFld-ContribAuthor ">R.  Huber</span>, <span class="hlFld-ContribAuthor ">M.  Augustin</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Analysis of the Human Fibroblast Growth Factor Receptor 4 Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Biology</span><span> <strong>2014,</strong> <em>426 </em>
                                    (22)
                                     , 3744-3756. <a href="https://doi.org/10.1016/j.jmb.2014.09.004" title="DOI URL">https://doi.org/10.1016/j.jmb.2014.09.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmb.2014.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmb.2014.09.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Biology%26atitle%3DStructural%252BAnalysis%252Bof%252Bthe%252BHuman%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252B4%252BKinase%26aulast%3DLesca%26aufirst%3DE.%26date%3D2014%26volume%3D426%26issue%3D22%26spage%3D3744%26epage%3D3756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pinrao  Song</span>, <span class="hlFld-ContribAuthor ">Peng  Peng</span>, <span class="hlFld-ContribAuthor ">Mengmeng  Han</span>, <span class="hlFld-ContribAuthor ">Xianchao  Cao</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Tao  Liu</span>, <span class="hlFld-ContribAuthor ">Yubo  Zhou</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of thienopyridinones as Chk1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (17)
                                     , 4882-4892. <a href="https://doi.org/10.1016/j.bmc.2014.06.044" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.06.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.06.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.06.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bthienopyridinones%252Bas%252BChk1%252Binhibitors%26aulast%3DSong%26aufirst%3DPinrao%26date%3D2014%26volume%3D22%26issue%3D17%26spage%3D4882%26epage%3D4892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed  Temirak</span>, <span class="hlFld-ContribAuthor ">Yasser M.  Shaker</span>, <span class="hlFld-ContribAuthor ">Fatma A. F.  Ragab</span>, <span class="hlFld-ContribAuthor ">Mamdouh M.  Ali</span>, <span class="hlFld-ContribAuthor ">Salwa M.  Soliman</span>, <span class="hlFld-ContribAuthor ">Jeremie  Mortier</span>, <span class="hlFld-ContribAuthor ">Gerhard  Wolber</span>, <span class="hlFld-ContribAuthor ">Hamed I.  Ali</span>, <span class="hlFld-ContribAuthor ">Hoda I. El  Diwani</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Biological Evaluation, and Docking Studies of New 2-Furylbenzimidazoles as Anti-Angiogenic Agents: Part II. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2014,</strong> <em>347 </em>
                                    (4)
                                     , 291-304. <a href="https://doi.org/10.1002/ardp.201300356" title="DOI URL">https://doi.org/10.1002/ardp.201300356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201300356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201300356%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%25252C%252BBiological%252BEvaluation%25252C%252Band%252BDocking%252BStudies%252Bof%252BNew%252B2-Furylbenzimidazoles%252Bas%252BAnti-Angiogenic%252BAgents%25253A%252BPart%252BII%26aulast%3DTemirak%26aufirst%3DAhmed%26date%3D2014%26date%3D2014%26volume%3D347%26issue%3D4%26spage%3D291%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nuria  Eritja</span>, <span class="hlFld-ContribAuthor ">Mónica  Domingo</span>, <span class="hlFld-ContribAuthor ">Maria Alba  Dosil</span>, <span class="hlFld-ContribAuthor ">Cristina  Mirantes</span>, <span class="hlFld-ContribAuthor ">Maria  Santacana</span>, <span class="hlFld-ContribAuthor ">Joan  Valls</span>, <span class="hlFld-ContribAuthor ">Antonio  Llombart-Cussac</span>, <span class="hlFld-ContribAuthor ">Xavier  Matias-Guiu</span>, <span class="hlFld-ContribAuthor ">Xavier  Dolcet</span>. </span><span class="cited-content_cbyCitation_article-title">Combinatorial Therapy Using Dovitinib and ICI182.780 (Fulvestrant) Blocks Tumoral Activity of Endometrial Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2014,</strong> <em>13 </em>
                                    (4)
                                     , 776-787. <a href="https://doi.org/10.1158/1535-7163.MCT-13-0794" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-13-0794</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-13-0794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-13-0794%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DCombinatorial%252BTherapy%252BUsing%252BDovitinib%252Band%252BICI182.780%252B%252528Fulvestrant%252529%252BBlocks%252BTumoral%252BActivity%252Bof%252BEndometrial%252BCancer%252BCells%26aulast%3DEritja%26aufirst%3DNuria%26date%3D2014%26date%3D2014%26volume%3D13%26issue%3D4%26spage%3D776%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Mortlock</span>, <span class="hlFld-ContribAuthor ">K.  Foote</span>, <span class="hlFld-ContribAuthor ">J.  Kettle</span>, <span class="hlFld-ContribAuthor ">B.  Aquila</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.11033-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.11033-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.11033-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.11033-9%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%252Bin%252BCancer%26aulast%3DMortlock%26aufirst%3DA.%26date%3D2014%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2014%26volume%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han Kiat  Ho</span>, <span class="hlFld-ContribAuthor ">Angie Hui Ling  Yeo</span>, <span class="hlFld-ContribAuthor ">Tse Siang  Kang</span>, <span class="hlFld-ContribAuthor ">Boon Tin  Chua</span>. </span><span class="cited-content_cbyCitation_article-title">Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerations. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2014,</strong> <em>19 </em>
                                    (1)
                                     , 51-62. <a href="https://doi.org/10.1016/j.drudis.2013.07.021" title="DOI URL">https://doi.org/10.1016/j.drudis.2013.07.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2013.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2013.07.021%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DCurrent%252Bstrategies%252Bfor%252Binhibiting%252BFGFR%252Bactivities%252Bin%252Bclinical%252Bapplications%25253A%252Bopportunities%25252C%252Bchallenges%252Band%252Btoxicological%252Bconsiderations%26aulast%3DHo%26aufirst%3DHan%2BKiat%26date%3D2014%26volume%3D19%26issue%3D1%26spage%3D51%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanghye  Shin</span>, <span class="hlFld-ContribAuthor ">Yechan  Kim</span>, <span class="hlFld-ContribAuthor ">Kiho  Kim</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">A copper-mediated cross-coupling approach for the synthesis of 3-heteroaryl quinolone and related analogues. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2014,</strong> <em>12 </em>
                                    (30)
                                     , 5719-5726. <a href="https://doi.org/10.1039/C4OB00939H" title="DOI URL">https://doi.org/10.1039/C4OB00939H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB00939H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB00939H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DA%252Bcopper-mediated%252Bcross-coupling%252Bapproach%252Bfor%252Bthe%252Bsynthesis%252Bof%252B3-heteroaryl%252Bquinolone%252Band%252Brelated%252Banalogues%26aulast%3DShin%26aufirst%3DSanghye%26date%3D2014%26date%3D2014%26volume%3D12%26issue%3D30%26spage%3D5719%26epage%3D5726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandre  Bruneau</span>, <span class="hlFld-ContribAuthor ">Jean-Daniel  Brion</span>, <span class="hlFld-ContribAuthor ">Samir  Messaoudi</span>, <span class="hlFld-ContribAuthor ">Mouad  Alami</span>. </span><span class="cited-content_cbyCitation_article-title">A general Pd/Cu-catalyzed C–H heteroarylation of 3-bromoquinolin-2(1H)-ones. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2014,</strong> <em>12 </em>
                                    (42)
                                     , 8533-8541. <a href="https://doi.org/10.1039/C4OB01610F" title="DOI URL">https://doi.org/10.1039/C4OB01610F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB01610F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB01610F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DA%252Bgeneral%252BPd%25252FCu-catalyzed%252BC%2525E2%252580%252593H%252Bheteroarylation%252Bof%252B3-bromoquinolin-2%2525281H%252529-ones%26aulast%3DBruneau%26aufirst%3DAlexandre%26date%3D2014%26date%3D2014%26volume%3D12%26issue%3D42%26spage%3D8533%26epage%3D8541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shikha  Gaur</span>, <span class="hlFld-ContribAuthor ">Linling  Chen</span>, <span class="hlFld-ContribAuthor ">Vincent  Ann</span>, <span class="hlFld-ContribAuthor ">Wei-Chen  Lin</span>, <span class="hlFld-ContribAuthor ">Yafan  Wang</span>, <span class="hlFld-ContribAuthor ">Vincent HS  Chang</span>, <span class="hlFld-ContribAuthor ">Nan  Hsu</span>, <span class="hlFld-ContribAuthor ">Her-Shuyong  Shia</span>, <span class="hlFld-ContribAuthor ">Yun  Yen</span>. </span><span class="cited-content_cbyCitation_article-title">Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer</span><span> <strong>2014,</strong> <em>13 </em>
                                    (1)
                                     , 21. <a href="https://doi.org/10.1186/1476-4598-13-21" title="DOI URL">https://doi.org/10.1186/1476-4598-13-21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/1476-4598-13-21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F1476-4598-13-21%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%26atitle%3DDovitinib%252Bsynergizes%252Bwith%252Boxaliplatin%252Bin%252Bsuppressing%252Bcell%252Bproliferation%252Band%252Binducing%252Bapoptosis%252Bin%252Bcolorectal%252Bcancer%252Bcells%252Bregardless%252Bof%252BRAS-RAF%252Bmutation%252Bstatus%26aulast%3DGaur%26aufirst%3DShikha%26date%3D2014%26volume%3D13%26issue%3D1%26spage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guang  Liang</span>, <span class="hlFld-ContribAuthor ">Gaozhi  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Wei</span>, <span class="hlFld-ContribAuthor ">Yunjie  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaokun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule inhibition of fibroblast growth factor receptors in cancer. </span><span class="cited-content_cbyCitation_journal-name">Cytokine & Growth Factor Reviews</span><span> <strong>2013,</strong> <em>24 </em>
                                    (5)
                                     , 467-475. <a href="https://doi.org/10.1016/j.cytogfr.2013.05.002" title="DOI URL">https://doi.org/10.1016/j.cytogfr.2013.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cytogfr.2013.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cytogfr.2013.05.002%26sid%3Dliteratum%253Aachs%26jtitle%3DCytokine%2520%2526%2520Growth%2520Factor%2520Reviews%26atitle%3DSmall%252Bmolecule%252Binhibition%252Bof%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptors%252Bin%252Bcancer%26aulast%3DLiang%26aufirst%3DGuang%26date%3D2013%26volume%3D24%26issue%3D5%26spage%3D467%26epage%3D475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel G.  Liao</span>, <span class="hlFld-ContribAuthor ">Joonil  Jung</span>, <span class="hlFld-ContribAuthor ">Jeremy  Tchaicha</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Wilkerson</span>, <span class="hlFld-ContribAuthor ">Andrey  Sivachenko</span>, <span class="hlFld-ContribAuthor ">Ellen M.  Beauchamp</span>, <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, <span class="hlFld-ContribAuthor ">Trevor J.  Pugh</span>, <span class="hlFld-ContribAuthor ">Chandra Sekhar  Pedamallu</span>, <span class="hlFld-ContribAuthor ">D. Neil  Hayes</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Gad  Getz</span>, <span class="hlFld-ContribAuthor ">Kwok-Kin  Wong</span>, <span class="hlFld-ContribAuthor ">Robert I.  Haddad</span>, <span class="hlFld-ContribAuthor ">Matthew  Meyerson</span>, <span class="hlFld-ContribAuthor ">Peter S.  Hammerman</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2013,</strong> <em>73 </em>
                                    (16)
                                     , 5195-5205. <a href="https://doi.org/10.1158/0008-5472.CAN-12-3950" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-12-3950</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-12-3950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-12-3950%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DInhibitor-Sensitive%252BFGFR2%252Band%252BFGFR3%252BMutations%252Bin%252BLung%252BSquamous%252BCell%252BCarcinoma%26aulast%3DLiao%26aufirst%3DRachel%2BG.%26date%3D2013%26date%3D2013%26volume%3D73%26issue%3D16%26spage%3D5195%26epage%3D5205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara A  Byron</span>, <span class="hlFld-ContribAuthor ">Huaibin  Chen</span>, <span class="hlFld-ContribAuthor ">Andreas  Wortmann</span>, <span class="hlFld-ContribAuthor ">David  Loch</span>, <span class="hlFld-ContribAuthor ">Michael G  Gartside</span>, <span class="hlFld-ContribAuthor ">Farhad  Dehkhoda</span>, <span class="hlFld-ContribAuthor ">Steven P  Blais</span>, <span class="hlFld-ContribAuthor ">Thomas A  Neubert</span>, <span class="hlFld-ContribAuthor ">Moosa  Mohammadi</span>, <span class="hlFld-ContribAuthor ">Pamela M  Pollock</span>. </span><span class="cited-content_cbyCitation_article-title">The N550K/H Mutations in FGFR2 Confer Differential Resistance to PD173074, Dovitinib, and Ponatinib ATP-Competitive Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Neoplasia</span><span> <strong>2013,</strong> <em>15 </em>
                                    (8)
                                     , 975-IN30. <a href="https://doi.org/10.1593/neo.121106" title="DOI URL">https://doi.org/10.1593/neo.121106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1593/neo.121106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1593%2Fneo.121106%26sid%3Dliteratum%253Aachs%26jtitle%3DNeoplasia%26atitle%3DThe%252BN550K%25252FH%252BMutations%252Bin%252BFGFR2%252BConfer%252BDifferential%252BResistance%252Bto%252BPD173074%25252C%252BDovitinib%25252C%252Band%252BPonatinib%252BATP-Competitive%252BInhibitors%26aulast%3DByron%26aufirst%3DSara%2BA%26date%3D2013%26volume%3D15%26issue%3D8%26spage%3D975%26epage%3DIN30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ke Tao  Chen</span>, <span class="hlFld-ContribAuthor ">Zheng  Fang</span>, <span class="hlFld-ContribAuthor ">Zhao  Yang</span>, <span class="hlFld-ContribAuthor ">Kai  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of Sunitinib Analogues to Improve Aqueous Solubility. </span><span class="cited-content_cbyCitation_journal-name">Advanced Materials Research</span><span> <strong>2013,</strong> <em>749 </em>, 350-353. <a href="https://doi.org/10.4028/www.scientific.net/AMR.749.350" title="DOI URL">https://doi.org/10.4028/www.scientific.net/AMR.749.350</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4028/www.scientific.net/AMR.749.350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4028%2Fwww.scientific.net%2FAMR.749.350%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Materials%2520Research%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BSunitinib%252BAnalogues%252Bto%252BImprove%252BAqueous%252BSolubility%26aulast%3DChen%26aufirst%3DKe%2BTao%26date%3D2013%26date%3D2013%26volume%3D749%26spage%3D350%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huaibin  Chen</span>, <span class="hlFld-ContribAuthor ">Zhifeng  Huang</span>, <span class="hlFld-ContribAuthor ">Kaushik  Dutta</span>, <span class="hlFld-ContribAuthor ">Steven  Blais</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Neubert</span>, <span class="hlFld-ContribAuthor ">Xiaokun  Li</span>, <span class="hlFld-ContribAuthor ">David  Cowburn</span>, <span class="hlFld-ContribAuthor ">Nathaniel J.  Traaseth</span>, <span class="hlFld-ContribAuthor ">Moosa  Mohammadi</span>. </span><span class="cited-content_cbyCitation_article-title">Cracking the Molecular Origin of Intrinsic Tyrosine Kinase Activity through Analysis of Pathogenic Gain-of-Function Mutations. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2013,</strong> <em>4 </em>
                                    (2)
                                     , 376-384. <a href="https://doi.org/10.1016/j.celrep.2013.06.025" title="DOI URL">https://doi.org/10.1016/j.celrep.2013.06.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2013.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2013.06.025%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DCracking%252Bthe%252BMolecular%252BOrigin%252Bof%252BIntrinsic%252BTyrosine%252BKinase%252BActivity%252Bthrough%252BAnalysis%252Bof%252BPathogenic%252BGain-of-Function%252BMutations%26aulast%3DChen%26aufirst%3DHuaibin%26date%3D2013%26volume%3D4%26issue%3D2%26spage%3D376%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen L.  Richey</span>, <span class="hlFld-ContribAuthor ">Thomas E.  Hutson</span>. </span><span class="cited-content_cbyCitation_article-title">Angiopoietins and Non–Vascular Endothelial Growth Factor Antiangiogenic Targets in Advanced Renal Cell Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">The Cancer Journal</span><span> <strong>2013,</strong> <em>19 </em>
                                    (4)
                                     , 307-310. <a href="https://doi.org/10.1097/PPO.0b013e31829d5d15" title="DOI URL">https://doi.org/10.1097/PPO.0b013e31829d5d15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/PPO.0b013e31829d5d15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FPPO.0b013e31829d5d15%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Cancer%2520Journal%26atitle%3DAngiopoietins%252Band%252BNon%2525E2%252580%252593Vascular%252BEndothelial%252BGrowth%252BFactor%252BAntiangiogenic%252BTargets%252Bin%252BAdvanced%252BRenal%252BCell%252BCarcinoma%26aulast%3DRichey%26aufirst%3DStephen%2BL.%26date%3D2013%26volume%3D19%26issue%3D4%26spage%3D307%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen L.  Chan</span>, <span class="hlFld-ContribAuthor ">Chi-Hang  Wong</span>, <span class="hlFld-ContribAuthor ">Cecilia P. Y.  Lau</span>, <span class="hlFld-ContribAuthor ">Qian  Zhou</span>, <span class="hlFld-ContribAuthor ">Connie W. C.  Hui</span>, <span class="hlFld-ContribAuthor ">Vivian W. Y.  Lui</span>, <span class="hlFld-ContribAuthor ">Brigette B. Y.  Ma</span>, <span class="hlFld-ContribAuthor ">Anthony T. C.  Chan</span>, <span class="hlFld-ContribAuthor ">Winnie  Yeo</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2013,</strong> <em>71 </em>
                                    (6)
                                     , 1417-1425. <a href="https://doi.org/10.1007/s00280-013-2139-4" title="DOI URL">https://doi.org/10.1007/s00280-013-2139-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-013-2139-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-013-2139-4%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DPreclinical%252Bevaluation%252Bof%252Bcombined%252BTKI-258%252Band%252BRAD001%252Bin%252Bhepatocellular%252Bcarcinoma%26aulast%3DChan%26aufirst%3DStephen%2BL.%26date%3D2013%26date%3D2013%26volume%3D71%26issue%3D6%26spage%3D1417%26epage%3D1425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sharad Kumar  Suthar</span>, <span class="hlFld-ContribAuthor ">Varun  Jaiswal</span>, <span class="hlFld-ContribAuthor ">Sandeep  Lohan</span>, <span class="hlFld-ContribAuthor ">Sumit  Bansal</span>, <span class="hlFld-ContribAuthor ">Anil  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Amit  Tiwari</span>, <span class="hlFld-ContribAuthor ">Angel Treasa  Alex</span>, <span class="hlFld-ContribAuthor ">Alex  Joesph</span>. </span><span class="cited-content_cbyCitation_article-title">Novel quinolone substituted thiazolidin-4-ones as anti-inflammatory, anticancer agents: Design, synthesis and biological screening. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>63 </em>, 589-602. <a href="https://doi.org/10.1016/j.ejmech.2013.03.011" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.03.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.03.011%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bquinolone%252Bsubstituted%252Bthiazolidin-4-ones%252Bas%252Banti-inflammatory%25252C%252Banticancer%252Bagents%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bscreening%26aulast%3DSuthar%26aufirst%3DSharad%2BKumar%26date%3D2013%26volume%3D63%26spage%3D589%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naoki  Miyamoto</span>, <span class="hlFld-ContribAuthor ">Nozomu  Sakai</span>, <span class="hlFld-ContribAuthor ">Takaharu  Hirayama</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Miwa</span>, <span class="hlFld-ContribAuthor ">Yuya  Oguro</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Oki</span>, <span class="hlFld-ContribAuthor ">Kengo  Okada</span>, <span class="hlFld-ContribAuthor ">Terufumi  Takagi</span>, <span class="hlFld-ContribAuthor ">Hidehisa  Iwata</span>, <span class="hlFld-ContribAuthor ">Yoshiko  Awazu</span>, <span class="hlFld-ContribAuthor ">Seiji  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Toshiyuki  Takeuchi</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Miki</span>, <span class="hlFld-ContribAuthor ">Akira  Hori</span>, <span class="hlFld-ContribAuthor ">Shinichi  Imamura</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N -[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2- b ]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1 H -pyrazole-5-carboxamide (TAK-593), a highly potent VEGFR2 kinase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (8)
                                     , 2333-2345. <a href="https://doi.org/10.1016/j.bmc.2013.01.074" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.01.074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.01.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.01.074%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN%252B-%25255B5-%252528%25257B2-%25255B%252528cyclopropylcarbonyl%252529amino%25255Dimidazo%25255B1%25252C2-%252Bb%252B%25255Dpyridazin-6-yl%25257Doxy%252529-2-methylphenyl%25255D-1%25252C3-dimethyl-1%252BH%252B-pyrazole-5-carboxamide%252B%252528TAK-593%252529%25252C%252Ba%252Bhighly%252Bpotent%252BVEGFR2%252Bkinase%252Binhibitor%26aulast%3DMiyamoto%26aufirst%3DNaoki%26date%3D2013%26volume%3D21%26issue%3D8%26spage%3D2333%26epage%3D2345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin J.  Deadman</span>, <span class="hlFld-ContribAuthor ">Mark D.  Hopkin</span>, <span class="hlFld-ContribAuthor ">Ian R.  Baxendale</span>, <span class="hlFld-ContribAuthor ">Steven V.  Ley</span>. </span><span class="cited-content_cbyCitation_article-title">The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2013,</strong> <em>11 </em>
                                    (11)
                                     , 1766-1800. <a href="https://doi.org/10.1039/C2OB27003J" title="DOI URL">https://doi.org/10.1039/C2OB27003J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C2OB27003J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC2OB27003J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DThe%252Bsynthesis%252Bof%252BBcr-Abl%252Binhibiting%252Banticancer%252Bpharmaceutical%252Bagents%252Bimatinib%25252C%252Bnilotinib%252Band%252Bdasatinib%26aulast%3DDeadman%26aufirst%3DBenjamin%2BJ.%26date%3D2013%26date%3D2013%26volume%3D11%26issue%3D11%26spage%3D1766%26epage%3D1800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weibing  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhou</span>, <span class="hlFld-ContribAuthor ">Cui  Chen</span>, <span class="hlFld-ContribAuthor ">Qing  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhibo  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Direct construction of 5-methyl-2-phenylisoxazol-3(2H)-ones via hypervalent iodine mediated sequential tandem oxidative cyclization of 3-oxo-N-phenylbutanamides catalyzed by zinc oxide (ZnO). </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2013,</strong> <em>11 </em>
                                    (4)
                                     , 542-544. <a href="https://doi.org/10.1039/C2OB27145A" title="DOI URL">https://doi.org/10.1039/C2OB27145A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C2OB27145A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC2OB27145A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DDirect%252Bconstruction%252Bof%252B5-methyl-2-phenylisoxazol-3%2525282H%252529-ones%252Bvia%252Bhypervalent%252Biodine%252Bmediated%252Bsequential%252Btandem%252Boxidative%252Bcyclization%252Bof%252B3-oxo-N-phenylbutanamides%252Bcatalyzed%252Bby%252Bzinc%252Boxide%252B%252528ZnO%252529%26aulast%3DLiu%26aufirst%3DWeibing%26date%3D2013%26date%3D2013%26volume%3D11%26issue%3D4%26spage%3D542%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhao  Yang</span>, <span class="hlFld-ContribAuthor ">Zhi Xiang  Wang</span>, <span class="hlFld-ContribAuthor ">Zheng  Fang</span>, <span class="hlFld-ContribAuthor ">Kai  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Syntheses and Biological Evaluation of 3-Arylurea-5-Fluoroindolin-2-One Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Advanced Materials Research</span><span> <strong>2013,</strong> <em>634-638 </em>, 922-925. <a href="https://doi.org/10.4028/www.scientific.net/AMR.634-638.922" title="DOI URL">https://doi.org/10.4028/www.scientific.net/AMR.634-638.922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4028/www.scientific.net/AMR.634-638.922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4028%2Fwww.scientific.net%2FAMR.634-638.922%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Materials%2520Research%26atitle%3DDesign%25252C%252BSyntheses%252Band%252BBiological%252BEvaluation%252Bof%252B3-Arylurea-5-Fluoroindolin-2-One%252BDerivatives%26aulast%3DYang%26aufirst%3DZhao%26date%3D2013%26date%3D2013%26volume%3D634-638%26spage%3D922%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bao Hua  Zou</span>, <span class="hlFld-ContribAuthor ">Zheng  Fang</span>, <span class="hlFld-ContribAuthor ">Zhao  Yang</span>, <span class="hlFld-ContribAuthor ">Kai  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Syntheses and Biological Evaluation of 5-Fluoroindolin-2-One Derivatives with Urea Linkage. </span><span class="cited-content_cbyCitation_journal-name">Advanced Materials Research</span><span> <strong>2013,</strong> <em>634-638 </em>, 926-929. <a href="https://doi.org/10.4028/www.scientific.net/AMR.634-638.926" title="DOI URL">https://doi.org/10.4028/www.scientific.net/AMR.634-638.926</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4028/www.scientific.net/AMR.634-638.926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4028%2Fwww.scientific.net%2FAMR.634-638.926%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Materials%2520Research%26atitle%3DDesign%25252C%252BSyntheses%252Band%252BBiological%252BEvaluation%252Bof%252B5-Fluoroindolin-2-One%252BDerivatives%252Bwith%252BUrea%252BLinkage%26aulast%3DZou%26aufirst%3DBao%2BHua%26date%3D2013%26date%3D2013%26volume%3D634-638%26spage%3D926%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naoki  Miyamoto</span>, <span class="hlFld-ContribAuthor ">Yuya  Oguro</span>, <span class="hlFld-ContribAuthor ">Terufumi  Takagi</span>, <span class="hlFld-ContribAuthor ">Hidehisa  Iwata</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Miki</span>, <span class="hlFld-ContribAuthor ">Akira  Hori</span>, <span class="hlFld-ContribAuthor ">Shinichi  Imamura</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of imidazo[1,2-b]pyridazine derivatives having a benzamide unit as novel VEGFR2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (24)
                                     , 7051-7058. <a href="https://doi.org/10.1016/j.bmc.2012.10.004" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.10.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bimidazo%25255B1%25252C2-b%25255Dpyridazine%252Bderivatives%252Bhaving%252Ba%252Bbenzamide%252Bunit%252Bas%252Bnovel%252BVEGFR2%252Bkinase%252Binhibitors%26aulast%3DMiyamoto%26aufirst%3DNaoki%26date%3D2012%26volume%3D20%26issue%3D24%26spage%3D7051%26epage%3D7058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Larissa  Sweeny</span>, <span class="hlFld-ContribAuthor ">Terence M.  Zimmermann</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Liu</span>, <span class="hlFld-ContribAuthor ">Eben L.  Rosenthal</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of tyrosine receptor kinases in the interactions of head and neck squamous cell carcinoma cells and fibroblasts. </span><span class="cited-content_cbyCitation_journal-name">Oral Oncology</span><span> <strong>2012,</strong> <em>48 </em>
                                    (12)
                                     , 1242-1249. <a href="https://doi.org/10.1016/j.oraloncology.2012.06.011" title="DOI URL">https://doi.org/10.1016/j.oraloncology.2012.06.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.oraloncology.2012.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.oraloncology.2012.06.011%26sid%3Dliteratum%253Aachs%26jtitle%3DOral%2520Oncology%26atitle%3DEvaluation%252Bof%252Btyrosine%252Breceptor%252Bkinases%252Bin%252Bthe%252Binteractions%252Bof%252Bhead%252Band%252Bneck%252Bsquamous%252Bcell%252Bcarcinoma%252Bcells%252Band%252Bfibroblasts%26aulast%3DSweeny%26aufirst%3DLarissa%26date%3D2012%26volume%3D48%26issue%3D12%26spage%3D1242%26epage%3D1249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rodrigo  Abonia</span>, <span class="hlFld-ContribAuthor ">Daniel  Insuasty</span>, <span class="hlFld-ContribAuthor ">Juan  Castillo</span>, <span class="hlFld-ContribAuthor ">Braulio  Insuasty</span>, <span class="hlFld-ContribAuthor ">Jairo  Quiroga</span>, <span class="hlFld-ContribAuthor ">Manuel  Nogueras</span>, <span class="hlFld-ContribAuthor ">Justo  Cobo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel quinoline-2-one based chalcones of potential anti-tumor activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>57 </em>, 29-40. <a href="https://doi.org/10.1016/j.ejmech.2012.08.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.08.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.08.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bnovel%252Bquinoline-2-one%252Bbased%252Bchalcones%252Bof%252Bpotential%252Banti-tumor%252Bactivity%26aulast%3DAbonia%26aufirst%3DRodrigo%26date%3D2012%26volume%3D57%26spage%3D29%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guang  Liang</span>, <span class="hlFld-ContribAuthor ">Zhiguo  Liu</span>, <span class="hlFld-ContribAuthor ">Jianzhang  Wu</span>, <span class="hlFld-ContribAuthor ">Yuepiao  Cai</span>, <span class="hlFld-ContribAuthor ">Xiaokun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer molecules targeting fibroblast growth factor receptors. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2012,</strong> <em>33 </em>
                                    (10)
                                     , 531-541. <a href="https://doi.org/10.1016/j.tips.2012.07.001" title="DOI URL">https://doi.org/10.1016/j.tips.2012.07.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2012.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2012.07.001%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DAnticancer%252Bmolecules%252Btargeting%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptors%26aulast%3DLiang%26aufirst%3DGuang%26date%3D2012%26volume%3D33%26issue%3D10%26spage%3D531%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Uwe  Knippschild</span>, <span class="hlFld-ContribAuthor ">Christian  Peifer</span>, <span class="hlFld-ContribAuthor ">Joachim  Bischof</span>, <span class="hlFld-ContribAuthor ">Klaus  Kramer</span>. </span><span class="cited-content_cbyCitation_article-title">Other tyrosine kinase inhibitors in development and future directions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 50-63. <a href="https://doi.org/10.2217/ebo.12.16" title="DOI URL">https://doi.org/10.2217/ebo.12.16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/ebo.12.16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Febo.12.16%26sid%3Dliteratum%253Aachs%26atitle%3DOther%252Btyrosine%252Bkinase%252Binhibitors%252Bin%252Bdevelopment%252Band%252Bfuture%252Bdirections%26aulast%3DKnippschild%26aufirst%3DUwe%26date%3D2012%26date%3D2012%26spage%3D50%26epage%3D63%26pub%3DFuture%2520Medicine%2520Ltd%26atitle%3DTyrosine%252BKinase%252BInhibitors%252Bfor%252BGastrointestinal%252BStromal%252BTumors%26aulast%3DReichardt%26aufirst%3DPeter%26date%3D2012%26date%3D2012%26volume%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sun-Young  Han</span>, <span class="hlFld-ContribAuthor ">Jie Won  Choi</span>, <span class="hlFld-ContribAuthor ">Jeon  Yang</span>, <span class="hlFld-ContribAuthor ">Chong Hack  Chae</span>, <span class="hlFld-ContribAuthor ">Jongkook  Lee</span>, <span class="hlFld-ContribAuthor ">Heejung  Jung</span>, <span class="hlFld-ContribAuthor ">Kwangho  Lee</span>, <span class="hlFld-ContribAuthor ">Jae Du  Ha</span>, <span class="hlFld-ContribAuthor ">Hyoung Rae  Kim</span>, <span class="hlFld-ContribAuthor ">Sung Yun  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (8)
                                     , 2837-2842. <a href="https://doi.org/10.1016/j.bmcl.2012.02.073" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.02.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.02.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.02.073%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252B3-%2525284%25252C5%25252C6%25252C7-tetrahydro-3H-imidazo%25255B4%25252C5-c%25255Dpyridin-2-yl%252529-1H-quinolin-2-ones%252Bas%252BVEGFR-2%252Bkinase%252Binhibitors%26aulast%3DHan%26aufirst%3DSun-Young%26date%3D2012%26volume%3D22%26issue%3D8%26spage%3D2837%26epage%3D2842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Tien  Tai</span>, <span class="hlFld-ContribAuthor ">Ann-Lii  Cheng</span>, <span class="hlFld-ContribAuthor ">Chung-Wai  Shiau</span>, <span class="hlFld-ContribAuthor ">Chun-Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Ching-Huai  Ko</span>, <span class="hlFld-ContribAuthor ">Mai-Wei  Lin</span>, <span class="hlFld-ContribAuthor ">Pei-Jer  Chen</span>, <span class="hlFld-ContribAuthor ">Kuen-Feng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Dovitinib Induces Apoptosis and Overcomes Sorafenib Resistance in Hepatocellular Carcinoma through SHP-1–Mediated Inhibition of STAT3. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2012,</strong> <em>11 </em>
                                    (2)
                                     , 452-463. <a href="https://doi.org/10.1158/1535-7163.MCT-11-0412" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-11-0412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-11-0412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-11-0412%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DDovitinib%252BInduces%252BApoptosis%252Band%252BOvercomes%252BSorafenib%252BResistance%252Bin%252BHepatocellular%252BCarcinoma%252Bthrough%252BSHP-1%2525E2%252580%252593Mediated%252BInhibition%252Bof%252BSTAT3%26aulast%3DTai%26aufirst%3DWei-Tien%26date%3D2012%26date%3D2011%26volume%3D11%26issue%3D2%26spage%3D452%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James W.  Mier</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms of Resistance to VEGF-Directed Therapy and Implications for Future Trial Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 283-303. <a href="https://doi.org/10.1007/978-1-4614-2400-0_14" title="DOI URL">https://doi.org/10.1007/978-1-4614-2400-0_14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4614-2400-0_14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4614-2400-0_14%26sid%3Dliteratum%253Aachs%26atitle%3DMechanisms%252Bof%252BResistance%252Bto%252BVEGF-Directed%252BTherapy%252Band%252BImplications%252Bfor%252BFuture%252BTrial%252BDesign%26aulast%3DMier%26aufirst%3DJames%2BW.%26date%3D2012%26date%3D2012%26spage%3D283%26epage%3D303%26pub%3DSpringer%2520US%26atitle%3DRenal%252BCell%252BCarcinoma%26aulast%3DFiglin%26aufirst%3DRobert%2BA.%26date%3D2012%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. Lance  Cowey</span>, <span class="hlFld-ContribAuthor ">Thomas E.  Hutson</span>. </span><span class="cited-content_cbyCitation_article-title">Angiopoietins and Other Non-VEGF Antiangiogenic Targets in Advanced Renal Cell Carcinoma. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 135-160. <a href="https://doi.org/10.1007/978-1-4614-2400-0_7" title="DOI URL">https://doi.org/10.1007/978-1-4614-2400-0_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4614-2400-0_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4614-2400-0_7%26sid%3Dliteratum%253Aachs%26atitle%3DAngiopoietins%252Band%252BOther%252BNon-VEGF%252BAntiangiogenic%252BTargets%252Bin%252BAdvanced%252BRenal%252BCell%252BCarcinoma%26aulast%3DCowey%26aufirst%3DC.%2BLance%26date%3D2012%26date%3D2012%26spage%3D135%26epage%3D160%26pub%3DSpringer%2520US%26atitle%3DRenal%252BCell%252BCarcinoma%26aulast%3DFiglin%26aufirst%3DRobert%2BA.%26date%3D2012%26volume%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberta  Ferraldeschi</span>, <span class="hlFld-ContribAuthor ">Paul  Lorigan</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-Angiogenesis Therapy for Melanoma. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 281-294. <a href="https://doi.org/10.1007/978-1-60761-433-3_21" title="DOI URL">https://doi.org/10.1007/978-1-60761-433-3_21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-60761-433-3_21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-60761-433-3_21%26sid%3Dliteratum%253Aachs%26atitle%3DAnti-Angiogenesis%252BTherapy%252Bfor%252BMelanoma%26aulast%3DFerraldeschi%26aufirst%3DRoberta%26date%3D2012%26date%3D2011%26spage%3D281%26epage%3D294%26pub%3DSpringer%2520New%2520York%26atitle%3DDiagnostic%252Band%252BPrognostic%252BBiomarkers%252Band%252BTherapeutic%252BTargets%252Bin%252BMelanoma%26aulast%3DMurphy%26aufirst%3DMichael%2BJ.%26date%3D2012%26volume%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory T.  Notte</span>. </span><span class="cited-content_cbyCitation_article-title">New Chemical Entities Entering Phase III Trials in 2011. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 477-498. <a href="https://doi.org/10.1016/B978-0-12-396492-2.00030-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-396492-2.00030-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396492-2.00030-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396492-2.00030-8%26sid%3Dliteratum%253Aachs%26atitle%3DNew%252BChemical%252BEntities%252BEntering%252BPhase%252BIII%252BTrials%252Bin%252B2011%26aulast%3DNotte%26aufirst%3DGregory%2BT.%26date%3D2012%26spage%3D477%26epage%3D498%26pub%3DElsevier%26atitle%3DAnnual%252BReports%252Bin%252BMedicinal%252BChemistry%252BVolume%252B47%26date%3D2012%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johannes  Taeger</span>, <span class="hlFld-ContribAuthor ">Christian  Moser</span>, <span class="hlFld-ContribAuthor ">Claus  Hellerbrand</span>, <span class="hlFld-ContribAuthor ">Maria E.  Mycielska</span>, <span class="hlFld-ContribAuthor ">Gabriel  Glockzin</span>, <span class="hlFld-ContribAuthor ">Hans J.  Schlitt</span>, <span class="hlFld-ContribAuthor ">Edward K.  Geissler</span>, <span class="hlFld-ContribAuthor ">Oliver  Stoeltzing</span>, <span class="hlFld-ContribAuthor ">Sven A.  Lang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting FGFR/PDGFR/VEGFR Impairs Tumor Growth, Angiogenesis, and Metastasis by Effects on Tumor Cells, Endothelial Cells, and Pericytes in Pancreatic Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2011,</strong> <em>10 </em>
                                    (11)
                                     , 2157-2167. <a href="https://doi.org/10.1158/1535-7163.MCT-11-0312" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-11-0312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-11-0312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-11-0312%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DTargeting%252BFGFR%25252FPDGFR%25252FVEGFR%252BImpairs%252BTumor%252BGrowth%25252C%252BAngiogenesis%25252C%252Band%252BMetastasis%252Bby%252BEffects%252Bon%252BTumor%252BCells%25252C%252BEndothelial%252BCells%25252C%252Band%252BPericytes%252Bin%252BPancreatic%252BCancer%26aulast%3DTaeger%26aufirst%3DJohannes%26date%3D2011%26date%3D2011%26volume%3D10%26issue%3D11%26spage%3D2157%26epage%3D2167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rodrigo  Abonia</span>, <span class="hlFld-ContribAuthor ">Edwar  Cortés</span>, <span class="hlFld-ContribAuthor ">Braulio  Insuasty</span>, <span class="hlFld-ContribAuthor ">Jairo  Quiroga</span>, <span class="hlFld-ContribAuthor ">Manuel  Nogueras</span>, <span class="hlFld-ContribAuthor ">Justo  Cobo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel 1,2,5-trisubstituted benzimidazoles as potential antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (9)
                                     , 4062-4070. <a href="https://doi.org/10.1016/j.ejmech.2011.06.006" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bnovel%252B1%25252C2%25252C5-trisubstituted%252Bbenzimidazoles%252Bas%252Bpotential%252Bantitumor%252Bagents%26aulast%3DAbonia%26aufirst%3DRodrigo%26date%3D2011%26volume%3D46%26issue%3D9%26spage%3D4062%26epage%3D4070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujia  Dai</span>. </span><span class="cited-content_cbyCitation_article-title">Platelet-derived growth factor receptor tyrosine kinase inhibitors: a review of the recent patent literature. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2010,</strong> <em>20 </em>
                                    (7)
                                     , 885-897. <a href="https://doi.org/10.1517/13543776.2010.493559" title="DOI URL">https://doi.org/10.1517/13543776.2010.493559</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2010.493559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2010.493559%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DPlatelet-derived%252Bgrowth%252Bfactor%252Breceptor%252Btyrosine%252Bkinase%252Binhibitors%25253A%252Ba%252Breview%252Bof%252Bthe%252Brecent%252Bpatent%252Bliterature%26aulast%3DDai%26aufirst%3DYujia%26date%3D2010%26date%3D2010%26volume%3D20%26issue%3D7%26spage%3D885%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang-jun  Luan</span>, <span class="hlFld-ContribAuthor ">Cheng  Guo</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-qiang  Wang</span>, <span class="hlFld-ContribAuthor ">Ren-jun  Du</span>. </span><span class="cited-content_cbyCitation_article-title">5-(4-Methylpiperazin-1-yl)-2-nitroaniline. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section E Structure Reports Online</span><span> <strong>2010,</strong> <em>66 </em>
                                    (6)
                                     , o1268-o1268. <a href="https://doi.org/10.1107/S1600536810015953" title="DOI URL">https://doi.org/10.1107/S1600536810015953</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S1600536810015953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS1600536810015953%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520E%2520Structure%2520Reports%2520Online%26atitle%3D5-%2525284-Methylpiperazin-1-yl%252529-2-nitroaniline%26aulast%3DLuan%26aufirst%3DChang-jun%26date%3D2010%26date%3D2010%26volume%3D66%26issue%3D6%26spage%3Do1268%26epage%3Do1268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien H.  Dey</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Bianchi</span>, <span class="hlFld-ContribAuthor ">Johannes  Voshol</span>, <span class="hlFld-ContribAuthor ">Debora  Bonenfant</span>, <span class="hlFld-ContribAuthor ">Edward J.  Oakeley</span>, <span class="hlFld-ContribAuthor ">Nancy E.  Hynes</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2010,</strong> <em>70 </em>
                                    (10)
                                     , 4151-4162. <a href="https://doi.org/10.1158/0008-5472.CAN-09-4479" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-09-4479</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-09-4479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-09-4479%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DTargeting%252BFibroblast%252BGrowth%252BFactor%252BReceptors%252BBlocks%252BPI3K%25252FAKT%252BSignaling%25252C%252BInduces%252BApoptosis%25252C%252Band%252BImpairs%252BMammary%252BTumor%252BOutgrowth%252Band%252BMetastasis%26aulast%3DDey%26aufirst%3DJulien%2BH.%26date%3D2010%26date%3D2010%26volume%3D70%26issue%3D10%26spage%3D4151%26epage%3D4162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rodrigo  Abonia</span>, <span class="hlFld-ContribAuthor ">Juan  Castillo</span>, <span class="hlFld-ContribAuthor ">Paola  Cuervo</span>, <span class="hlFld-ContribAuthor ">Braulio  Insuasty</span>, <span class="hlFld-ContribAuthor ">Jairo  Quiroga</span>, <span class="hlFld-ContribAuthor ">Alejandro  OrtÃ­z</span>, <span class="hlFld-ContribAuthor ">Manuel  Nogueras</span>, <span class="hlFld-ContribAuthor ">Justo  Cobo</span>. </span><span class="cited-content_cbyCitation_article-title">A Simple One-Pot Synthesis of New Imidazol-2-yl-1
              H
              -quinolin-2-ones from the Direct Reaction of 2-Chloroquinolin-3-carbaldehyde with Aromatic
              o
              -Diamines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2010,</strong> <em>2010 </em>
                                    (2)
                                     , 317-325. <a href="https://doi.org/10.1002/ejoc.200901014" title="DOI URL">https://doi.org/10.1002/ejoc.200901014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.200901014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.200901014%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BSimple%252BOne-Pot%252BSynthesis%252Bof%252BNew%252BImidazol-2-yl-1%252BH%252B-quinolin-2-ones%252Bfrom%252Bthe%252BDirect%252BReaction%252Bof%252B2-Chloroquinolin-3-carbaldehyde%252Bwith%252BAromatic%252Bo%252B-Diamines%26aulast%3DAbonia%26aufirst%3DRodrigo%26date%3D2010%26volume%3D2010%26issue%3D2%26spage%3D317%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm800790t&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm800790t%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-2%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=101&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Multikinase Inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. 3-Benzimidazol-2-ylhydroquinolin-2-one Scaffold and <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0004.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of 3-Benzimidazol-2-ylhydroquinolin-2-one Scaffold</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0005.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-one Scaffold via the Isatoic Anhydride Route<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LHMDS, THF (b) Tf<sub>2</sub>O, Pyr (c) R′R′′NH<sub>2</sub>, DIEA; (d) triflic acid, HCl, 80 °C.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0006.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-one Scaffold via the LHMDS Route</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0007.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Novel Benzimidazole Acetates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>2</sub>NH, Et<sub>3</sub>N, NMP, 90 °C; (b)H<sub>2</sub>, Pd/c, EtOH; (c)EtOH, 80 °C, (d) ROH, PPh<sub>3</sub>, DIAD, THF.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0008.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Late Stage Modifications to the 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-one Core<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EtOH, KOH; (b) <i>N</i>-methylpiperazine, EDCI, HOAT, Et<sub>3</sub>N, DMF; (c) DIBAL-H, PhMe; (d) MnO<sub>2</sub>, DMA; (e) <i>N</i>-methylpiperazine, Na(OAc)<sub>3</sub>BH, DMA; (f) bromoacetyl chloride, DMA, Et<sub>3</sub>N; (g) dimethylamine, EtOH.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0009.jpeg" id="rightTab-gs6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Ring A Substituted 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-methylpiperazine, DMF, 90°C; (b) H<sub>2</sub>, Pd/C, EtOH; (c) ethyl 2-benzimidazol-2-ylacetate, LHMDS, THF; (d) NaH, NMP, 100°C; (e) <i>N</i>-methylpiperazine, Et<sub>3</sub>N, NMP, 50°C; (f) 23b, LHMDS, THF; (g) NaOH, EtOH, 100°C; (h) benzylamine, EDCI, HOAT, Et<sub>3</sub>N, DMF.</p></p></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding site model for compound <b>5</b> in the VEGFR-2 homology model. (a) Cartoon representation of the kinase with residues interacting with the ligand in stick model. (b) Surface representation, with the surface colored by atom type (red = oxygen, blue = nitrogen, yellow = sulfur, gray = carbon/hydrogen). The donor−acceptor−donor motif is shown to interact with the hinge region while the 1-methylpiperazine substituent on C5′ points into solution.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/medium/jm-2008-00790t_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Treatment with <b>5</b> inhibits angiogenesis in a bFGF-induced Matrigel model in vivo. Matrigel containing bFGF was injected subcutaneously into mice, and <b>5</b> was administrated orally for 8 days (0−200 mg/kg/d). The Matrigel plugs were removed, and hemoglobin concentration was measured (<i>n</i> = 8 mice/group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800790t/production/images/large/jm-2008-00790t_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800790t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i94">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20358" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20358" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Folkman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abernathy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G.</span><span> </span><span class="NLM_article-title">Isolation of a tumor factor responsible for angiogenesis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=1971&pages=275-288&issue=2&author=J.+Folkmanauthor=E.+Merlerauthor=C.+Abernathyauthor=G.+Williams&title=Isolation+of+a+tumor+factor+responsible+for+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26aulast%3DMerler%26aufirst%3DE.%26aulast%3DAbernathy%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DG.%26atitle%3DIsolation%2520of%2520a%2520tumor%2520factor%2520responsible%2520for%2520angiogenesis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1971%26volume%3D133%26issue%3D2%26spage%3D275%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Carmeliet, P.</span><span> </span><span class="NLM_article-title">Mechanisms of angiogenesis and arteriogenesis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1038%2F74651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=10742145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVOrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=389-395&issue=4&author=P.+Carmeliet&title=Mechanisms+of+angiogenesis+and+arteriogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of angiogenesis and arteriogenesis</span></div><div class="casAuthors">Carmeliet, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">389-395</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">A review with 71 refs., on the cellular and mol. mechanisms underlying the formation of endothelium-lined channels (angiogenesis) and their maturation via recruitment of smooth muscle cells (arteriogenesis) during physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC5duTZ_-aV7Vg90H21EOLACvtfcHk0liXREW8-AEV9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVOrur4%253D&md5=a8a3874f286a4e46a9eeaaa9ff8b17dc</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F74651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F74651%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DMechanisms%2520of%2520angiogenesis%2520and%2520arteriogenesis%26jtitle%3DNat.%2520Med.%26date%3D2000%26volume%3D6%26issue%3D4%26spage%3D389%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Penault-Llorca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelaiede, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquemier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLapeyriere, O.</span><span> </span><span class="NLM_article-title">Expression of FGF and FGF receptor genes in human breast cancer</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1002%2Fijc.2910610205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=7705943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADyaK2MXlsVCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1995&pages=170-176&issue=2&author=F.+Penault-Llorcaauthor=F.+Bertucciauthor=J.+Adelaiedeauthor=P.+Parcauthor=F.+Coulierauthor=J.+Jacquemierauthor=D.+Birnbaumauthor=O.+DeLapeyriere&title=Expression+of+FGF+and+FGF+receptor+genes+in+human+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of FGF and FGF receptor genes in human breast cancer</span></div><div class="casAuthors">Penault-Llorca, Frederique; Bertucci, Francois; Adelaiede, Jose; Parc, Patricia; Coulier, Francois; Jacquemier, Jocelyne; Birnbaum, Daniel; DeLapeyriere, Odile</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">170-6</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">The family of FGF growth factors is involved in several biol. processes and might play an important role in tumorigenesis.  The authors have studied the resp. expression of 8 of the 9 characterized FGF genes, and of the 4 known FGF receptor genes, in a panel of 10 tumor-cell lines and 103 breast-tumor samples, using RT-PCR and Northern-blot analyses.  FGF1 and FGF2 were expressed in almost all samples, whereas expression of FGF5, FGF6, FGF7 and FGF9 was more restricted.  FGFR1, FGFR2, and FGFR4 were expressed at high levels in resp. 22%, 4%, and 32% of tumors.  FGFR3 expression was not detected.  The transcript encoding an FGFR1 isoform with 2 Ig-like domains was the most prevalent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM4Ndkn4BdcLVg90H21EOLACvtfcHk0liXREW8-AEV9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsVCmt7g%253D&md5=ce0eda6c49f3504d032c36d6cfb805e5</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910610205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910610205%26sid%3Dliteratum%253Aachs%26aulast%3DPenault-Llorca%26aufirst%3DF.%26aulast%3DBertucci%26aufirst%3DF.%26aulast%3DAdelaiede%26aufirst%3DJ.%26aulast%3DParc%26aufirst%3DP.%26aulast%3DCoulier%26aufirst%3DF.%26aulast%3DJacquemier%26aufirst%3DJ.%26aulast%3DBirnbaum%26aufirst%3DD.%26aulast%3DDeLapeyriere%26aufirst%3DO.%26atitle%3DExpression%2520of%2520FGF%2520and%2520FGF%2520receptor%2520genes%2520in%2520human%2520breast%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1995%26volume%3D61%26issue%3D2%26spage%3D170%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kyzas, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batistatou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnantis, N. J.</span><span> </span><span class="NLM_article-title">Potential autocrine function of vascular endothelial growth factor in head and neck cancer via vascular endothelial growth factor receptor-2</span> <span class="citation_source-journal">Mod. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1038%2Fmodpathol.3800295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=15475932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVSht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=485-494&issue=4&author=P.+A.+Kyzasauthor=D.+Stefanouauthor=A.+Batistatouauthor=N.+J.+Agnantis&title=Potential+autocrine+function+of+vascular+endothelial+growth+factor+in+head+and+neck+cancer+via+vascular+endothelial+growth+factor+receptor-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Potential autocrine function of vascular endothelial growth factor in head and neck cancer via vascular endothelial growth factor receptor-2</span></div><div class="casAuthors">Kyzas, Panayiotis A.; Stefanou, Dimitrios; Batistatou, Anna; Agnantis, Niki J.</div><div class="citationInfo"><span class="NLM_cas:title">Modern Pathology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">485-494</span>CODEN:
                <span class="NLM_cas:coden">MODPEO</span>;
        ISSN:<span class="NLM_cas:issn">0893-3952</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Vascular endothelial growth factor is a peptide with well-defined actions on the vasculature and fundamental role in tumor angiogenesis.  Its action in vascular endothelium is exerted in a paracrine manner.  The immunohistochem. expression of this protein by cancer cells in head and neck squamous cell carcinoma was correlated with increased tumor aggressiveness and poor survival in previous studies.  In the past years, an increasing amt. of studies demonstrated potential autocrine action of vascular endothelial growth factor in various neoplasms.  However, the existence and the impact of such autocrine action in head and neck cancer have not been demonstrated yet.  In this retrospective study, we evaluated the expression of vascular endothelial growth factor and its receptors in neoplastic cells, in a cohort of patients with head and neck squamous cell carcinoma, and compared this expression with tumor aggressiveness, clinicopathol. parameters and outcome.  High expression of vascular endothelial growth factor was strongly correlated with high expression of vascular endothelial growth factor receptor-2 (but not vascular endothelial growth factor receptor-1) on the cancer cells (P<0.001).  The co-overexpression of both the protein and vascular endothelial growth factor receptor-2 was assocd. with higher tumor proliferation rate (P<0.001).  The above co-overexpression also correlated with worse survival (log rank P<0.05) in patients with oral-larynx squamous cell carcinoma.  Our results suggest that an autocrine vascular endothelial growth factor loop, mediated via vascular endothelial growth factor receptor-2, probably exists in head and neck squamous cell carcinoma.  These observations support the hypothesis that the use of vascular endothelial growth factor receptor-2 inhibitors as adjuvant antiangiogenic therapy might have beneficial effects for these patients, by disrupting both paracrine (endothelial-dependent) and autocrine actions of vascular endothelial growth factor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWBHGb6re0ybVg90H21EOLACvtfcHk0ljOWGg7GM2OHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVSht7g%253D&md5=29dc98d41d914a6b64703b1d2a16130b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fmodpathol.3800295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmodpathol.3800295%26sid%3Dliteratum%253Aachs%26aulast%3DKyzas%26aufirst%3DP.%2BA.%26aulast%3DStefanou%26aufirst%3DD.%26aulast%3DBatistatou%26aufirst%3DA.%26aulast%3DAgnantis%26aufirst%3DN.%2BJ.%26atitle%3DPotential%2520autocrine%2520function%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520in%2520head%2520and%2520neck%2520cancer%2520via%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%26jtitle%3DMod.%2520Pathol.%26date%3D2005%26volume%3D18%26issue%3D4%26spage%3D485%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Oestman, A.</span><span> </span><span class="NLM_article-title">PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma</span> <span class="citation_source-journal">Cytokine Growth Factor Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1016%2Fj.cytogfr.2004.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=15207817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltVKhtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=275-286&issue=4&author=A.+Oestman&title=PDGF+receptors-mediators+of+autocrine+tumor+growth+and+regulators+of+tumor+vasculature+and+stroma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma</span></div><div class="casAuthors">Oestman, Arne</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & Growth Factor Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">275-286</span>CODEN:
                <span class="NLM_cas:coden">CGFRFB</span>;
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with refs.  PDGFs and their cognate tyrosine kinase α- and β-receptors are involved in multiple tumor-assocd. processes including autocrine growth stimulation of tumor cells, stimulation of tumor angiogenesis and recruitment and regulation of tumor fibroblasts.  The recent development of clin. useful PDGF antagonists, like STI571/Glivec, has increased the interest in PDGF receptors as cancer drug targets.  Autocrine PDGF receptor signaling occurs in certain malignancies characterized by mutational activation of PDGF or PDGF receptors, for instance, dermatofibrosarcoma protuberans, gastrointestinal stromal tumors, and hypereosinophilic syndrome.  The roles of PDGF in regulation of tumor angiogenesis and tumor fibroblasts are more general, and probably occur in most common solid tumors.  Concerning tumor angiogenesis recent studies have predominantly focused on the importance of PDGF receptor signaling for tumor pericyte recruitment.  PDGF receptors in the tumor stroma have also attracted attention as interesting drug targets because of their function as regulators of tumor interstitial fluid pressure, tumor trans-vascular transport and tumor drug uptake.  In summary, the improved understanding of the role of PDGF signaling in tumor biol., and the introduction of PDGF antagonists, has set the stage for a continued development of PDGF antagonists as novel cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8-4CVipxax7Vg90H21EOLACvtfcHk0ljOWGg7GM2OHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltVKhtLw%253D&md5=1acb20873a7a3b8e18799bb255792a46</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cytogfr.2004.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cytogfr.2004.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DOestman%26aufirst%3DA.%26atitle%3DPDGF%2520receptors-mediators%2520of%2520autocrine%2520tumor%2520growth%2520and%2520regulators%2520of%2520tumor%2520vasculature%2520and%2520stroma%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2004%26volume%3D15%26issue%3D4%26spage%3D275%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Patel, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaganti, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motzer, R. J.</span><span> </span><span class="NLM_article-title">Targeted therapy for metastatic renal cell carcinoma</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=16465192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVyjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=614-619&issue=5&author=P.+H.+Patelauthor=R.+S.+Chagantiauthor=R.+J.+Motzer&title=Targeted+therapy+for+metastatic+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted therapy for metastatic renal cell carcinoma</span></div><div class="casAuthors">Patel, P. H.; Chaganti, R. S. K.; Motzer, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">614-619</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Metastatic renal cell carcinoma (RCC) has historically been refractory to cytotoxic and hormonal agents; only interleukin 2 and interferon alpha provide response in a minority of patients.  We reviewed RCC biol. and explored the ways in which this understanding led to development of novel, effective targeted therapies.  Small mol. tyrosine kinase inhibitors, monoclonal antibodies and novel agents are all being studied, and phase II studies show promising activity of sunitinib, sorafenib and bevacizumab.  The results of phase III studies will det. the role of these agents in metastatic RCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWE44JTS3olLVg90H21EOLACvtfcHk0ljOWGg7GM2OHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVyjsbk%253D&md5=fc726443c9e627eb2453ba04b93f2def</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DP.%2BH.%26aulast%3DChaganti%26aufirst%3DR.%2BS.%26aulast%3DMotzer%26aufirst%3DR.%2BJ.%26atitle%3DTargeted%2520therapy%2520for%2520metastatic%2520renal%2520cell%2520carcinoma%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D94%26issue%3D5%26spage%3D614%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Liao, J. J.-L.</span><span> </span><span class="NLM_article-title">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=409-424&issue=3&author=J.+J.-L.+Liao&title=Molecular+Recognition+of+Protein+Kinase+Binding+Pockets+for+Design+of+Potent+and+Selective+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span></div><div class="casAuthors">Liao, Jeffrey Jie-Lou</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-424</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Many kinase inhibitors have failed in preclin. or clin. development because of the lack of such selectivity that induces intolerable side effects, mostly because the catalytic cleft is highly conserved in sequence and conformation.  Systematic anal. of the crystal structures of protein kinases can offer insight into the design of highly selective kinase inhibitors to overcome these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDTl2SBUfbbVg90H21EOLACvtfcHk0lhYx8nautzwPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D&md5=77542d3ba589bd834a0d2b97a24eea05</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm0608107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608107%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%2BJ.-L.%26atitle%3DMolecular%2520Recognition%2520of%2520Protein%2520Kinase%2520Binding%2520Pockets%2520for%2520Design%2520of%2520Potent%2520and%2520Selective%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D3%26spage%3D409%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Albert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magoc, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, R.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghoreishi-Haack, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukofzer, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavropoulos, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartandi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niquette, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCall, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donawho, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelides, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span> </span><span class="NLM_article-title">Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">1006</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1158%2F1535-7163.MCT-05-0410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=16648571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFCkt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=995-1006&issue=4&author=D.+H.+Albertauthor=P.+Tapangauthor=T.+J.+Magocauthor=L.+J.+Peaseauthor=D.+R.+Reuterauthor=R.-Q.+Weiauthor=J.+Liauthor=J.+Guoauthor=P.+F.+Bousquetauthor=N.+S.+Ghoreishi-Haackauthor=B.+Wangauthor=G.+T.+Bukofzerauthor=Y.-C.+Wangauthor=J.+A.+Stavropoulosauthor=K.+Hartandiauthor=A.+L.+Niquetteauthor=N.+Soniauthor=E.+F.+Johnsonauthor=J.+O.+McCallauthor=J.+J.+Bouskaauthor=Y.+Luoauthor=C.+K.+Donawhoauthor=Y.+Daiauthor=P.+A.+Marcotteauthor=K.+B.+Glaserauthor=M.+R.+Michaelidesauthor=S.+K.+Davidsen&title=Preclinical+activity+of+ABT-869%2C+a+multitargeted+receptor+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor</span></div><div class="casAuthors">Albert, Daniel H.; Tapang, Paul; Magoc, Terrance J.; Pease, Lori J.; Reuter, David R.; Wei, Ru-Qi; Li, Junling; Guo, Jun; Bousquet, Peter F.; Ghoreishi-Haack, Nayereh S.; Wang, Baole; Bukofzer, Gail T.; Wang, Yi-Chun; Stavropoulos, Jason A.; Hartandi, Kresna; Niquette, Amanda L.; Soni, Nirupama; Johnson, Eric F.; McCall, J. Owen; Bouska, Jennifer J.; Luo, Yanping; Donawho, Cherrie K.; Dai, Yujia; Marcotte, Patrick A.; Glaser, Keith B.; Michaelides, Michael R.; Davidsen, Steven K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">995-1006</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">ABT-869 is a structurally novel, receptor tyrosine kinase (RTK) inhibitor that is a potent inhibitor of members of the vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptor families (e.g., KDR IC50 = 4 nmol/L) but has much less activity (IC50s > 1 μmol/L) against unrelated RTKs, sol. tyrosine kinases, or serine/threonine kinases.  The inhibition profile of ABT-869 is evident in cellular assays of RTK phosphorylation (IC50 = 2, 4, and 7 nmol/L for PDGFR-β, KDR, and CSF-1R, resp.) and VEGF-stimulated proliferation (IC50 = 0.2 nmol/L for human endothelial cells).  ABT-869 is not a general antiproliferative agent because, in most cancer cells, >1,000-fold higher concns. of ABT-869 are required for inhibition of proliferation.  However, ABT-869 exhibits potent antiproliferative and apoptotic effects on cancer cells whose proliferation is dependent on mutant kinases, such as FLT3.  In vivo ABT-869 is effective orally in the mechanism-based murine models of VEGF-induced uterine edema (ED50 = 0.5 mg/kg) and corneal angiogenesis (>50% inhibition, 15 mg/kg).  In tumor growth studies, ABT-869 exhibits efficacy in human fibrosarcoma and breast, colon, and small cell lung carcinoma xenograft models (ED50 = 1.5-5 mg/kg, twice daily) and is also effective (>50% inhibition) in orthotopic breast and glioma models.  Redn. in tumor size and tumor regression was obsd. in epidermoid carcinoma and leukemia xenograft models, resp.  In combination, ABT-869 produced at least additive effects when given with cytotoxic therapies.  Based on pharmacokinetic anal. from tumor growth studies, efficacy correlated more strongly with time over a threshold value (cellular KDR IC50 cor. for blood plasma protein binding = 0.08 μg/mL, ≥7 h) than with plasma area under the curve or Cmax.  These results support clin. assessment of ABT-869 as a therapeutic agent for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkn2KBvMa4wrVg90H21EOLACvtfcHk0lhYx8nautzwPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFCkt7g%253D&md5=a5a60b591b4da7a3c589f1618d9cffb9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0410%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DTapang%26aufirst%3DP.%26aulast%3DMagoc%26aufirst%3DT.%2BJ.%26aulast%3DPease%26aufirst%3DL.%2BJ.%26aulast%3DReuter%26aufirst%3DD.%2BR.%26aulast%3DWei%26aufirst%3DR.-Q.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DBousquet%26aufirst%3DP.%2BF.%26aulast%3DGhoreishi-Haack%26aufirst%3DN.%2BS.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DBukofzer%26aufirst%3DG.%2BT.%26aulast%3DWang%26aufirst%3DY.-C.%26aulast%3DStavropoulos%26aufirst%3DJ.%2BA.%26aulast%3DHartandi%26aufirst%3DK.%26aulast%3DNiquette%26aufirst%3DA.%2BL.%26aulast%3DSoni%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DMcCall%26aufirst%3DJ.%2BO.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DDonawho%26aufirst%3DC.%2BK.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DMarcotte%26aufirst%3DP.%2BA.%26aulast%3DGlaser%26aufirst%3DK.%2BB.%26aulast%3DMichaelides%26aufirst%3DM.%2BR.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26atitle%3DPreclinical%2520activity%2520of%2520ABT-869%252C%2520a%2520multitargeted%2520receptor%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26issue%3D4%26spage%3D995%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">George, D. J.</span><span> </span><span class="NLM_article-title">Phase 2 Studies of Sunitinib and AG013736 in Patients with Cytokine-Refractory Renal Cell Carcinoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">2, Pt. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">753s</span><span class="NLM_x">–</span> <span class="NLM_lpage">757s</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=753s-757s&issue=2%2C+Pt.+2&author=D.+J.+George&title=Phase+2+Studies+of+Sunitinib+and+AG013736+in+Patients+with+Cytokine-Refractory+Renal+Cell+Carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DD.%2BJ.%26atitle%3DPhase%25202%2520Studies%2520of%2520Sunitinib%2520and%2520AG013736%2520in%2520Patients%2520with%2520Cytokine-Refractory%2520Renal%2520Cell%2520Carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26issue%3D2%252C%2520Pt.%25202%26spage%3D753s%26epage%3D757s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lee, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes de Menezes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vora, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordahl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aukerman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C.</span><span> </span><span class="NLM_article-title">In Vivo Target Modulation and Biological Activity of CHIR-258, a Multitargeted Growth Factor Receptor Kinase Inhibitor, in Colon Cancer Models</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">3633</span><span class="NLM_x">–</span> <span class="NLM_lpage">3641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1158%2F1078-0432.CCR-04-2129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=15897558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFyrsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=3633-3641&issue=10&author=S.+H.+Leeauthor=D.+Lopes+de+Menezesauthor=J.+Voraauthor=A.+Harrisauthor=H.+Yeauthor=L.+Nordahlauthor=E.+Garrettauthor=E.+Samaraauthor=S.+L.+Aukermanauthor=A.+B.+Gelbauthor=C.+Heise&title=In+Vivo+Target+Modulation+and+Biological+Activity+of+CHIR-258%2C+a+Multitargeted+Growth+Factor+Receptor+Kinase+Inhibitor%2C+in+Colon+Cancer+Models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo Target Modulation and Biological Activity of CHIR-258, a Multitargeted Growth Factor Receptor Kinase Inhibitor, in Colon Cancer Models</span></div><div class="casAuthors">Lee, Sang Hoon; Lopes de Menezes, Daniel; Vora, Jayesh; Harris, Alex; Ye, Helen; Nordahl, Lara; Garrett, Evelyn; Samara, Emil; Aukerman, Sharon Lea; Gelb, Arnold B.; Heise, Carla</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3633-3641</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: To evaluate the therapeutic and biol. effects of CHIR-258, an orally bioavailable, potent inhibitor of class III-V receptor tyrosine kinases, in colon cancer models.  Exptl. Design: The pharmacol. activity of CHIR-258 was characterized by monitoring target modulation as well as by evaluating the antitumor and antiangiogenic effects in human colon xenograft models.  Results: CHIR-258 inhibits vascular endothelial growth factor receptor 1/2, fibroblast growth factor receptor 1/3, and platelet-derived growth factor receptor β (PDGFRβ) and shows both antitumor and antiangiogenic activities in vivo.  Treatment of KM12L4a human colon cancer cells with CHIR-258 resulted in a dose-dependent inhibition of vascular endothelial growth factor receptor 1 and PDGFRβ phosphorylation and redn. of phosphorylated extracellular signal-regulated kinase (ERK) levels, indicating modulation of target receptors and downstream signaling.  In vivo administration of CHIR-258 resulted in significant tumor growth inhibition and tumor regressions, including large, established tumors (500-1,000 mm3).  Immunohistochem. anal. showed a redn. of phosphorylated PDGFRβ and phosphorylated ERK in tumor cells after oral dosing with CHIR-258 compared with control tumors.  These changes were accompanied by decreased tumor cell proliferation rate and reduced intratumoral microvessel d.  CHIR-258 inhibited the phosphorylation of PDGFRβ and ERK phosphorylation in tumors within 2 h following dosing and the inhibitory activity was sustained for >24 h.  Significant antitumor activity was obsd. with intermittent dosing schedules, indicating a sustained biol. activity.  Conclusion: These studies provide evidence that biol. activity of CHIR-258 in tumors correlates with efficacy and aids in the identification of potential biomarkers of this multitargeted receptor tyrosine kinase inhibitor.  CHIR-258 exhibits properties that make it a promising candidate for clin. development in a variety of solid and hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBYM9bzT_QQLVg90H21EOLACvtfcHk0ligKYrlTwQXHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFyrsb4%253D&md5=eeca79fe190dcdc2db251d6e836ec4ab</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-2129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-2129%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DLopes%2Bde%2BMenezes%26aufirst%3DD.%26aulast%3DVora%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DA.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DNordahl%26aufirst%3DL.%26aulast%3DGarrett%26aufirst%3DE.%26aulast%3DSamara%26aufirst%3DE.%26aulast%3DAukerman%26aufirst%3DS.%2BL.%26aulast%3DGelb%26aufirst%3DA.%2BB.%26aulast%3DHeise%26aufirst%3DC.%26atitle%3DIn%2520Vivo%2520Target%2520Modulation%2520and%2520Biological%2520Activity%2520of%2520CHIR-258%252C%2520a%2520Multitargeted%2520Growth%2520Factor%2520Receptor%2520Kinase%2520Inhibitor%252C%2520in%2520Colon%2520Cancer%2520Models%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26issue%3D10%26spage%3D3633%26epage%3D3641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Lopes de Menezes, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shephard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldbeck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aukerman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C.</span><span> </span><span class="NLM_article-title">CHIR-258: A Potent Inhibitor of FLT3 Kinase in Experimental Tumor Xenograft Models of Human Acute Myelogenous Leukemia</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">5281</span><span class="NLM_x">–</span> <span class="NLM_lpage">5291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1158%2F1078-0432.CCR-05-0358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=16033847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt12qurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=5281-5291&issue=14&author=D.+E.+Lopes+de+Menezesauthor=J.+Pengauthor=E.+N.+Garrettauthor=S.+G.+Louieauthor=S.+H.+Leeauthor=M.+Wiesmannauthor=Y.+Tangauthor=L.+Shephardauthor=C.+Goldbeckauthor=Y.+Oeiauthor=H.+Yeauthor=S.+L.+Aukermanauthor=C.+Heise&title=CHIR-258%3A+A+Potent+Inhibitor+of+FLT3+Kinase+in+Experimental+Tumor+Xenograft+Models+of+Human+Acute+Myelogenous+Leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">CHIR-258: A Potent Inhibitor of FLT3 Kinase in Experimental Tumor Xenograft Models of Human Acute Myelogenous Leukemia</span></div><div class="casAuthors">Lopes de Menezes, Daniel E.; Peng, Jing; Garrett, Evelyn N.; Louie, Sharianne G.; Lee, Sang H.; Wiesmann, Marion; Tang, Yan; Shephard, Lee; Goldbeck, Cheryl; Oei, Yoko; Ye, Helen; Aukerman, Sharon L.; Heise, Carla</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5281-5291</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Fms-like tyrosine kinase 3 (FLT3) encodes a receptor tyrosine kinase (RTK) for which activating mutations have been identified in a proportion of acute myelogenous leukemia (AML) patients and assocd. with poor clin. prognosis.  Given the relevance of FLT3 mutations in AML, we investigated the activity of CHIR-258, an orally active, multitargeted small mol., with potent activity against FLT3 kinase and class III, IV, and V RTKs involved in endothelial and tumor cell proliferation in AML models.  Exptl. Design: CHIR-258 was tested on two human leukemic cell lines in vitro and in vivo with differing FLT3 mutational status [MV4;11 cells express FLT3 internal tandem duplications (ITD) vs. RS4;11 cells with wild-type (WT) FLT3].  Results: Antiproliferative activity of CHIR-258 against MV4;11 was ∼24-fold greater compared with RS4;11, indicating more potent inhibition against cells with constitutively activated FLT3 ITD.  Dose-dependent down modulation of receptor phosphorylation and downstream signaling [signal transducer and activator of transcription 5 (STAT5) and extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase] in MV4;11 cells with CHIR-258 confirmed the mol. mechanism of action.  Target modulation of phospho-FLT3, phospho-STAT5, and phospho-ERK in MV4;11 tumors was achieved at biol. active doses of CHIR-258.  Tumor regressions and eradication of AML cells from the bone marrow were shown in s.c. and bone marrow engraftment leukemic xenograft models.  Tumor responses were characterized by decreased cellular proliferation and pos. immunohistochem. staining for active caspase-3 and cleaved poly(ADP-ribose) polymerase, suggesting cell death was mediated in part via apoptosis.  Conclusions: These data indicate that CHIR-258 may be an effective therapy in FLT3-assocd. AML and warrants clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqguTG7oB17arVg90H21EOLACvtfcHk0ljfW9yUgAiPeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt12qurc%253D&md5=81dc564d120f28420fdd69f685f877c2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0358%26sid%3Dliteratum%253Aachs%26aulast%3DLopes%2Bde%2BMenezes%26aufirst%3DD.%2BE.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DGarrett%26aufirst%3DE.%2BN.%26aulast%3DLouie%26aufirst%3DS.%2BG.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DWiesmann%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DShephard%26aufirst%3DL.%26aulast%3DGoldbeck%26aufirst%3DC.%26aulast%3DOei%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DAukerman%26aufirst%3DS.%2BL.%26aulast%3DHeise%26aufirst%3DC.%26atitle%3DCHIR-258%253A%2520A%2520Potent%2520Inhibitor%2520of%2520FLT3%2520Kinase%2520in%2520Experimental%2520Tumor%2520Xenograft%2520Models%2520of%2520Human%2520Acute%2520Myelogenous%2520Leukemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26issue%3D14%26spage%3D5281%26epage%3D5291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Trudel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reece, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. K.</span><span> </span><span class="NLM_article-title">CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2941</span><span class="NLM_x">–</span> <span class="NLM_lpage">2948</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=2941-2948&issue=7&author=S.+Trudelauthor=Z.+H.+Liauthor=E.+Weiauthor=M.+Wiesmannauthor=H.+Changauthor=C.+Chenauthor=D.+Reeceauthor=C.+Heiseauthor=A.+K.+Stewart&title=CHIR-258%2C+a+novel%2C+multitargeted+tyrosine+kinase+inhibitor+for+the+potential+treatment+of+t%284%3B14%29+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrudel%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DZ.%2BH.%26aulast%3DWei%26aufirst%3DE.%26aulast%3DWiesmann%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DReece%26aufirst%3DD.%26aulast%3DHeise%26aufirst%3DC.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26atitle%3DCHIR-258%252C%2520a%2520novel%252C%2520multitargeted%2520tyrosine%2520kinase%2520inhibitor%2520for%2520the%2520potential%2520treatment%2520of%2520t%25284%253B14%2529%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26issue%3D7%26spage%3D2941%26epage%3D2948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ukrainets, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezuglyi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treskach, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turov, A. V.</span><span> </span><span class="NLM_article-title">2-(Carbethoxymethyl)-4<i>H</i>-3,1-benzoxazin-4-one. 3. Condensation with <i>o</i>-phenylenediamine</span> <span class="citation_source-journal">Khim. Geterotsikl. Soedin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&pages=239-241&issue=2&author=I.+V.+Ukrainetsauthor=P.+A.+Bezuglyiauthor=V.+I.+Treskachauthor=A.+V.+Turov&title=2-%28Carbethoxymethyl%29-4H-3%2C1-benzoxazin-4-one.+3.+Condensation+with+o-phenylenediamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUkrainets%26aufirst%3DI.%2BV.%26aulast%3DBezuglyi%26aufirst%3DP.%2BA.%26aulast%3DTreskach%26aufirst%3DV.%2BI.%26aulast%3DTurov%26aufirst%3DA.%2BV.%26atitle%3D2-%2528Carbethoxymethyl%2529-4H-3%252C1-benzoxazin-4-one.%25203.%2520Condensation%2520with%2520o-phenylenediamine%26jtitle%3DKhim.%2520Geterotsikl.%2520Soedin.%26date%3D1992%26issue%3D2%26spage%3D239%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Ukrainets, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taran, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turov, A. V.</span><span> </span><span class="NLM_article-title">4-Hydroxy-2-quinolones. 16. Condensation of 2-carboxymalonanilic acid <i>N</i>-<i>R</i>-substituted amides with <i>o</i>-phenylenediamine</span> <span class="citation_source-journal">Khim. Geterotsikl. Soedin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1105</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&pages=1105-1108&issue=8&author=I.+V.+Ukrainetsauthor=S.+G.+Taranauthor=A.+V.+Turov&title=4-Hydroxy-2-quinolones.+16.+Condensation+of+2-carboxymalonanilic+acid+N-R-substituted+amides+with+o-phenylenediamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUkrainets%26aufirst%3DI.%2BV.%26aulast%3DTaran%26aufirst%3DS.%2BG.%26aulast%3DTurov%26aufirst%3DA.%2BV.%26atitle%3D4-Hydroxy-2-quinolones.%252016.%2520Condensation%2520of%25202-carboxymalonanilic%2520acid%2520N-R-substituted%2520amides%2520with%2520o-phenylenediamine%26jtitle%3DKhim.%2520Geterotsikl.%2520Soedin.%26date%3D1993%26issue%3D8%26spage%3D1105%26epage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ukrainets, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezugly, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taran, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorokhova, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turov, A. V.</span><span> </span><span class="NLM_article-title">Effective Synthesis of 3-(Benzimidazol-2-yl)-4-hydroxy-2-<i>oxo</i>-1,2-dihydroquinolines</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">42</span><span class="NLM_x">) </span> <span class="NLM_fpage">7747</span><span class="NLM_x">–</span> <span class="NLM_lpage">7748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=7747-7748&issue=42&author=I.+V.+Ukrainetsauthor=P.+A.+Bezuglyauthor=S.+G.+Taranauthor=O.+V.+Gorokhovaauthor=A.+V.+Turov&title=Effective+Synthesis+of+3-%28Benzimidazol-2-yl%29-4-hydroxy-2-oxo-1%2C2-dihydroquinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUkrainets%26aufirst%3DI.%2BV.%26aulast%3DBezugly%26aufirst%3DP.%2BA.%26aulast%3DTaran%26aufirst%3DS.%2BG.%26aulast%3DGorokhova%26aufirst%3DO.%2BV.%26aulast%3DTurov%26aufirst%3DA.%2BV.%26atitle%3DEffective%2520Synthesis%2520of%25203-%2528Benzimidazol-2-yl%2529-4-hydroxy-2-oxo-1%252C2-dihydroquinolines%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26issue%3D42%26spage%3D7747%26epage%3D7748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ukrainets, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezugly, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorokhova, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treskach, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turov, A. V.</span><span> </span><span class="NLM_article-title">4-Hydroxy-2-quinolones. 7. Synthesis and biological properties of 1-<i>R</i>-3-(benzimidazolyl-2)-4-hydroxy-2-quinolones</span> <span class="citation_source-journal">Khim. Geterotsikl. Soedin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&pages=105-108&issue=1&author=I.+V.+Ukrainetsauthor=P.+A.+Bezuglyauthor=O.+V.+Gorokhovaauthor=V.+I.+Treskachauthor=A.+V.+Turov&title=4-Hydroxy-2-quinolones.+7.+Synthesis+and+biological+properties+of+1-R-3-%28benzimidazolyl-2%29-4-hydroxy-2-quinolones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUkrainets%26aufirst%3DI.%2BV.%26aulast%3DBezugly%26aufirst%3DP.%2BA.%26aulast%3DGorokhova%26aufirst%3DO.%2BV.%26aulast%3DTreskach%26aufirst%3DV.%2BI.%26aulast%3DTurov%26aufirst%3DA.%2BV.%26atitle%3D4-Hydroxy-2-quinolones.%25207.%2520Synthesis%2520and%2520biological%2520properties%2520of%25201-R-3-%2528benzimidazolyl-2%2529-4-hydroxy-2-quinolones%26jtitle%3DKhim.%2520Geterotsikl.%2520Soedin.%26date%3D1993%26issue%3D1%26spage%3D105%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Matei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coltea, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grecu, R.</span><span> </span><span class="NLM_article-title">Condensation of ethyl 2-benzimidazoleacetate with carbonyl compounds</span> <span class="citation_source-journal">Rev. Chim. (Bucharest, Rom.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADyaL38XlvVahu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1982&pages=527-530&issue=6&author=S.+Mateiauthor=J.+Russuauthor=P.+Colteaauthor=R.+Grecu&title=Condensation+of+ethyl+2-benzimidazoleacetate+with+carbonyl+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Condensation of ethyl 2-benzimidazoleacetate with carbonyl compounds</span></div><div class="casAuthors">Matei, Simion; Russu, Jana; Coltea, Petronela; Grecu, Rodica</div><div class="citationInfo"><span class="NLM_cas:title">Revistade Chimie (Bucharest, Romania)</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">527-30</span>CODEN:
                <span class="NLM_cas:coden">RCBUAU</span>;
        ISSN:<span class="NLM_cas:issn">0034-7752</span>.
    </div><div class="casAbstract">I (R = H, Me; R1 = H, Cl, Me) reacted with PhCHO to give II; III (Z = O, NH) were obtained from I (R1 = H) and 2-HOC6H4CHO or 2-H2NC6H4CHO resp.  I (R = R1 = H), PhCHO, and piperidine in EtOH was refluxed to give II (R = R1 = H).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZNxnFmXjrzrVg90H21EOLACvtfcHk0lj5KB6JNNnTHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XlvVahu78%253D&md5=0e5a6c60475629e05afa5f598787fc00</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatei%26aufirst%3DS.%26aulast%3DRussu%26aufirst%3DJ.%26aulast%3DColtea%26aufirst%3DP.%26aulast%3DGrecu%26aufirst%3DR.%26atitle%3DCondensation%2520of%2520ethyl%25202-benzimidazoleacetate%2520with%2520carbonyl%2520compounds%26jtitle%3DRev.%2520Chim.%2520%2528Bucharest%252C%2520Rom.%2529%26date%3D1982%26volume%3D33%26issue%3D6%26spage%3D527%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Ni, Z.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsanti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brammeier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diebes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poon, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfister, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renhowe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramurthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagman, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussiere, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesner, T. G.</span><span> </span><span class="NLM_article-title">4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3121</span><span class="NLM_x">–</span> <span class="NLM_lpage">3124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3121-3124&issue=12&author=Z.-J.+Niauthor=P.+Barsantiauthor=N.+Brammeierauthor=A.+Diebesauthor=D.+J.+Poonauthor=S.+Ngauthor=S.+Pecchiauthor=K.+Pfisterauthor=P.+A.+Renhoweauthor=S.+Ramurthyauthor=A.+S.+Wagmanauthor=D.+E.+Bussiereauthor=V.+Leauthor=Y.+Zhouauthor=J.+M.+Jansenauthor=S.+Maauthor=T.+G.+Gesner&title=4-%28Aminoalkylamino%29-3-benzimidazole-quinolinones+as+potent+CHK-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DZ.-J.%26aulast%3DBarsanti%26aufirst%3DP.%26aulast%3DBrammeier%26aufirst%3DN.%26aulast%3DDiebes%26aufirst%3DA.%26aulast%3DPoon%26aufirst%3DD.%2BJ.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DPecchi%26aufirst%3DS.%26aulast%3DPfister%26aufirst%3DK.%26aulast%3DRenhowe%26aufirst%3DP.%2BA.%26aulast%3DRamurthy%26aufirst%3DS.%26aulast%3DWagman%26aufirst%3DA.%2BS.%26aulast%3DBussiere%26aufirst%3DD.%2BE.%26aulast%3DLe%26aufirst%3DV.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DJansen%26aufirst%3DJ.%2BM.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DGesner%26aufirst%3DT.%2BG.%26atitle%3D4-%2528Aminoalkylamino%2529-3-benzimidazole-quinolinones%2520as%2520potent%2520CHK-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D12%26spage%3D3121%26epage%3D3124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Antonios-McCrea, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazier, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jazan, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machajewski, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renhowe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C.</span><span> </span><span class="NLM_article-title">LHMDS mediated tandem acylation-cyclization of 2-aminobenzenecarbonitriles with 2-benzymidazol-2-yl acetates: a short and efficient route to the synthesis of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=657-660&issue=5&author=W.+R.+Antonios-McCreaauthor=K.+A.+Frazierauthor=E.+M.+Jazanauthor=T.+D.+Machajewskiauthor=C.+M.+McBrideauthor=S.+Pecchiauthor=P.+A.+Renhoweauthor=C.+M.+Shaferauthor=C.+Taylor&title=LHMDS+mediated+tandem+acylation-cyclization+of+2-aminobenzenecarbonitriles+with+2-benzymidazol-2-yl+acetates%3A+a+short+and+efficient+route+to+the+synthesis+of+4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAntonios-McCrea%26aufirst%3DW.%2BR.%26aulast%3DFrazier%26aufirst%3DK.%2BA.%26aulast%3DJazan%26aufirst%3DE.%2BM.%26aulast%3DMachajewski%26aufirst%3DT.%2BD.%26aulast%3DMcBride%26aufirst%3DC.%2BM.%26aulast%3DPecchi%26aufirst%3DS.%26aulast%3DRenhowe%26aufirst%3DP.%2BA.%26aulast%3DShafer%26aufirst%3DC.%2BM.%26aulast%3DTaylor%26aufirst%3DC.%26atitle%3DLHMDS%2520mediated%2520tandem%2520acylation-cyclization%2520of%25202-aminobenzenecarbonitriles%2520with%25202-benzymidazol-2-yl%2520acetates%253A%2520a%2520short%2520and%2520efficient%2520route%2520to%2520the%2520synthesis%2520of%25204-amino-3-benzimidazol-2-ylhydroquinolin-2-ones%26jtitle%3DTetrahedron%2520Lett.%26date%3D2006%26volume%3D47%26issue%3D5%26spage%3D657%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Church, T. J.; Cutshall, N. S.; Gangloff, A. R.; Jenkins, T. E.; Linsell, M. S.; Litvak, J.; Rice, K. D.; Spencer, J. R.; Wang, V. R.</span><span> </span><span class="NLM_article-title">Preparation of compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity</span> Patent 9845275,<span class="NLM_x"> </span><span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=T.+J.+Church&author=N.+S.+Cutshall&author=A.+R.+Gangloff&author=T.+E.+Jenkins&author=M.+S.+Linsell&author=J.+Litvak&author=K.+D.+Rice&author=J.+R.+Spencer&author=V.+R.+Wang&title=Preparation+of+compounds+and+compositions+for+treating+diseases+associated+with+serine+protease%2C+particularly+tryptase%2C+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChurch%26aufirst%3DT.%2BJ.%26atitle%3DPreparation%2520of%2520compounds%2520and%2520compositions%2520for%2520treating%2520diseases%2520associated%2520with%2520serine%2520protease%252C%2520particularly%2520tryptase%252C%2520activity%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Klaubert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellstedt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guinosso, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capetola, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, S. C.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Aminophenyl)oxamic acids and esters as potent, orally active antiallergy agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00138a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1981&pages=742-748&issue=6&author=D.+H.+Klaubertauthor=J.+H.+Sellstedtauthor=C.+J.+Guinossoauthor=R.+J.+Capetolaauthor=S.+C.+Bell&title=N-%28Aminophenyl%29oxamic+acids+and+esters+as+potent%2C+orally+active+antiallergy+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00138a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00138a020%26sid%3Dliteratum%253Aachs%26aulast%3DKlaubert%26aufirst%3DD.%2BH.%26aulast%3DSellstedt%26aufirst%3DJ.%2BH.%26aulast%3DGuinosso%26aufirst%3DC.%2BJ.%26aulast%3DCapetola%26aufirst%3DR.%2BJ.%26aulast%3DBell%26aufirst%3DS.%2BC.%26atitle%3DN-%2528Aminophenyl%2529oxamic%2520acids%2520and%2520esters%2520as%2520potent%252C%2520orally%2520active%2520antiallergy%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1981%26volume%3D24%26issue%3D6%26spage%3D742%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Elslager, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werbel, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worth, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davoll, J.</span><span> </span><span class="NLM_article-title">Antimalarial drugs. 25. Folate antagonists. 3. 2,4-Diamino-6-(heterocyclic)quinazolines, a novel class of antimetabolites with potent antimalarial and antibacterial activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">836</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00278a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1972&pages=827-836&issue=8&author=E.+F.+Elslagerauthor=J.+Clarkeauthor=L.+M.+Werbelauthor=D.+F.+Worthauthor=J.+Davoll&title=Antimalarial+drugs.+25.+Folate+antagonists.+3.+2%2C4-Diamino-6-%28heterocyclic%29quinazolines%2C+a+novel+class+of+antimetabolites+with+potent+antimalarial+and+antibacterial+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm00278a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00278a008%26sid%3Dliteratum%253Aachs%26aulast%3DElslager%26aufirst%3DE.%2BF.%26aulast%3DClarke%26aufirst%3DJ.%26aulast%3DWerbel%26aufirst%3DL.%2BM.%26aulast%3DWorth%26aufirst%3DD.%2BF.%26aulast%3DDavoll%26aufirst%3DJ.%26atitle%3DAntimalarial%2520drugs.%252025.%2520Folate%2520antagonists.%25203.%25202%252C4-Diamino-6-%2528heterocyclic%2529quinazolines%252C%2520a%2520novel%2520class%2520of%2520antimetabolites%2520with%2520potent%2520antimalarial%2520and%2520antibacterial%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1972%26volume%3D15%26issue%3D8%26spage%3D827%26epage%3D836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><div class="note"><p class="first last">At pH 7, the solubility of <b>8c</b> was <0.030 μg/mL while the solubility of <b>16c</b> was 107 μg/mL</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=At+pH+7%2C+the+solubility+of+8c+was+%3C0.030+%CE%BCg%2FmL+while+the+solubility+of+16c+was+107+%CE%BCg%2FmL."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><div class="note"><p class="first last">Unpublished results</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Features of Selective Kinase Inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&issue=6&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+Selective+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0ljS_l_L6ojOiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520Selective%2520Kinase%2520Inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26issue%3D6%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Wiesmann, M.; Lee, S. H.; LaPointe, G.; Javandel, M.; Heise, C.; Renhowe, P.; Wernette-Hammond, M.-E.; Gesner, T.; Harrison, S.; Harris, A. L.</span> In  <span class="citation_source-book">In Vitro Characterization of a Potent Tyrosine Kinase Inhibitor, CHIR258, That Modulates Angiogenesis and Proliferation of Selected Cancer Cell Lines</span>, <span class="NLM_publisher-name">American Association of Cancer Research</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=M.+Wiesmann&author=S.+H.+Lee&author=G.+LaPointe&author=M.+Javandel&author=C.+Heise&author=P.+Renhowe&author=M.-E.+Wernette-Hammond&author=T.+Gesner&author=S.+Harrison&author=A.+L.+Harris&title=In+Vitro+Characterization+of+a+Potent+Tyrosine+Kinase+Inhibitor%2C+CHIR258%2C+That+Modulates+Angiogenesis+and+Proliferation+of+Selected+Cancer+Cell+Lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWiesmann%26aufirst%3DM.%26btitle%3DIn%2520Vitro%2520Characterization%2520of%2520a%2520Potent%2520Tyrosine%2520Kinase%2520Inhibitor%252C%2520CHIR258%252C%2520That%2520Modulates%2520Angiogenesis%2520and%2520Proliferation%2520of%2520Selected%2520Cancer%2520Cell%2520Lines%26pub%3DAmerican%2520Association%2520of%2520Cancer%2520Research%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><div class="note"><p class="first last">Additional modeling information can be found in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Additional+modeling+information+can+be+found+in+the+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Cowan-Jacob, S. W.</span><span> </span><span class="NLM_article-title">Structural biology of protein tyrosine kinases</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">2608</span><span class="NLM_x">–</span> <span class="NLM_lpage">2625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1007%2Fs00018-006-6202-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm800790t&amp;key=17041812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWqtr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2006&pages=2608-2625&issue=22&author=S.+W.+Cowan-Jacob&title=Structural+biology+of+protein+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structural biology of protein tyrosine kinases</span></div><div class="casAuthors">Cowan-Jacob, S. W.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2608-2625</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  The current understanding of the structure, reaction mechanism, and modes of regulation of the protein tyrosine kinase family owes a great deal to structural biol.  Structures are now available for >20 different tyrosine kinase domains, many of these in multiple conformational states.  They form the basis for the design of expts. to further investigate the role of different structural elements in the normal function and regulation of the protein and in the pathogenesis of many human diseases.  Once thought to be too similar to be specifically inhibited by a small mol., structural differences between kinases allow the design of compds. which inhibit only an acceptable few.  Here, the author provides a general overview of protein tyrosine kinase structural biol., including a discussion of the strengths and limitations of the investigative methods involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2S0MIZlhimLVg90H21EOLACvtfcHk0ljS_l_L6ojOiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWqtr%252FF&md5=a21a90ccdda010e192aef7519d717e10</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs00018-006-6202-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-006-6202-8%26sid%3Dliteratum%253Aachs%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26atitle%3DStructural%2520biology%2520of%2520protein%2520tyrosine%2520kinases%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2006%26volume%3D63%26issue%3D22%26spage%3D2608%26epage%3D2625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Vogtherr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimme, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieborr, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescatore, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delarbre, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, K. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwalbe, H.</span><span> </span><span class="NLM_article-title">NMR characterization of kinase p38 dynamics in free and ligand-bound forms</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=993-997&issue=6&author=M.+Vogtherrauthor=K.+Saxenaauthor=S.+Hoelderauthor=S.+Grimmeauthor=M.+Betzauthor=U.+Schieborrauthor=B.+Pescatoreauthor=M.+Robinauthor=L.+Delarbreauthor=T.+Langerauthor=K.+U.+Wendtauthor=H.+Schwalbe&title=NMR+characterization+of+kinase+p38+dynamics+in+free+and+ligand-bound+forms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVogtherr%26aufirst%3DM.%26aulast%3DSaxena%26aufirst%3DK.%26aulast%3DHoelder%26aufirst%3DS.%26aulast%3DGrimme%26aufirst%3DS.%26aulast%3DBetz%26aufirst%3DM.%26aulast%3DSchieborr%26aufirst%3DU.%26aulast%3DPescatore%26aufirst%3DB.%26aulast%3DRobin%26aufirst%3DM.%26aulast%3DDelarbre%26aufirst%3DL.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DWendt%26aufirst%3DK.%2BU.%26aulast%3DSchwalbe%26aufirst%3DH.%26atitle%3DNMR%2520characterization%2520of%2520kinase%2520p38%2520dynamics%2520in%2520free%2520and%2520ligand-bound%2520forms%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26issue%3D6%26spage%3D993%26epage%3D997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bold, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guagnano, V.</span><span> </span><span class="NLM_article-title">Aromatic Interactions with Phenylalanine 691 and Cysteine 828: A Concept for FMS-like Tyrosine Kinase-3 Inhibition. Application to the Discovery of a New Class of Potential Antileukemia Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4451</span><span class="NLM_x">–</span> <span class="NLM_lpage">4454</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060368s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4451-4454&issue=15&author=P.+Furetauthor=G.+Boldauthor=T.+Meyerauthor=J.+Roeselauthor=V.+Guagnano&title=Aromatic+Interactions+with+Phenylalanine+691+and+Cysteine+828%3A+A+Concept+for+FMS-like+Tyrosine+Kinase-3+Inhibition.+Application+to+the+Discovery+of+a+New+Class+of+Potential+Antileukemia+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm060368s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060368s%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DBold%26aufirst%3DG.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DRoesel%26aufirst%3DJ.%26aulast%3DGuagnano%26aufirst%3DV.%26atitle%3DAromatic%2520Interactions%2520with%2520Phenylalanine%2520691%2520and%2520Cysteine%2520828%253A%2520A%2520Concept%2520for%2520FMS-like%2520Tyrosine%2520Kinase-3%2520Inhibition.%2520Application%2520to%2520the%2520Discovery%2520of%2520a%2520New%2520Class%2520of%2520Potential%2520Antileukemia%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D15%26spage%3D4451%26epage%3D4454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><div class="note"><p class="first last">Compound <b>5</b> was analyzed in plasma using a qualified LC/MS/MS method with a calibration range of 1−8000 ng/mL, as described previously (Lee, S. H. et al. <i>Clin. Cancer Res.</i><b>2005</b>, <i>11</i>, 3633−3641). Average concentration−time data was subject to PK analyses using standard noncompartmental methods using WinNonlin software (Pharsight Corporation, Mountain View, CA)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Compound+5+was+analyzed+in+plasma+using+a+qualified+LC%2FMS%2FMS+method+with+a+calibration+range+of+1%E2%88%928000+ng%2FmL%2C+as+described+previously+%28Lee%2C+S.+H.+et+al.+Clin.+Cancer+Res.2005%2C+11%2C+3633%E2%88%923641%29.+Average+concentration%E2%88%92time+data+was+subject+to+PK+analyses+using+standard+noncompartmental+methods+using+WinNonlin+software+%28Pharsight+Corporation%2C+Mountain+View%2C+CA%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Harris, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowden, K.</span><span> </span><span class="NLM_article-title">Antifolate and antibacterial activities of 6-substituted 2,4-diaminoquinazolines</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1992&pages=7-18&issue=1&author=N.+V.+Harrisauthor=C.+Smithauthor=K.+Bowden&title=Antifolate+and+antibacterial+activities+of+6-substituted+2%2C4-diaminoquinazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DN.%2BV.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DBowden%26aufirst%3DK.%26atitle%3DAntifolate%2520and%2520antibacterial%2520activities%2520of%25206-substituted%25202%252C4-diaminoquinazolines%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1992%26volume%3D27%26issue%3D1%26spage%3D7%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase inhibitors for potential use in Alzheimer’s disease: molecular modeling, synthesis and kinetic evaluation of 11<i>H</i>-indeno-[1,2-<i>b</i>]-quinolin-10-ylamine derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2000&pages=497-506&issue=3&author=A.+Rampaauthor=A.+Bisiauthor=F.+Bellutiauthor=S.+Gobbiauthor=P.+Valentiauthor=V.+Andrisanoauthor=V.+Cavriniauthor=A.+Cavalliauthor=M.+Recanatini&title=Acetylcholinesterase+inhibitors+for+potential+use+in+Alzheimer%E2%80%99s+disease%3A+molecular+modeling%2C+synthesis+and+kinetic+evaluation+of+11H-indeno-%5B1%2C2-b%5D-quinolin-10-ylamine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3DAcetylcholinesterase%2520inhibitors%2520for%2520potential%2520use%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520molecular%2520modeling%252C%2520synthesis%2520and%2520kinetic%2520evaluation%2520of%252011H-indeno-%255B1%252C2-b%255D-quinolin-10-ylamine%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2000%26volume%3D8%26issue%3D3%26spage%3D497%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Badawey, E. S. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rida, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soliman, F. S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kappe, T.</span><span> </span><span class="NLM_article-title">Benzimidazole condensed ring systems. 4. New approaches to the synthesis of substituted pyrimido[1,6-<i>a</i>]benzimidazole-1,3(2<i>H</i>,5<i>H</i>)-diones</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1989&pages=405-408&issue=2&author=E.+S.+A.+M.+Badaweyauthor=S.+M.+Ridaauthor=F.+S.+G.+Solimanauthor=T.+Kappe&title=Benzimidazole+condensed+ring+systems.+4.+New+approaches+to+the+synthesis+of+substituted+pyrimido%5B1%2C6-a%5Dbenzimidazole-1%2C3%282H%2C5H%29-diones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBadawey%26aufirst%3DE.%2BS.%2BA.%2BM.%26aulast%3DRida%26aufirst%3DS.%2BM.%26aulast%3DSoliman%26aufirst%3DF.%2BS.%2BG.%26aulast%3DKappe%26aufirst%3DT.%26atitle%3DBenzimidazole%2520condensed%2520ring%2520systems.%25204.%2520New%2520approaches%2520to%2520the%2520synthesis%2520of%2520substituted%2520pyrimido%255B1%252C6-a%255Dbenzimidazole-1%252C3%25282H%252C5H%2529-diones%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1989%26volume%3D26%26issue%3D2%26spage%3D405%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Self, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillings, M. R.</span><span> </span><span class="NLM_article-title">Cine and tele substitutions in the reaction of 2,3-dinitroaniline with secondary amines</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1980&pages=281-282&issue=6&author=D.+P.+Selfauthor=D.+E.+Westauthor=M.+R.+Stillings&title=Cine+and+tele+substitutions+in+the+reaction+of+2%2C3-dinitroaniline+with+secondary+amines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSelf%26aufirst%3DD.%2BP.%26aulast%3DWest%26aufirst%3DD.%2BE.%26aulast%3DStillings%26aufirst%3DM.%2BR.%26atitle%3DCine%2520and%2520tele%2520substitutions%2520in%2520the%2520reaction%2520of%25202%252C3-dinitroaniline%2520with%2520secondary%2520amines%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1980%26issue%3D6%26spage%3D281%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Crosby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moilliet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parratt, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. J.</span><span> </span><span class="NLM_article-title">Regioselective hydrolysis of aromatic dinitriles using a whole cell catalyst</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1679</span><span class="NLM_x">–</span> <span class="NLM_lpage">1687</span><div class="note"><p class="first last">1972−1999.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1994&pages=1679-1687&author=J.+Crosbyauthor=J.+Moillietauthor=J.+S.+Parrattauthor=N.+J.+Turner&title=Regioselective+hydrolysis+of+aromatic+dinitriles+using+a+whole+cell+catalyst"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrosby%26aufirst%3DJ.%26aulast%3DMoilliet%26aufirst%3DJ.%26aulast%3DParratt%26aufirst%3DJ.%2BS.%26aulast%3DTurner%26aufirst%3DN.%2BJ.%26atitle%3DRegioselective%2520hydrolysis%2520of%2520aromatic%2520dinitriles%2520using%2520a%2520whole%2520cell%2520catalyst%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1994%26volume%3D13%26spage%3D1679%26epage%3D1687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Adachi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugasawa, T.</span><span> </span><span class="NLM_article-title">Exclusive ortho cyanation and alkylthiocarbonylation of anilines and phenols using boron trichloride</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm800790t&amp;key=10.1080%2F00397919008054617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm800790t&amp;key=1%3ACAS%3A528%3ADyaK3cXhvFOkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1990&pages=71-84&issue=1&author=M.+Adachiauthor=T.+Sugasawa&title=Exclusive+ortho+cyanation+and+alkylthiocarbonylation+of+anilines+and+phenols+using+boron+trichloride"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Exclusive ortho cyanation and alkylthiocarbonylation of anilines and phenols using boron trichloride</span></div><div class="casAuthors">Adachi, Makoto; Sugasawa, Tsutomu</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-84</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">BCl3 with or without an addnl. Lewis acid is used in a one-pot synthesis of 2-cyano- and 2-alkylthiocarbonylanilines and -phenols.  Thus, treating RC6H4NHR1 (R = H, 3-Me, 4-Cl, 3-F, 4-OMe, R1 = H, Me, Ph, CH2Ph) with BCl3 in the presence of AlCl3, followed by reaction with Cl3CCN or R2SCN (R2 = Me, CH2Ph, Bu) and work-up with 4N NaOH or water, gave 2-cyanoanilines I or 2-(alkylthiocarbonyl)anilines II, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5VPl0R71i-7Vg90H21EOLACvtfcHk0lhGIc-bfIwJpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhvFOkurw%253D&md5=e6da99387aba222829878184b42b2503</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1080%2F00397919008054617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919008054617%26sid%3Dliteratum%253Aachs%26aulast%3DAdachi%26aufirst%3DM.%26aulast%3DSugasawa%26aufirst%3DT.%26atitle%3DExclusive%2520ortho%2520cyanation%2520and%2520alkylthiocarbonylation%2520of%2520anilines%2520and%2520phenols%2520using%2520boron%2520trichloride%26jtitle%3DSynth.%2520Commun.%26date%3D1990%26volume%3D20%26issue%3D1%26spage%3D71%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Achab, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morral, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banos, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivas, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">4657</span><span class="NLM_x">–</span> <span class="NLM_lpage">4666</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000980y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4657-4666&issue=24&author=P.+Campsauthor=R.+El+Achabauthor=J.+Morralauthor=D.+Munoz-Torreroauthor=A.+Badiaauthor=J.+E.+Banosauthor=N.+M.+Vivasauthor=X.+Barrilauthor=M.+Orozcoauthor=F.+J.+Luque&title=New+tacrine-huperzine+A+hybrids+%28huprines%29%3A+highly+potent+tight-binding+acetylcholinesterase+inhibitors+of+interest+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm000980y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000980y%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DEl%2BAchab%26aufirst%3DR.%26aulast%3DMorral%26aufirst%3DJ.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DBanos%26aufirst%3DJ.%2BE.%26aulast%3DVivas%26aufirst%3DN.%2BM.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DNew%2520tacrine-huperzine%2520A%2520hybrids%2520%2528huprines%2529%253A%2520highly%2520potent%2520tight-binding%2520acetylcholinesterase%2520inhibitors%2520of%2520interest%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D24%26spage%3D4657%26epage%3D4666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FGI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FGI','PDB','2FGI'); return false;">PDB: 2FGI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GDO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GDO','PDB','2GDO'); return false;">PDB: 2GDO</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i93"><a href="/doi/suppl/10.1021/jm800790t">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82066"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis data or high resolution mass spectrometry data for key compounds, MS, HPLC traces, and <sup>1</sup>H NMR for <b>5</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800790t/suppl_file/jm800790t_si_001.pdf">jm800790t_si_001.pdf (417.7 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm800790t&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm800790t%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-2%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm800790t" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                506KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995969d9331991","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
